[
  {
    "eunumber": 1,
    "emanumber": "71",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Follitropin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 137,
    "authorisationactivetime": 107,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Belgium",
    "decisiondate": "1995-10-20",
    "brandname": "GONAL-f",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 2,
    "emanumber": "73",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 193,
    "authorisationactivetime": 100,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "1995-11-27",
    "brandname": "Taxotere",
    "mah": "Sanofi Mature IP",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 3,
    "emanumber": "81",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon beta-1b",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 193,
    "authorisationactivetime": 138,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "1995-11-30",
    "brandname": "Betaferon",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 4,
    "emanumber": "91",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "Toremifene",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 290,
    "authorisationactivetime": 240,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "1996-02-14",
    "brandname": "Fareston",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 5,
    "emanumber": "82",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Mycophenolate mofetil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 290,
    "authorisationactivetime": 243,
    "authorisationstoppedtime": 47,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "1996-02-14",
    "brandname": "CellCept",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 6,
    "emanumber": "74",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Eptacog alfa (activated)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 290,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "1996-02-23",
    "brandname": "NovoSeven",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 7,
    "emanumber": "88",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 326,
    "authorisationactivetime": 245,
    "authorisationstoppedtime": 81,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "unknown",
    "decisiondate": "1996-04-30",
    "brandname": "Humalog",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 8,
    "emanumber": "86",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "follitropin beta",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 354,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 151,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "1996-05-03",
    "brandname": "Puregon",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 9,
    "emanumber": "110",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Stavudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 150,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Luxembourg",
    "decisiondate": "1996-05-08",
    "brandname": "Zerit",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 10,
    "emanumber": "109",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Riluzole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 202,
    "authorisationactivetime": 161,
    "authorisationstoppedtime": 41,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "1996-06-10",
    "brandname": "Rilutek",
    "mah": "Sanofi Mature IP",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 11,
    "emanumber": "89",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Doxorubicin hydrochloride",
    "legalbasis": "article 4.8a(3)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 222,
    "authorisationstoppedtime": 150,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "unknown",
    "decisiondate": "1996-06-21",
    "brandname": "Caelyx pegylated liposomal",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 12,
    "emanumber": "101",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 255,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 52,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "1996-06-25",
    "brandname": "Bondronat",
    "mah": "Atnahs Pharma Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 13,
    "emanumber": "103",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 255,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 52,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "1996-06-25",
    "brandname": "Destara",
    "mah": "Roche Registration Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 14,
    "emanumber": "93",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "DTPW-Hepatitis B",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 240,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "1996-07-19",
    "brandname": "Tritanrix HepB",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 15,
    "emanumber": "107",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Lamivudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 255,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "1996-08-08",
    "brandname": "Epivir",
    "mah": "ViiV Healthcare B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 16,
    "emanumber": "127",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Ritonavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 69,
    "authorisationactivetime": 69,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Luxembourg",
    "decisiondate": "1996-08-26",
    "brandname": "Norvir",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 17,
    "emanumber": "106",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Reteplase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 287,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 83,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "1996-08-29",
    "brandname": "Ecokinase",
    "mah": "Galenus Mannheim GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 18,
    "emanumber": "105",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Reteplase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 287,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 83,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "1996-08-29",
    "brandname": "Rapilysin",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 19,
    "emanumber": "68",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Anti-melanoma Mab fragments",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 507,
    "authorisationactivetime": 187,
    "authorisationstoppedtime": 320,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "1996-09-05",
    "brandname": "Tecnemab-K-1",
    "mah": "Sorin Radiofarmaci S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 20,
    "emanumber": "112",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Hepatitis A and hepatitis B vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 280,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 83,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "1996-09-20",
    "brandname": "Twinrix Adult",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 21,
    "emanumber": "114",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 254,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "France",
    "decisiondate": "1996-10-07",
    "brandname": "Olansek",
    "mah": "Eli Lilly UK Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 22,
    "emanumber": "115",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 254,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "France",
    "decisiondate": "1996-09-27",
    "brandname": "Zyprexa",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 23,
    "emanumber": "41",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Arcitumomab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 496,
    "authorisationactivetime": 110,
    "authorisationstoppedtime": 386,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "1996-10-04",
    "brandname": "CEA-Scan",
    "mah": "Immunomedics GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 24,
    "emanumber": "128",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Indinavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 97,
    "authorisationactivetime": 85,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "1996-10-04",
    "brandname": "Crixivan",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 25,
    "emanumber": "65",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Igovomab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 517,
    "authorisationactivetime": 154,
    "authorisationstoppedtime": 363,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "1996-10-04",
    "brandname": "Indimacis 125",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 26,
    "emanumber": "113",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Saquinavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Sweden",
    "decisiondate": "1996-10-04",
    "brandname": "Invirase",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 27,
    "emanumber": "123",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Topotecan hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 182,
    "authorisationactivetime": 154,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Finland",
    "decisiondate": "1996-11-12",
    "brandname": "Hycamtin",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 28,
    "emanumber": "124",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Topotecan hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 182,
    "authorisationactivetime": 154,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Finland",
    "decisiondate": "1996-12-09",
    "brandname": "Evotopin",
    "mah": "SmithKline Beecham plc",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 29,
    "emanumber": "129",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Hepatitis A and hepatitis B vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 167,
    "authorisationactivetime": 132,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "1997-02-10",
    "brandname": "Twinrix Paediatric",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 30,
    "emanumber": "201",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "human insulin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 340,
    "authorisationactivetime": 158,
    "authorisationstoppedtime": 182,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Netherlands",
    "decisiondate": "1997-02-21",
    "brandname": "Insuman",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 31,
    "emanumber": "116",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "Epoetin beta",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 349,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 140,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "1997-07-16",
    "brandname": "NeoRecormon",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 32,
    "emanumber": "111",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Sulesomab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "1997-02-14",
    "brandname": "LeukoScan",
    "mah": "Immunomedics GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 33,
    "emanumber": "102",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon Beta - 1a",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 523,
    "authorisationactivetime": 216,
    "authorisationstoppedtime": 307,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "1997-03-13",
    "brandname": "Avonex",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 34,
    "emanumber": "120",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ganciclovir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "1997-03-18",
    "brandname": "Vitrasert implant",
    "mah": "Dr Gerhard Mann Chem.-pharm. Fabrik GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 35,
    "emanumber": "122",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Lepirudin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 312,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "1997-03-13",
    "brandname": "Refludan",
    "mah": "Celgene Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 36,
    "emanumber": "138",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 0,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "unknown",
    "decisiondate": "1997-06-16",
    "brandname": "Humalog-Humaject",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 37,
    "emanumber": "121",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Cidofovir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 321,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "United Kingdom",
    "decisiondate": "1997-04-23",
    "brandname": "Vistide",
    "mah": "Gilead Sciences International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 38,
    "emanumber": "143",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 48,
    "authorisationactivetime": 48,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "unknown",
    "decisiondate": "1997-05-07",
    "brandname": "Liprolog",
    "mah": "Eli Lilly UK Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 39,
    "emanumber": "125",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Mercaptamine bitartrate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "1997-06-23",
    "brandname": "Cystagon",
    "mah": "Recordati Rare Diseases",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 40,
    "emanumber": "137",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Mangafodipir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 198,
    "authorisationactivetime": 171,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Netherlands",
    "decisiondate": "1997-05-22",
    "brandname": "Teslascan",
    "mah": "GE Healthcare AS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 41,
    "emanumber": "77",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Levacetylmethadol",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 688,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 487,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "unknown",
    "decisiondate": "1997-07-01",
    "brandname": "Orlaam",
    "mah": "Sipaco Internacional Lda",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 42,
    "emanumber": "153",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 0,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "unknown",
    "decisiondate": "1997-06-16",
    "brandname": "Humalog-Pen",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 43,
    "emanumber": "104",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Desirudin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 579,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 398,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "1997-07-09",
    "brandname": "Revasc",
    "mah": "Canyon Pharmaceuticals Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 44,
    "emanumber": "132",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "Tolcapone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 170,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Sweden",
    "decisiondate": "1997-08-27",
    "brandname": "Tasmar",
    "mah": "Meda AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 45,
    "emanumber": "140",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V04",
    "activesubstance": "¬π¬≥C - urea",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 162,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Netherlands",
    "decisiondate": "1997-08-14",
    "brandname": "Helicobacter Test INFAI",
    "mah": "INFAI GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 46,
    "emanumber": "141",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 163,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "1997-08-27",
    "brandname": "Aprovel",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 47,
    "emanumber": "139",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Nonacog alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 217,
    "authorisationactivetime": 162,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "1997-08-27",
    "brandname": "BeneFIX",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 48,
    "emanumber": "126",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphteria, tetanus, acellular pertussis and hepatitis B",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 416,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 217,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "1997-07-30",
    "brandname": "Infanrix HepB",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 49,
    "emanumber": "142",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 163,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "1997-08-27",
    "brandname": "Karvea",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 50,
    "emanumber": "133",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 349,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Finland",
    "decisiondate": "1997-10-14",
    "brandname": "Sifrol",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 51,
    "emanumber": "134",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 349,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Finland",
    "decisiondate": "1998-02-23",
    "brandname": "Mirapexin",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 52,
    "emanumber": "135",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 349,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Finland",
    "decisiondate": "1997-10-27",
    "brandname": "Daquiran",
    "mah": "Dr Karl Thomae GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 53,
    "emanumber": "157",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "imiglucerase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 205,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "1997-11-17",
    "brandname": "Cerezyme",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 54,
    "emanumber": "164",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Nelfinavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 214,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "1998-01-22",
    "brandname": "Viracept",
    "mah": "Roche Registration Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 55,
    "emanumber": "183",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "nevirapine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 125,
    "authorisationactivetime": 125,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "1998-02-05",
    "brandname": "Viramune",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 56,
    "emanumber": "156",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "diphteria, tetanus and hepatitis B (recombinant) vaccine, adsorbed",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 269,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 68,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "France",
    "decisiondate": "1998-02-05",
    "brandname": "Primavax",
    "mah": "Aventis Pasteur MSD",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 57,
    "emanumber": "150",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "Samarium [153 Sm] lexidronam pentasodium",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 293,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 95,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "1998-02-05",
    "brandname": "Quadramet",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 58,
    "emanumber": "190",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "lamivudine / zidovudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 119,
    "authorisationactivetime": 119,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "1998-03-18",
    "brandname": "Combivir",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 59,
    "emanumber": "160",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "trovafloxacin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "1998-07-03",
    "brandname": "Trovan",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 60,
    "emanumber": "161",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "alatrofloxacin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "1998-07-03",
    "brandname": "Trovan IV",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 61,
    "emanumber": "158",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "trovafloxacin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "1998-07-08",
    "brandname": "Turvel",
    "mah": "Roerig Farmaceutici Italiana S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 62,
    "emanumber": "159",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "alatrofloxacin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "1998-07-03",
    "brandname": "Turvel IV",
    "mah": "Roerig Farmaceutici Italiana S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 63,
    "emanumber": "136",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon beta-1a",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 466,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 285,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Greece",
    "decisiondate": "1998-05-04",
    "brandname": "Rebif",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 64,
    "emanumber": "151",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V04",
    "activesubstance": "¬π¬≥C-urea",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 321,
    "authorisationactivetime": 163,
    "authorisationstoppedtime": 158,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "1998-05-07",
    "brandname": "Pylobactell",
    "mah": "Torbet Laboratories Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 65,
    "emanumber": "166",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Perflutren",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 314,
    "authorisationactivetime": 192,
    "authorisationstoppedtime": 122,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "1998-05-18",
    "brandname": "Optison",
    "mah": "GE Healthcare AS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 66,
    "emanumber": "169",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 283,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "1998-05-12",
    "brandname": "Exelon",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 67,
    "emanumber": "165",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 311,
    "authorisationactivetime": 179,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "1998-06-02",
    "brandname": "Mabthera",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 68,
    "emanumber": "182",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V04",
    "activesubstance": "¬π¬≥C-urea",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 250,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "1998-06-15",
    "brandname": "Pylori-Chek",
    "mah": "Alimentarics B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 69,
    "emanumber": "174",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 312,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "1998-07-15",
    "brandname": "Plavix",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 70,
    "emanumber": "175",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 312,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "1998-07-15",
    "brandname": "Iscover",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 71,
    "emanumber": "154",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A08",
    "activesubstance": "Orlistat",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 438,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 255,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Greece",
    "decisiondate": "1998-07-29",
    "brandname": "Xenical",
    "mah": "CHEPLAPHARM Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 72,
    "emanumber": "149",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Dodecafluoropentane",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 446,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 270,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "1998-07-17",
    "brandname": "EchoGen",
    "mah": "Sonus Pharmaceuticals Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 73,
    "emanumber": "184",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Raloxifene hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Belgium",
    "decisiondate": "1998-08-05",
    "brandname": "Evista",
    "mah": "SUBSTIPHARM",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 74,
    "emanumber": "185",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Raloxifene hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Belgium",
    "decisiondate": "1998-08-05",
    "brandname": "Optruma",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 75,
    "emanumber": "178",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Saquinavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 306,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Sweden",
    "decisiondate": "1998-08-20",
    "brandname": "Fortovase",
    "mah": "Roche Registration Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 76,
    "emanumber": "187",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 296,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Luxembourg",
    "decisiondate": "1998-08-17",
    "brandname": "NovoNorm",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 77,
    "emanumber": "202",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 216,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "1998-09-14",
    "brandname": "Viagra",
    "mah": "Upjohn EESV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 78,
    "emanumber": "204",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 216,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "1998-09-15",
    "brandname": "Patrex",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 79,
    "emanumber": "180",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D06",
    "activesubstance": "Imiquimod",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 341,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "1998-09-18",
    "brandname": "Zartra",
    "mah": "Laboratoires 3M Sant√©",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 80,
    "emanumber": "179",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D06",
    "activesubstance": "Imiquimod",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 341,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "1998-09-18",
    "brandname": "Aldara",
    "mah": "Meda AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 81,
    "emanumber": "171",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "entacapone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 402,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Luxembourg",
    "decisiondate": "1998-09-22",
    "brandname": "Comtan",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 82,
    "emanumber": "170",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "entacapone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 402,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Luxembourg",
    "decisiondate": "1998-09-16",
    "brandname": "Comtess",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 83,
    "emanumber": "145",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "votumumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 552,
    "authorisationactivetime": 145,
    "authorisationstoppedtime": 407,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "1998-09-25",
    "brandname": "HumaSPECT",
    "mah": "KS Biomedix Llmited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 84,
    "emanumber": "207",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "basiliximab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 244,
    "authorisationactivetime": 153,
    "authorisationstoppedtime": 91,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "1998-10-09",
    "brandname": "Simulect",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 85,
    "emanumber": "221",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 216,
    "authorisationactivetime": 153,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "1998-10-16",
    "brandname": "Karvezide",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 86,
    "emanumber": "222",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 216,
    "authorisationactivetime": 153,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "1998-10-15",
    "brandname": "CoAprovel",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 87,
    "emanumber": "186",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon alfacon-1",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 363,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "1999-02-01",
    "brandname": "Infergen",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 88,
    "emanumber": "181",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "combined diphtheria, tetanus, and acellular pertussis vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 397,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "1999-01-11",
    "brandname": "Triacelluvax",
    "mah": "Chiron spa",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 89,
    "emanumber": "210",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "1998-12-11",
    "brandname": "Pritor",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 90,
    "emanumber": "209",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "1998-12-16",
    "brandname": "Micardis",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 91,
    "emanumber": "211",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "1998-12-16",
    "brandname": "Kinzalmono",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 92,
    "emanumber": "255",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 4.8a(1)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 53,
    "authorisationactivetime": 53,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "1998-12-04",
    "brandname": "Prometax",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 93,
    "emanumber": "197",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Calcitonin (salmon)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "1999-01-11",
    "brandname": "Forcaltonin",
    "mah": "Unigene UK Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 95,
    "emanumber": "223",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "emedastine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "1999-01-27",
    "brandname": "Emadine",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 96,
    "emanumber": "229",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 263,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 60,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "1999-01-26",
    "brandname": "Temodal",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 97,
    "emanumber": "206",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Tasonermin (Tumor Necrosis Factor alfa-1a)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 392,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "1999-04-13",
    "brandname": "Beromun",
    "mah": "BELPHARMA s.a.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 98,
    "emanumber": "198",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "daclizumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 419,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 214,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Sweden",
    "decisiondate": "1999-02-26",
    "brandname": "Zenapax",
    "mah": "Roche Registration Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 99,
    "emanumber": "228",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Zaleplon",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Greece",
    "decisiondate": "1999-03-12",
    "brandname": "Zerene",
    "mah": "Meda AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 100,
    "emanumber": "233",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Cetrorelix (as acetate)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 294,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 121,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "1999-04-13",
    "brandname": "Cetrotide",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 101,
    "emanumber": "212",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D03",
    "activesubstance": "becaplermin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 391,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 203,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "1999-03-29",
    "brandname": "Regranex",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 102,
    "emanumber": "227",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Zaleplon",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Greece",
    "decisiondate": "1999-03-12",
    "brandname": "Sonata",
    "mah": "Meda AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 103,
    "emanumber": "232",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Moroctocog alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 294,
    "authorisationactivetime": 146,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Norway",
    "decisiondate": "1999-04-13",
    "brandname": "ReFacto AF",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 104,
    "emanumber": "231",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Haemophilus b conjugate (Meningococcal Protein conjugate) and Hepatitis B vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 328,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "1999-05-07",
    "brandname": "Procomvax",
    "mah": "Sanofi Pasteur MSD, SNC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 105,
    "emanumber": "192",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Rotavirus vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 568,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 393,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "1999-05-07",
    "brandname": "RotaShield",
    "mah": "Wyeth-Lederle Vaccines S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 106,
    "emanumber": "247",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 185,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "1999-05-07",
    "brandname": "Cotronak",
    "mah": "Schering-Plough Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 107,
    "emanumber": "246",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 242,
    "authorisationactivetime": 185,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "1999-05-07",
    "brandname": "Rebetol",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 108,
    "emanumber": "236",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Deferiprone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 335,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "1999-08-25",
    "brandname": "Ferriprox",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 109,
    "emanumber": "230",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Eptifibatide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 389,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "1999-07-01",
    "brandname": "Integrilin",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 110,
    "emanumber": "249",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 210,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Sweden",
    "decisiondate": "1999-05-28",
    "brandname": "Sustiva",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 111,
    "emanumber": "250",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 210,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Sweden",
    "decisiondate": "1999-05-28",
    "brandname": "Stocrin",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 112,
    "emanumber": "252",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "abacavir sulfate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 238,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "1999-07-08",
    "brandname": "Ziagen",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 113,
    "emanumber": "216",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "paclitaxel",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 430,
    "authorisationactivetime": 179,
    "authorisationstoppedtime": 251,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Sweden",
    "decisiondate": "1999-07-19",
    "brandname": "Paxene",
    "mah": "Norton Healthcare Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 114,
    "emanumber": "242",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Lamivudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 361,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "1999-07-29",
    "brandname": "Zeffix",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 115,
    "emanumber": "244",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Fomivirsen",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 141,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "1999-07-29",
    "brandname": "Vitravene",
    "mah": "Novartis Ophtalmics Europe Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 116,
    "emanumber": "240",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "infliximab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 444,
    "authorisationactivetime": 185,
    "authorisationstoppedtime": 259,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "1999-08-13",
    "brandname": "Remicade",
    "mah": "Janssen Biologics B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 117,
    "emanumber": "257",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "palivizumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 269,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 95,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "1999-08-13",
    "brandname": "Synagis",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 118,
    "emanumber": "235",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 445,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 259,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "1999-09-02",
    "brandname": "Arava",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 119,
    "emanumber": "258",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin aspart",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 241,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "1999-09-07",
    "brandname": "NovoRapid",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 120,
    "emanumber": "219",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Sodium phenylbutyrate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 670,
    "authorisationactivetime": 189,
    "authorisationstoppedtime": 481,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Greece",
    "decisiondate": "1999-12-08",
    "brandname": "Ammonaps",
    "mah": "Immedica Pharma AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 121,
    "emanumber": "238",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Dofetilide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 179,
    "authorisationstoppedtime": 333,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "United Kingdom",
    "decisiondate": "1999-11-29",
    "brandname": "Tikosyn",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 122,
    "emanumber": "220",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Thyrotropin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 581,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 373,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Germany",
    "decisiondate": "2000-03-09",
    "brandname": "Thyrogen",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 123,
    "emanumber": "254",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Sevelamer",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 412,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 213,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Belgium",
    "decisiondate": "2000-01-28",
    "brandname": "Renagel",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 124,
    "emanumber": "253",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G02",
    "activesubstance": "Atosiban",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 234,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Denmark",
    "decisiondate": "2000-01-20",
    "brandname": "Tractocile",
    "mah": "Ferring Pharmaceuticals A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 125,
    "emanumber": "287",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 180,
    "authorisationactivetime": 117,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "unknown",
    "decisiondate": "2000-02-03",
    "brandname": "Zyprexa Velotab",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 126,
    "emanumber": "262",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Etanercept",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2000-02-03",
    "brandname": "Enbrel",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 127,
    "emanumber": "281",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon alfa-2b",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 206,
    "authorisationactivetime": 108,
    "authorisationstoppedtime": 98,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Belgium",
    "decisiondate": "2000-03-09",
    "brandname": "IntronA",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 128,
    "emanumber": "282",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon alfa-2b",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 43,
    "authorisationactivetime": 43,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Belgium",
    "decisiondate": "2000-03-09",
    "brandname": "Viraferon",
    "mah": "Schering-Plough Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 129,
    "emanumber": "267",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Brinzolamide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 332,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2000-03-09",
    "brandname": "Azopt",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 130,
    "emanumber": "274",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "ganirelix",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 162,
    "authorisationstoppedtime": 189,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Netherlands",
    "decisiondate": "2000-05-17",
    "brandname": "Orgalutran",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 131,
    "emanumber": "280",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Peginterferon alfa-2b",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 328,
    "authorisationactivetime": 189,
    "authorisationstoppedtime": 139,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2000-05-25",
    "brandname": "PegIntron",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 132,
    "emanumber": "329",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Peginterferon alfa-2b",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 206,
    "authorisationactivetime": 108,
    "authorisationstoppedtime": 98,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2000-05-29",
    "brandname": "ViraferonPeg",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 133,
    "emanumber": "309",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 144,
    "authorisationactivetime": 116,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2000-06-27",
    "brandname": "Toujeo",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 134,
    "emanumber": "284",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 298,
    "authorisationactivetime": 215,
    "authorisationstoppedtime": 83,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2000-06-09",
    "brandname": "Lantus",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 135,
    "emanumber": "266",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Ioflupane (123I)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 450,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 272,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2000-07-27",
    "brandname": "DaTSCAN",
    "mah": "GE Healthcare B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 136,
    "emanumber": "261",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Triple antigen hepatitis B vaccine (recombinant)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 503,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 293,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2000-08-04",
    "brandname": "Hepacare",
    "mah": "Medeva Pharma Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 137,
    "emanumber": "268",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Rosiglitazone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 305,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2000-07-11",
    "brandname": "Avandia",
    "mah": "SmithKline Beecham Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 138,
    "emanumber": "270",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Rosiglitazone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 305,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2000-07-11",
    "brandname": "VENVIA",
    "mah": "SmithKline Beecham plc",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 139,
    "emanumber": "269",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Rosiglitazone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 305,
    "authorisationactivetime": 186,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2000-07-11",
    "brandname": "Nyracta",
    "mah": "SmithKline Beecham plc",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 140,
    "emanumber": "305",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "verteporfin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 201,
    "authorisationactivetime": 138,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "2000-07-27",
    "brandname": "Visudyne",
    "mah": "CHEPLAPHARM Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 141,
    "emanumber": "297",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Doxorubicin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 258,
    "authorisationactivetime": 167,
    "authorisationstoppedtime": 91,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2000-07-13",
    "brandname": "Myocet liposomal",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 142,
    "emanumber": "308",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin aspart",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 199,
    "authorisationactivetime": 144,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2000-08-01",
    "brandname": "NovoMix",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 143,
    "emanumber": "275",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Recombinant coagulation factor VIII (octocog alfa)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 383,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 201,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2000-08-04",
    "brandname": "KOGENATE Bayer",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 144,
    "emanumber": "276",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Recombinant coagulation factor VIII (octocog alfa)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 383,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 201,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2000-08-04",
    "brandname": "Helixate NexGen",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 145,
    "emanumber": "278",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 452,
    "authorisationactivetime": 147,
    "authorisationstoppedtime": 305,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2000-08-28",
    "brandname": "Herceptin",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 146,
    "emanumber": "277",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 487,
    "authorisationactivetime": 187,
    "authorisationstoppedtime": 300,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Sweden",
    "decisiondate": "2000-09-29",
    "brandname": "Keppra",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 147,
    "emanumber": "298",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 333,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2000-10-23",
    "brandname": "Hexavac",
    "mah": "Aventis Pasteur MSD",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 148,
    "emanumber": "264",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "amprenavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 543,
    "authorisationactivetime": 219,
    "authorisationstoppedtime": 324,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Luxembourg",
    "decisiondate": "2000-10-20",
    "brandname": "Agenerase",
    "mah": "Glaxo Group Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 149,
    "emanumber": "279",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "alitretinoin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 487,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 313,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "United Kingdom",
    "decisiondate": "2000-10-11",
    "brandname": "Panretin",
    "mah": "Amdipharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 150,
    "emanumber": "285",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 251,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Portugal",
    "decisiondate": "2000-10-13",
    "brandname": "Actos",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 151,
    "emanumber": "286",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 251,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Portugal",
    "decisiondate": "2000-10-10",
    "brandname": "Glustin",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 152,
    "emanumber": "296",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate vaccine (adsorbed)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 333,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2000-10-23",
    "brandname": "Infanrix hexa",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 153,
    "emanumber": "295",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 333,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2000-10-23",
    "brandname": "Infanrix penta",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 154,
    "emanumber": "263",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Depreotide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 608,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 404,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Denmark",
    "decisiondate": "2000-11-29",
    "brandname": "NeoSpect",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 155,
    "emanumber": "292",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Lutropin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 392,
    "authorisationactivetime": 192,
    "authorisationstoppedtime": 200,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "France",
    "decisiondate": "2000-11-29",
    "brandname": "Luveris",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 156,
    "emanumber": "338",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "abacavir, lamivudine, zidovudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 158,
    "authorisationactivetime": 158,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "France",
    "decisiondate": "2000-12-28",
    "brandname": "Trizivir",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 157,
    "emanumber": "310",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2001-01-15",
    "brandname": "Azomyr",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 158,
    "emanumber": "311",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2001-01-15",
    "brandname": "Opulis",
    "mah": "Schering-Plough Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 159,
    "emanumber": "312",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2001-01-15",
    "brandname": "Allex",
    "mah": "Schering-Plough Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 160,
    "emanumber": "313",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2001-01-15",
    "brandname": "Aerius",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 161,
    "emanumber": "314",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2001-01-15",
    "brandname": "Neoclarityn",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 162,
    "emanumber": "362",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": "article 4.8a(1)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 91,
    "authorisationactivetime": 91,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Luxembourg",
    "decisiondate": "2001-01-29",
    "brandname": "Prandin",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 163,
    "emanumber": "316",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2001-02-02",
    "brandname": "Xeloda",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 164,
    "emanumber": "315",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Somatropin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 186,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "2001-02-16",
    "brandname": "NutropinAq",
    "mah": "Ipsen Pharma",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 165,
    "emanumber": "320",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Choriogonadotrophin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 360,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 186,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2001-02-02",
    "brandname": "Ovitrelle",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 166,
    "emanumber": "301",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M03",
    "activesubstance": "Botulinum Toxin Type B",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 416,
    "authorisationactivetime": 187,
    "authorisationstoppedtime": 229,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Ireland",
    "decisiondate": "2001-01-22",
    "brandname": "NeuroBloc",
    "mah": "Sloan Pharma S.a.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 167,
    "emanumber": "323",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "pneumoccocal saccharide conjugated vaccine, adsorbed",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Sweden",
    "decisiondate": "2001-02-02",
    "brandname": "Prevenar",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 168,
    "emanumber": "307",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "tenecteplase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 391,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 215,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2001-02-23",
    "brandname": "Tenecteplase Boehringer Ingelheim Pharma GmbH & Co. KG",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 169,
    "emanumber": "306",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "tenecteplase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 391,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 215,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2001-02-23",
    "brandname": "Metalyse",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 170,
    "emanumber": "331",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "rasburicase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2001-02-23",
    "brandname": "Fasturtec",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 171,
    "emanumber": "273",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "sirolimus",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 607,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 393,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2001-03-13",
    "brandname": "Rapamune",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 172,
    "emanumber": "368",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "lopinavir / Ritonavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 145,
    "authorisationactivetime": 145,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Luxembourg",
    "decisiondate": "2001-03-20",
    "brandname": "Kaletra",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 173,
    "emanumber": "325",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "eflornithine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 339,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Sweden",
    "decisiondate": "2001-03-20",
    "brandname": "Vaniqa",
    "mah": "Almirall, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 174,
    "emanumber": "335",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "nateglinide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 179,
    "authorisationstoppedtime": 144,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Portugal",
    "decisiondate": "2001-04-03",
    "brandname": "Starlix",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 175,
    "emanumber": "383",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "nateglinide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 58,
    "authorisationactivetime": 58,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Portugal",
    "decisiondate": "2001-04-03",
    "brandname": "Trazec",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 176,
    "emanumber": "336",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2001-03-20",
    "brandname": "Zometa",
    "mah": "Phoenix Labs Unlimited Company",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 177,
    "emanumber": "303",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "sulphur hexafluoride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 470,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 276,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Netherlands",
    "decisiondate": "2001-03-26",
    "brandname": "SonoVue",
    "mah": "Bracco International B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 178,
    "emanumber": "326",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bexarotene",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 356,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2001-03-29",
    "brandname": "Targretin",
    "mah": "Eisai GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 179,
    "emanumber": "293",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "eptotermin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 498,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 297,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Ireland",
    "decisiondate": "2001-05-17",
    "brandname": "Osigraft",
    "mah": "Olympus Biotech International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 180,
    "emanumber": "327",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "apomorphine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 383,
    "authorisationactivetime": 156,
    "authorisationstoppedtime": 227,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2001-05-28",
    "brandname": "Uprima",
    "mah": "Abbott Laboratories Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 181,
    "emanumber": "328",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "apomorphine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 383,
    "authorisationactivetime": 156,
    "authorisationstoppedtime": 227,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2001-05-28",
    "brandname": "Ixense",
    "mah": "Takeda Europe R&D Centre Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 182,
    "emanumber": "386",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "apomorphine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 86,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2001-05-28",
    "brandname": "Taluvian",
    "mah": "Abbott SpA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 183,
    "emanumber": "373",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Recombinant Hepatitis B virus small surface antigen (HbsAg)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 85,
    "authorisationactivetime": 68,
    "authorisationstoppedtime": 17,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2001-04-27",
    "brandname": "HBVAXPRO",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 184,
    "emanumber": "333",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "darbepoetin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 199,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2001-06-08",
    "brandname": "Nespo",
    "mah": "Domp√© Biotec S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 185,
    "emanumber": "332",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "darbepoetin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 199,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2001-06-08",
    "brandname": "Aranesp",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 186,
    "emanumber": "348",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human coagulation factor IX",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 373,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 171,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2001-07-03",
    "brandname": "Nonafact",
    "mah": "Sanquin Plasma Products B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 187,
    "emanumber": "317",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Cytarabine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 489,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 313,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2001-07-11",
    "brandname": "DepoCyte",
    "mah": "Pacira Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 188,
    "emanumber": "370",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Agalsidase beta",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 251,
    "authorisationactivetime": 187,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2001-08-03",
    "brandname": "Fabrazyme",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 189,
    "emanumber": "369",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Agalsidase alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 249,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 49,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2001-08-03",
    "brandname": "Replagal",
    "mah": "Shire Human Genetic Therapies AB",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 190,
    "emanumber": "334",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Protein C",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 185,
    "authorisationstoppedtime": 243,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2001-07-16",
    "brandname": "Ceprotin",
    "mah": "Takeda Manufacturing Austria AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 191,
    "emanumber": "354",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "telithromycin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 345,
    "authorisationactivetime": 164,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2001-07-09",
    "brandname": "Ketek",
    "mah": "Aventis Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 192,
    "emanumber": "355",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "telithromycin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 345,
    "authorisationactivetime": 164,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2001-07-09",
    "brandname": "Levviax",
    "mah": "Aventis Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 193,
    "emanumber": "353",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Alemtuzumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 345,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 142,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2001-07-06",
    "brandname": "MabCampath",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 194,
    "emanumber": "337",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R07",
    "activesubstance": "Nitric oxide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 202,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Belgium",
    "decisiondate": "2001-08-01",
    "brandname": "INOmax",
    "mah": "Linde Healthcare AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 195,
    "emanumber": "393",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": "article 4.8a(1)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 86,
    "authorisationactivetime": 86,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2001-08-01",
    "brandname": "Liprolog",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 196,
    "emanumber": "379",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "caspofungin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Sweden",
    "decisiondate": "2001-10-24",
    "brandname": "CANCIDAS",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 197,
    "emanumber": "318",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temoporfin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 453,
    "authorisationactivetime": 215,
    "authorisationstoppedtime": 238,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2001-10-24",
    "brandname": "Foscan",
    "mah": "biolitec Pharma Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 198,
    "emanumber": "406",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 119,
    "authorisationactivetime": 119,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2001-11-07",
    "brandname": "Glivec",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 199,
    "emanumber": "390",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Travoprost",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 210,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 58,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2001-11-27",
    "brandname": "Travatan",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 200,
    "emanumber": "419",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "tenofovir disoproxil fumarate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 146,
    "authorisationactivetime": 83,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "2002-02-05",
    "brandname": "Viread",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 201,
    "emanumber": "374",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "Tacrolimus",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Austria",
    "decisiondate": "2002-02-28",
    "brandname": "Protopic",
    "mah": "Leo Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 202,
    "emanumber": "375",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "Tacrolimus",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Austria",
    "decisiondate": "2002-02-28",
    "brandname": "Protopy",
    "mah": "Astellas Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 203,
    "emanumber": "363",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Anakinra",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 477,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 273,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Portugal",
    "decisiondate": "2002-03-08",
    "brandname": "Kineret",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 204,
    "emanumber": "388",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Arsenic trioxide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 231,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 51,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2002-03-05",
    "brandname": "TRISENOX",
    "mah": "Teva B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 205,
    "emanumber": "391",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Bimatoprost",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 319,
    "authorisationactivetime": 192,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2002-03-08",
    "brandname": "Lumigan",
    "mah": "Allergan Pharmaceuticals Ireland",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 206,
    "emanumber": "403",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Fondaparinux sodium",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 283,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2002-03-21",
    "brandname": "Arixtra",
    "mah": "Mylan IRE Healthcare Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 207,
    "emanumber": "404",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Fondaparinux sodium",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 283,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2002-03-21",
    "brandname": "Quixidar",
    "mah": "Glaxo Group Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 208,
    "emanumber": "380",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Parecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 375,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 171,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2002-03-22",
    "brandname": "Xapit",
    "mah": "Pharmacia Europe EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 209,
    "emanumber": "381",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Parecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 375,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 171,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2002-03-22",
    "brandname": "Dynastat",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 210,
    "emanumber": "382",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Parecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 375,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 171,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2002-03-22",
    "brandname": "Rayzon",
    "mah": "Pharmacia Europe EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 211,
    "emanumber": "372",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "Epoetin delta",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 444,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 238,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2002-03-18",
    "brandname": "Dynepo",
    "mah": "Shire Pharmaceutical Contracts Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 212,
    "emanumber": "387",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "voriconazole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2002-03-19",
    "brandname": "Vfend",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 213,
    "emanumber": "413",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Telmisartan / hydrochlorothiazide",
    "legalbasis": "article 4.8a(2)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 263,
    "authorisationactivetime": 148,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2002-04-19",
    "brandname": "MicardisPlus",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 214,
    "emanumber": "415",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Telmisartan / hydrochlorothiazide",
    "legalbasis": "article 4.8a(2)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 263,
    "authorisationactivetime": 148,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2002-04-19",
    "brandname": "Kinzalkomb",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 215,
    "emanumber": "414",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Telmisartan / hydrochlorothiazide",
    "legalbasis": "article 4.8a(2)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 263,
    "authorisationactivetime": 148,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2002-04-22",
    "brandname": "PritorPlus",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 216,
    "emanumber": "389",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Ertapenem",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 381,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2002-04-18",
    "brandname": "Invanz",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 217,
    "emanumber": "407",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Olopatadine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 324,
    "authorisationactivetime": 223,
    "authorisationstoppedtime": 101,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Denmark",
    "decisiondate": "2002-05-17",
    "brandname": "Opatanol",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 218,
    "emanumber": "378",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 505,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 295,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Portugal",
    "decisiondate": "2002-05-17",
    "brandname": "Axura",
    "mah": "Merz Pharmaceuticals GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 219,
    "emanumber": "463",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 119,
    "authorisationactivetime": 55,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Portugal",
    "decisiondate": "2002-05-15",
    "brandname": "Ebixa",
    "mah": "H. Lundbeck A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 220,
    "emanumber": "401",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "bosentan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 354,
    "authorisationactivetime": 187,
    "authorisationstoppedtime": 167,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2002-05-15",
    "brandname": "Tracleer",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 221,
    "emanumber": "395",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "peginterferon alfa-2a",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2002-06-20",
    "brandname": "Pegasys",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 222,
    "emanumber": "402",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Oseltamivir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 384,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 180,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Portugal",
    "decisiondate": "2002-06-20",
    "brandname": "Tamiflu",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 223,
    "emanumber": "410",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Norelgestromin / Ethinyl estradiol",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 324,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2002-08-22",
    "brandname": "Evra",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 224,
    "emanumber": "426",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Inactivated hepatitis A virus, Hepatitis B surface antigen (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 341,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 163,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2002-08-30",
    "brandname": "Ambirix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 225,
    "emanumber": "396",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Drotrecogin alfa (activated)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 481,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 270,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2002-08-22",
    "brandname": "Xigris",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 226,
    "emanumber": "408",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Dibotermin alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 434,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 224,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2002-09-09",
    "brandname": "InductOs",
    "mah": "Medtronic BioPharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 227,
    "emanumber": "420",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2002-08-22",
    "brandname": "Neulasta",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 228,
    "emanumber": "422",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2002-08-22",
    "brandname": "Neupopeg",
    "mah": "Domp√© Biotec S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 229,
    "emanumber": "427",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 306,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Actraphane",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 230,
    "emanumber": "424",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 333,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Actrapid",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 231,
    "emanumber": "428",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 306,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Mixtard",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 232,
    "emanumber": "423",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 333,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Velosulin",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 233,
    "emanumber": "441",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 278,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Insulatard",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 234,
    "emanumber": "442",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 278,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Protaphane",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 235,
    "emanumber": "440",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 278,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Monotard",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 236,
    "emanumber": "439",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human (rDNA)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 278,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2002-10-07",
    "brandname": "Ultratard",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 237,
    "emanumber": "436",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "tadalafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 166,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Portugal",
    "decisiondate": "2002-11-12",
    "brandname": "Cialis",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 238,
    "emanumber": "435",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Miglustat",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 168,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2002-11-20",
    "brandname": "Zavesca",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 239,
    "emanumber": "431",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Valdecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 165,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2003-03-27",
    "brandname": "Bextra",
    "mah": "Pharmacia Europe EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 240,
    "emanumber": "409",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Pegvisomant",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 476,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 299,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "2002-11-13",
    "brandname": "Somavert",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 242,
    "emanumber": "432",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Valdecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 165,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2003-03-27",
    "brandname": "Valdyn",
    "mah": "Pharmacia Europe EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 244,
    "emanumber": "437",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M01",
    "activesubstance": "Valdecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 368,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 165,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2003-03-27",
    "brandname": "Valdyn (ex Kudeq)",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 245,
    "emanumber": "445",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 362,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 150,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2003-01-07",
    "brandname": "Theryttrex",
    "mah": "MDS Nordion S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 246,
    "emanumber": "461",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Carglumic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 355,
    "authorisationactivetime": 191,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "2003-01-24",
    "brandname": "Carbaglu",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 247,
    "emanumber": "425",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Teriparatide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 546,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 339,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2003-06-10",
    "brandname": "Forsteo",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 248,
    "emanumber": "475",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "Vardenafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2003-03-06",
    "brandname": "Levitra",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 249,
    "emanumber": "488",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "Vardenafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 96,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2003-03-04",
    "brandname": "Vivanza",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 250,
    "emanumber": "460",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 385,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2003-03-24",
    "brandname": "Ytracis",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 251,
    "emanumber": "485",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "adefovir dipivoxil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "2003-03-06",
    "brandname": "Hepsera",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 252,
    "emanumber": "514",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Enfuvirtide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 148,
    "authorisationactivetime": 139,
    "authorisationstoppedtime": 9,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2003-05-27",
    "brandname": "Fuzeon",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 253,
    "emanumber": "477",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Laronidase",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 324,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2003-06-10",
    "brandname": "Aldurazyme",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 254,
    "emanumber": "472",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "busulfan",
    "legalbasis": "article 4.8a(2)",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 353,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 180,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2003-07-09",
    "brandname": "Busilvex",
    "mah": "Pierre Fabre M√©dicament",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 255,
    "emanumber": "474",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Iloprost",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 474,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 265,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2003-09-16",
    "brandname": "Ventavis",
    "mah": "Bayer AG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 256,
    "emanumber": "481",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 390,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2003-09-08",
    "brandname": "Humira",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 257,
    "emanumber": "482",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 390,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2003-09-01",
    "brandname": "Trudexa",
    "mah": "Abbott Laboratories Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 258,
    "emanumber": "522",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "rosiglitazone / metformin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 245,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 67,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2003-10-20",
    "brandname": "Avandamet",
    "mah": "SmithKline Beecham Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 259,
    "emanumber": "466",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Celecoxib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 577,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 369,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Denmark",
    "decisiondate": "2003-10-17",
    "brandname": "Onsenal",
    "mah": "Pfizer Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 260,
    "emanumber": "511",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "Levodopa,carbidopa,entacapone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 273,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 79,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Portugal",
    "decisiondate": "2003-10-17",
    "brandname": "Stalevo",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 261,
    "emanumber": "533",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Emtricitabine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 198,
    "authorisationactivetime": 170,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2003-10-24",
    "brandname": "Emtriva",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 262,
    "emanumber": "527",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "aprepitant",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2003-11-11",
    "brandname": "Emend",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 263,
    "emanumber": "476",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Oral cholera vaccine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 478,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 277,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2004-04-28",
    "brandname": "Dukoral",
    "mah": "Valneva Sweden AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 264,
    "emanumber": "547",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "Ibritumomab tiuxetan",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 181,
    "authorisationactivetime": 153,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2004-01-16",
    "brandname": "Zevalin",
    "mah": "Ceft Biopharma s.r.o",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 265,
    "emanumber": "501",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 451,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "2004-02-23",
    "brandname": "Bonviva",
    "mah": "Atnahs Pharma Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 266,
    "emanumber": "502",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 451,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "2004-02-23",
    "brandname": "Bondenza",
    "mah": "Roche Registration Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 267,
    "emanumber": "494",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "atazanavir sulphate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 526,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 326,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2004-03-02",
    "brandname": "Reyataz",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 268,
    "emanumber": "512",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "colesevelam hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 405,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2004-03-10",
    "brandname": "Cholestagel",
    "mah": "CHEPLAPHARM Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 269,
    "emanumber": "540",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "Fulvestrant",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 230,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 54,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Finland",
    "decisiondate": "2004-03-10",
    "brandname": "Faslodex",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 270,
    "emanumber": "532",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "Oxybutynin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Portugal",
    "decisiondate": "2004-06-15",
    "brandname": "Kentera",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 271,
    "emanumber": "520",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "octocog alfa",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 356,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2004-03-02",
    "brandname": "Advate",
    "mah": "Takeda Manufacturing Austria AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 272,
    "emanumber": "493",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Porfimer sodium",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 518,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 321,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2004-03-25",
    "brandname": "PhotoBarr",
    "mah": "Pinnacle Biologics B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 273,
    "emanumber": "521",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Mitotane",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 430,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 236,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Italy",
    "decisiondate": "2004-04-28",
    "brandname": "Lysodren",
    "mah": "HRA Pharma Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 274,
    "emanumber": "539",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bortezomib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Finland",
    "decisiondate": "2004-04-26",
    "brandname": "VELCADE",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 275,
    "emanumber": "504",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Cladribine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 450,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2004-04-14",
    "brandname": "Litak",
    "mah": "Lipomed GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 276,
    "emanumber": "471",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 794,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 577,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Greece",
    "decisiondate": "2004-06-04",
    "brandname": "Abilify",
    "mah": "Otsuka Pharmaceutical Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 277,
    "emanumber": "505",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human Fibrinogen / Human Thrombin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 584,
    "authorisationactivetime": 228,
    "authorisationstoppedtime": 356,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2004-06-08",
    "brandname": "TachoSil",
    "mah": "Takeda Austria GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 278,
    "emanumber": "528",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin detemir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 465,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 284,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2004-06-01",
    "brandname": "Levemir",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 279,
    "emanumber": "546",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 325,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Portugal",
    "decisiondate": "2004-07-06",
    "brandname": "Lyrica",
    "mah": "Upjohn EESV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 280,
    "emanumber": "545",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "duloxetine hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 395,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 213,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2004-08-11",
    "brandname": "Yentreve",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 281,
    "emanumber": "558",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cetuximab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 236,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2004-06-29",
    "brandname": "Erbitux",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 282,
    "emanumber": "534",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Fosamprenavir",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 384,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 207,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Luxembourg",
    "decisiondate": "2004-07-12",
    "brandname": "Telzir",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 283,
    "emanumber": "552",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "duloxetine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 233,
    "authorisationstoppedtime": 161,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2004-08-11",
    "brandname": "Ariclaim",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 284,
    "emanumber": "549",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ibuprofen",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 276,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2004-07-29",
    "brandname": "Pedea",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 285,
    "emanumber": "557",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin glulisine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 346,
    "authorisationactivetime": 184,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2004-09-27",
    "brandname": "Apidra",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 286,
    "emanumber": "535",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Zinc acetate dihydrate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 457,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 269,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Austria",
    "decisiondate": "2004-10-13",
    "brandname": "Wilzin",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 287,
    "emanumber": "561",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Strontium ranelate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 184,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2004-09-21",
    "brandname": "Osseor",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 288,
    "emanumber": "560",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Strontium ranelate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 184,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2004-09-21",
    "brandname": "Protelos",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 289,
    "emanumber": "562",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Bivalirudin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 129,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2004-09-20",
    "brandname": "Angiox",
    "mah": "The Medicines Company UK Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 290,
    "emanumber": "564",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 108,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2004-09-20",
    "brandname": "Alimta",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 291,
    "emanumber": "542",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Efalizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 486,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 303,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2004-09-20",
    "brandname": "Raptiva",
    "mah": "Serono Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 292,
    "emanumber": "570",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Cinacalcet",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 276,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2004-10-22",
    "brandname": "Mimpara",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 293,
    "emanumber": "575",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Cinacalcet",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 276,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2004-10-22",
    "brandname": "Parareg",
    "mah": "Domp√© Biotec S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 294,
    "emanumber": "554",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "darifenacin hydrobromide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 402,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 221,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Belgium",
    "decisiondate": "2004-10-22",
    "brandname": "Emselex",
    "mah": "zr pharma& GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 295,
    "emanumber": "480",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "anagrelide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 452,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 271,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Belgium",
    "decisiondate": "2004-11-16",
    "brandname": "Xagrid",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 296,
    "emanumber": "572",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "duloxetine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2004-12-17",
    "brandname": "Cymbalta",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 297,
    "emanumber": "573",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "duloxetine hydrochloride",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2004-12-17",
    "brandname": "Nodetrip",
    "mah": "Esteve Pharmaceuticals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 298,
    "emanumber": "581",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "abacavir / Lamivudine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 293,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Portugal",
    "decisiondate": "2004-12-17",
    "brandname": "Kivexa",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 299,
    "emanumber": "550",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 531,
    "authorisationactivetime": 168,
    "authorisationstoppedtime": 363,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Norway",
    "decisiondate": "2005-02-02",
    "brandname": "Fendrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 300,
    "emanumber": "582",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bevacizumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 100,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Norway",
    "decisiondate": "2005-01-12",
    "brandname": "Avastin",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 301,
    "emanumber": "556",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphtheria, tetanus, pertussis (whole cell), hepatitis B (rDNA) and Haemophilus type b conjugate vaccine (adsorbed)",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 215,
    "authorisationstoppedtime": 297,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Italy",
    "decisiondate": "2005-02-17",
    "brandname": "Quintanrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 302,
    "emanumber": "551",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "ziconotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 542,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 346,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Ireland",
    "decisiondate": "2005-02-21",
    "brandname": "Prialt",
    "mah": "RIEMSER Pharma GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 303,
    "emanumber": "555",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Nitisinone",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 486,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 289,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Denmark",
    "decisiondate": "2005-02-21",
    "brandname": "Orfadin",
    "mah": "Swedish Orphan Biovitrum International AB",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 304,
    "emanumber": "574",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "rasagiline",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 388,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 180,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Ireland",
    "decisiondate": "2005-02-21",
    "brandname": "Azilect",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 305,
    "emanumber": "594",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir disoproxil fumarate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 234,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 52,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2005-02-21",
    "brandname": "Truvada",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 306,
    "emanumber": "563",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "Palonosetron",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Spain",
    "decisiondate": "2005-03-22",
    "brandname": "Aloxi",
    "mah": "Helsinn Birex Pharmaceuticals Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 307,
    "emanumber": "577",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "zonisamide",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 387,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 185,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Netherlands",
    "decisiondate": "2005-03-10",
    "brandname": "Zonegran",
    "mah": "Eisai GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 308,
    "emanumber": "595",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 248,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 67,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Iceland",
    "decisiondate": "2005-04-15",
    "brandname": "Aclasta",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 310,
    "emanumber": "619",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Alendronate Sodium / Colecalciferol",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 220,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 38,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Austria",
    "decisiondate": "2005-08-24",
    "brandname": "Fosavance",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 311,
    "emanumber": "618",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Erlotinib",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 276,
    "authorisationactivetime": 193,
    "authorisationstoppedtime": 83,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2005-09-19",
    "brandname": "Tarceva",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 312,
    "emanumber": "593",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Sodium oxybate",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 451,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 253,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Denmark",
    "decisiondate": "2005-10-13",
    "brandname": "Xyrem",
    "mah": "UCB Pharma S.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 313,
    "emanumber": "601",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Gadofosveset Trisodium",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 367,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 185,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2005-10-03",
    "brandname": "Ablavar",
    "mah": "TMC Pharma Services Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 314,
    "emanumber": "609",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Palifermin",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 373,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2005-10-25",
    "brandname": "Kepivance",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 315,
    "emanumber": "631",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Tipranavir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 254,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2005-10-25",
    "brandname": "APTIVUS",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 316,
    "emanumber": "597",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 436,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2005-10-25",
    "brandname": "Procoralan",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 317,
    "emanumber": "598",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 436,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2005-10-25",
    "brandname": "Corlentor",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 318,
    "emanumber": "638",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 219,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 42,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2005-10-28",
    "brandname": "Revatio",
    "mah": "Upjohn EESV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 319,
    "emanumber": "606",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "omalizumab",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 373,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2005-10-25",
    "brandname": "Xolair",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 320,
    "emanumber": "610",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "Posaconazole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 373,
    "authorisationactivetime": 219,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2005-10-25",
    "brandname": "Noxafil",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 321,
    "emanumber": "611",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "Posaconazole",
    "legalbasis": null,
    "legalscope": "regulation 2309/93",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 373,
    "authorisationactivetime": 219,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2005-10-25",
    "brandname": "Posaconazole SP",
    "mah": "SP Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 322,
    "emanumber": "596",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "Yttrium (<sup>90</sup>Y) Chloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 423,
    "authorisationactivetime": 216,
    "authorisationstoppedtime": 207,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-01-19",
    "brandname": "Yttriga",
    "mah": "Eckert & Ziegler Radiopharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 323,
    "emanumber": "622",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Measles, Mumps, Rubella and Varicella Vaccine (Live)",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 332,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 123,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2006-04-06",
    "brandname": "ProQuad",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 324,
    "emanumber": "640",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "galsulfase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 269,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2006-01-24",
    "brandname": "Naglazyme",
    "mah": "BioMarin International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 325,
    "emanumber": "620",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "pegaptanib sodium",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 386,
    "authorisationactivetime": 216,
    "authorisationstoppedtime": 170,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Sweden",
    "decisiondate": "2006-01-31",
    "brandname": "Macugen",
    "mah": "PharmaSwiss Cesk√° republika s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 326,
    "emanumber": "612",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "Fentanyl",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 451,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 252,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2006-01-24",
    "brandname": "Ionsys",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 327,
    "emanumber": "588",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 598,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 390,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2006-01-24",
    "brandname": "Exubera",
    "mah": "Pfizer Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 328,
    "emanumber": "637",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Daptomycin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 332,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 115,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2006-01-19",
    "brandname": "Cubicin",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 329,
    "emanumber": "628",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "Human normal immunoglobulin (IVIg)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 395,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2006-01-19",
    "brandname": "Kiovig",
    "mah": "Takeda Manufacturing Austria AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 330,
    "emanumber": "639",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Rotavirus vaccine, live",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 329,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Norway",
    "decisiondate": "2006-02-21",
    "brandname": "Rotarix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 331,
    "emanumber": "626",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "Rotigotine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 220,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-02-15",
    "brandname": "Neupro",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 332,
    "emanumber": "607",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Somatropin",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2006-04-12",
    "brandname": "Omnitrope",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 333,
    "emanumber": "636",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "alglucosidase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 402,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 206,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "France",
    "decisiondate": "2006-03-29",
    "brandname": "Myozyme",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 334,
    "emanumber": "613",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "clofarabine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 553,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 344,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-05-29",
    "brandname": "Evoltra",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 335,
    "emanumber": "602",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Somatropin",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 581,
    "authorisationactivetime": 179,
    "authorisationstoppedtime": 402,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-04-24",
    "brandname": "Valtropin",
    "mah": "BioPartners GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 336,
    "emanumber": "644",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Tigecycline",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 392,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 210,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2006-04-24",
    "brandname": "Tygacil",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 337,
    "emanumber": "604",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Measles, Mumps and Rubella Vaccine (Live)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 581,
    "authorisationactivetime": 193,
    "authorisationstoppedtime": 388,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2006-05-05",
    "brandname": "M-M-RVAXPRO",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 338,
    "emanumber": "665",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Travoprost / Timolol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 278,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 82,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2006-04-24",
    "brandname": "DuoTrav",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 339,
    "emanumber": "659",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Parathyroid hormone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 329,
    "authorisationactivetime": 224,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2006-04-24",
    "brandname": "Preotact",
    "mah": "NPS Pharma Holdings Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 340,
    "emanumber": "668",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "bimatoprost / timolol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2006-05-19",
    "brandname": "Ganfort",
    "mah": "Allergan Pharmaceuticals Ireland",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 341,
    "emanumber": "674",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "shingles (herpes zoster) vaccine (live)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 79,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2006-05-19",
    "brandname": "Zostavax",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 342,
    "emanumber": "690",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Sorafenib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2006-07-19",
    "brandname": "Nexavar",
    "mah": "Bayer AG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 343,
    "emanumber": "623",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "entecavir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 553,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 343,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2006-06-26",
    "brandname": "Baraclude",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 344,
    "emanumber": "666",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A08",
    "activesubstance": "Rimonabant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 142,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-06-19",
    "brandname": "ACOMPLIA",
    "mah": "Sanofi-Aventis",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 345,
    "emanumber": "691",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A08",
    "activesubstance": "Rimonabant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 151,
    "authorisationactivetime": 85,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-06-19",
    "brandname": "Zimulti",
    "mah": "Sanofi-Aventis",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 346,
    "emanumber": "603",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Natalizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 672,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 496,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2006-06-27",
    "brandname": "Tysabri",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 347,
    "emanumber": "687",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "sunitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Denmark",
    "decisiondate": "2006-07-19",
    "brandname": "Sutent",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 348,
    "emanumber": "669",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Rotavirus vaccine (live, oral)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 190,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2006-06-27",
    "brandname": "RotaTeq",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 349,
    "emanumber": "675",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Rosiglitazone / glimepiride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2006-06-27",
    "brandname": "Avaglim",
    "mah": "SmithKline Beecham Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 350,
    "emanumber": "682",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Dexrazoxane",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "2006-07-28",
    "brandname": "Savene",
    "mah": "Clinigen Healthcare B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 351,
    "emanumber": "630",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "testosterone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 563,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 353,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2006-07-28",
    "brandname": "Livensa",
    "mah": "Warner Chilcott Deutschland Gmbh",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 352,
    "emanumber": "634",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "testosterone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 563,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 353,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2006-07-28",
    "brandname": "Intrinsa",
    "mah": "Warner Chilcott UK Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 353,
    "emanumber": "679",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "Sitaxentan sodium",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2006-08-10",
    "brandname": "Thelin",
    "mah": "Pfizer Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 354,
    "emanumber": "655",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Pioglitazone / metformin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 430,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 226,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Spain",
    "decisiondate": "2006-07-28",
    "brandname": "Competact",
    "mah": "CHEPLAPHARM Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 355,
    "emanumber": "587",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "antithrombin alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 728,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 521,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2006-07-28",
    "brandname": "ATryn",
    "mah": "Laboratoire fran√ßais du Fractionnement et des Biotechnologies",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 356,
    "emanumber": "670",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "deferasirox",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 376,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 202,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2006-08-28",
    "brandname": "Exjade",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 357,
    "emanumber": "703",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2006-09-20",
    "brandname": "Gardasil",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 358,
    "emanumber": "732",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 145,
    "authorisationactivetime": 117,
    "authorisationstoppedtime": 28,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2006-09-20",
    "brandname": "Silgard",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 359,
    "emanumber": "697",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "buprenorphine / naloxone",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2006-09-26",
    "brandname": "Suboxone",
    "mah": "Indivior Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 360,
    "emanumber": "699",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "varenicline tartrate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-09-26",
    "brandname": "Champix",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 361,
    "emanumber": "654",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Perflutren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 521,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 314,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Spain",
    "decisiondate": "2006-09-20",
    "brandname": "Luminity",
    "mah": "Lantheus EU Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 362,
    "emanumber": "698",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "exenatide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 94,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2006-11-20",
    "brandname": "Byetta",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 363,
    "emanumber": "709",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Dasatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 232,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Portugal",
    "decisiondate": "2006-11-20",
    "brandname": "Sprycel",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 364,
    "emanumber": "759",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Alendronate Sodium / Colecalciferol",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 89,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Austria",
    "decisiondate": "2007-01-04",
    "brandname": "Adrovance",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 365,
    "emanumber": "700",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Idursulfase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 294,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-01-08",
    "brandname": "Elaprase",
    "mah": "Shire Human Genetic Therapies AB",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 366,
    "emanumber": "680",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Pioglitazone / Glimepiride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 427,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 231,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-01-08",
    "brandname": "Tandemact",
    "mah": "CHEPLAPHARM Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 367,
    "emanumber": "664",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "Stiripentol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 518,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 317,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2007-01-04",
    "brandname": "Diacomit",
    "mah": "Biocodex",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 368,
    "emanumber": "761",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin human",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 118,
    "authorisationactivetime": 110,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-01-17",
    "brandname": "Insulin Human Winthrop",
    "mah": "Sanofi-Aventis Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 369,
    "emanumber": "784",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 50,
    "authorisationactivetime": 50,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2007-01-19",
    "brandname": "Irbesartan HCT BMS",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 370,
    "emanumber": "716",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine / valsartan",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 255,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 82,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2007-01-17",
    "brandname": "Exforge",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 371,
    "emanumber": "776",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine / valsartan",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2007-01-16",
    "brandname": "Dafiro",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 372,
    "emanumber": "774",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine / valsartan",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2007-01-16",
    "brandname": "Copalia",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 373,
    "emanumber": "775",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine / valsartan",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2007-01-17",
    "brandname": "Imprida",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 374,
    "emanumber": "715",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "ranibizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 195,
    "authorisationstoppedtime": 65,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2007-01-22",
    "brandname": "Lucentis",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 375,
    "emanumber": "786",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 50,
    "authorisationactivetime": 50,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2007-01-19",
    "brandname": "Irbesartan BMS",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 376,
    "emanumber": "785",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 50,
    "authorisationactivetime": 50,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2007-01-19",
    "brandname": "Irbesartan Zentiva",
    "mah": "Zentiva k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 377,
    "emanumber": "783",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 50,
    "authorisationactivetime": 50,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2007-01-19",
    "brandname": "Irbesartan HCT Zentiva",
    "mah": "Zentiva k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 378,
    "emanumber": "660",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "Rufinamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 339,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2007-01-16",
    "brandname": "Inovelon",
    "mah": "Eisai GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 379,
    "emanumber": "678",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Betaine anhydrous",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 290,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-02-15",
    "brandname": "Cystadane",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 380,
    "emanumber": "707",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "darunavir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-02-12",
    "brandname": "PREZISTA",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 381,
    "emanumber": "706",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "A/Viet Nam/1194/2004 (H5N1) whole virus inactivated antigen",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 142,
    "authorisationstoppedtime": 174,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2007-03-21",
    "brandname": "Daronrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 382,
    "emanumber": "762",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 129,
    "authorisationactivetime": 85,
    "authorisationstoppedtime": 44,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2007-03-21",
    "brandname": "Xelevia",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 383,
    "emanumber": "722",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 301,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2007-03-21",
    "brandname": "Januvia",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 384,
    "emanumber": "808",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2007-04-20",
    "brandname": "Docetaxel Zentiva",
    "mah": "Zentiva k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 385,
    "emanumber": "710",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H1N1) (surface antigen, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-181)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 386,
    "authorisationactivetime": 162,
    "authorisationstoppedtime": 224,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-05-02",
    "brandname": "Focetria",
    "mah": "Novartis Vaccines and Diagnostics S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 386,
    "emanumber": "723",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "fesoterodine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2007-04-20",
    "brandname": "Toviaz",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 387,
    "emanumber": "712",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Tacrolimus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Lithuania",
    "decisiondate": "2007-04-23",
    "brandname": "Advagraf",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 388,
    "emanumber": "713",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "telbivudine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-04-24",
    "brandname": "Sebivo",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 389,
    "emanumber": "701",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "abatacept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 245,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Hungary",
    "decisiondate": "2007-05-21",
    "brandname": "Orencia",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 390,
    "emanumber": "757",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D06",
    "activesubstance": "retapamulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 191,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2007-05-24",
    "brandname": "Altargo",
    "mah": "Glaxo Group Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 391,
    "emanumber": "717",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Lenalidomide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2007-06-14",
    "brandname": "Revlimid",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 392,
    "emanumber": "695",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Melatonin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 338,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Greece",
    "decisiondate": "2007-06-29",
    "brandname": "Circadin",
    "mah": "RAD Neurim Pharmaceuticals EEC SARL",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 393,
    "emanumber": "791",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Eculizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 147,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2007-06-20",
    "brandname": "Soliris",
    "mah": "Alexion Europe SAS",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 394,
    "emanumber": "758",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Influenza vaccine (surface antigen, inactivated, prepared in cell culture)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 79,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2007-06-01",
    "brandname": "Optaflu",
    "mah": "Seqirus GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 395,
    "emanumber": "746",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "paliperidone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 135,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2007-06-25",
    "brandname": "Invega",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 396,
    "emanumber": "714",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "follitropin alfa / lutropin alfa",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 185,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2007-06-25",
    "brandname": "Pergoveris",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 397,
    "emanumber": "689",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "hydroxycarbamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 339,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Greece",
    "decisiondate": "2007-06-29",
    "brandname": "Siklos",
    "mah": "Addmedica",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 398,
    "emanumber": "745",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V08",
    "activesubstance": "Gadoversetamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-07-23",
    "brandname": "Optimark",
    "mah": "Guerbet",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 399,
    "emanumber": "772",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine; pseudoephedrine sulphate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2007-07-30",
    "brandname": "Aerinaze",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 400,
    "emanumber": "739",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "methoxy polyethylene glycol-epoetin beta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 189,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Finland",
    "decisiondate": "2007-07-20",
    "brandname": "Mircera",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 401,
    "emanumber": "854",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A08",
    "activesubstance": "Orlistat",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Greece",
    "decisiondate": "2007-07-23",
    "brandname": "alli",
    "mah": "GlaxoSmithKline Dungarvan Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 402,
    "emanumber": "704",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Mecasermin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 304,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-03",
    "brandname": "INCRELEX",
    "mah": "Ipsen Pharma",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 403,
    "emanumber": "752",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "nelarabine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-08-22",
    "brandname": "Atriance",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 404,
    "emanumber": "781",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "Human normal immunoglobulin (IVIg)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2007-08-23",
    "brandname": "Flebogamma DIF",
    "mah": "Instituto Grifols, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 405,
    "emanumber": "780",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 194,
    "authorisationstoppedtime": 73,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-22",
    "brandname": "Rasilez",
    "mah": "Noden Pharma DAC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 406,
    "emanumber": "850",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 77,
    "authorisationstoppedtime": 11,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-22",
    "brandname": "Enviage",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 407,
    "emanumber": "851",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 77,
    "authorisationstoppedtime": 11,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-22",
    "brandname": "Sprimeo",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 408,
    "emanumber": "852",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 77,
    "authorisationstoppedtime": 11,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-22",
    "brandname": "Tekturna",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 409,
    "emanumber": "853",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 77,
    "authorisationstoppedtime": 11,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2007-08-22",
    "brandname": "Riprazo",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 410,
    "emanumber": "725",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin alfa",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2007-08-28",
    "brandname": "Binocrit",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 411,
    "emanumber": "726",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin alfa",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2007-08-28",
    "brandname": "Epoetin alfa Hexal",
    "mah": "Hexal AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 412,
    "emanumber": "727",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin alfa",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2007-08-28",
    "brandname": "Abseamed",
    "mah": "Medice Arzneimittel P√ºtter GmbH & Co KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 413,
    "emanumber": "744",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "5-aminolevulinic acid hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 194,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Poland",
    "decisiondate": "2007-09-07",
    "brandname": "Gliolan",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 414,
    "emanumber": "771",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2007-09-26",
    "brandname": "Galvus",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 415,
    "emanumber": "792",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2007-09-27",
    "brandname": "Zalasta",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 416,
    "emanumber": "788",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "anidulafungin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2007-09-20",
    "brandname": "Ecalta",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 417,
    "emanumber": "773",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Trabectedin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2007-09-17",
    "brandname": "Yondelis",
    "mah": "Pharma Mar S.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 418,
    "emanumber": "811",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "maraviroc",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 169,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2007-09-18",
    "brandname": "Celsentri",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 419,
    "emanumber": "721",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Human Papilloma Virus-16 and Human Papilloma Virus 18 L1 proteins",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 477,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 275,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2007-09-20",
    "brandname": "Cervarix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 420,
    "emanumber": "806",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "hydroxocobalamin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-11-23",
    "brandname": "Cyanokit",
    "mah": "SERB S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 421,
    "emanumber": "893",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Pioglitazone / metformin hydrochloride",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 59,
    "authorisationactivetime": 59,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Spain",
    "decisiondate": "2007-12-11",
    "brandname": "Glubrava",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 422,
    "emanumber": "798",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Nilotinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 130,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "2007-11-19",
    "brandname": "Tasigna",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 423,
    "emanumber": "741",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "panitumumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 161,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2007-12-03",
    "brandname": "Vectibix",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 424,
    "emanumber": "799",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Temsirolimus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2007-11-19",
    "brandname": "Torisel",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 425,
    "emanumber": "807",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin / metformin hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2007-11-14",
    "brandname": "Eucreas",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 426,
    "emanumber": "793",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 332,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2007-11-14",
    "brandname": "Olanzapine Cipla",
    "mah": "Cipla (EU) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 427,
    "emanumber": "810",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "No Co-rap",
    "decisiondate": "2007-12-12",
    "brandname": "Olanzapine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 428,
    "emanumber": "778",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "paclitaxel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 386,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 184,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2008-01-11",
    "brandname": "Abraxane",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 430,
    "emanumber": "797",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz / emtricitabine / tenofovir disoproxil fumarate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2007-12-13",
    "brandname": "Atripla",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 431,
    "emanumber": "872",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin zeta",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 151,
    "authorisationactivetime": 85,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-12-18",
    "brandname": "Retacrit",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 432,
    "emanumber": "760",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin zeta",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 254,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2007-12-18",
    "brandname": "Silapo",
    "mah": "STADA Arzneimittel AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 433,
    "emanumber": "818",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "nepafenac",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Denmark",
    "decisiondate": "2007-12-11",
    "brandname": "Nevanac",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 434,
    "emanumber": "770",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R01",
    "activesubstance": "Fluticasone furoate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 226,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "Ireland",
    "decisiondate": "2008-01-11",
    "brandname": "Avamys",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 435,
    "emanumber": "910",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2008-01-10",
    "brandname": "TESAVEL",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 436,
    "emanumber": "860",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "raltegravir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 141,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2007-12-20",
    "brandname": "Isentress",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 437,
    "emanumber": "743",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "fosaprepitant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 540,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 343,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-01-11",
    "brandname": "IVEMEND",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 438,
    "emanumber": "884",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Mycophenolate mofetil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 146,
    "authorisationactivetime": 138,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-02-21",
    "brandname": "Myfenax",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 439,
    "emanumber": "882",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Mycophenolate mofetil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 146,
    "authorisationactivetime": 138,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-02-21",
    "brandname": "Mycophenolate mofetil Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 440,
    "emanumber": "795",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "lapatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 414,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 212,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2008-06-10",
    "brandname": "Tyverb",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 441,
    "emanumber": "833",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "fentanyl citrate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2008-04-04",
    "brandname": "Effentora",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 442,
    "emanumber": "829",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "dabigatran etexilate mesilate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "France",
    "decisiondate": "2008-03-18",
    "brandname": "Pradaxa",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 443,
    "emanumber": "823",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Thalidomide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2008-04-16",
    "brandname": "Thalidomide Celgene",
    "mah": "Celgene Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 444,
    "emanumber": "825",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-09-15",
    "brandname": "Ratiograstim",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 445,
    "emanumber": "827",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-09-15",
    "brandname": "Tevagrastim",
    "mah": "Teva GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 446,
    "emanumber": "831",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "Human normal immunoglobulin (IVIg)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 177,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2008-04-25",
    "brandname": "Privigen",
    "mah": "CSL Behring GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 447,
    "emanumber": "777",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "febuxostat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 324,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Sweden",
    "decisiondate": "2008-04-21",
    "brandname": "Adenuric",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 448,
    "emanumber": "734",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "micafungin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 638,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 435,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2008-04-25",
    "brandname": "Mycamine",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 449,
    "emanumber": "824",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-09-15",
    "brandname": "Filgrastim ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 450,
    "emanumber": "826",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-09-15",
    "brandname": "Biograstim",
    "mah": "AbZ-Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 451,
    "emanumber": "839",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "Ambrisentan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Czech Republic",
    "decisiondate": "2008-04-21",
    "brandname": "Volibris",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 452,
    "emanumber": "832",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 161,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-05-20",
    "brandname": "Pandemrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 453,
    "emanumber": "822",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 189,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-05-14",
    "brandname": "Prepandrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 454,
    "emanumber": "933",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Interferon beta-1b",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 157,
    "authorisationactivetime": 77,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2008-05-20",
    "brandname": "Extavia",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 455,
    "emanumber": "861",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin / metformin hydrochloride",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 340,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2008-07-16",
    "brandname": "Janumet",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 456,
    "emanumber": "862",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin / metformin hydrochloride",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2008-07-16",
    "brandname": "Velmetia",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 457,
    "emanumber": "896",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin / metformin hydrochloride",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2008-07-16",
    "brandname": "Efficib",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 458,
    "emanumber": "897",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "nicotinic acid / laropiprant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 77,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-07-03",
    "brandname": "Trevaclyn",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 459,
    "emanumber": "889",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "nicotinic acid / laropiprant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 279,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 77,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-07-03",
    "brandname": "Tredaptive",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 460,
    "emanumber": "903",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "nicotinic acid / laropiprant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 77,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-07-03",
    "brandname": "Pelzont",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 461,
    "emanumber": "899",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "icatibant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 49,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2008-07-11",
    "brandname": "Firazyr",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 462,
    "emanumber": "805",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "ranolazine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 307,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2008-07-09",
    "brandname": "Ranexa",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 463,
    "emanumber": "870",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A06",
    "activesubstance": "methylnaltrexone bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2008-07-02",
    "brandname": "Relistor",
    "mah": "Bausch Health Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 464,
    "emanumber": "974",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "2008-07-16",
    "brandname": "Clopidogrel BMS",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 465,
    "emanumber": "975",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "2008-07-16",
    "brandname": "Clopidogrel Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 466,
    "emanumber": "885",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "sugammadex",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 315,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 101,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-07-25",
    "brandname": "Bridion",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 467,
    "emanumber": "891",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "doripenem",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 315,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Estonia",
    "decisiondate": "2008-07-25",
    "brandname": "Doribax",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 468,
    "emanumber": "900",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "etravirine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 138,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Portugal",
    "decisiondate": "2008-08-28",
    "brandname": "Intelence",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 469,
    "emanumber": "941",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 218,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 41,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-09-12",
    "brandname": "Oprymea",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 470,
    "emanumber": "863",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "lacosamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2008-08-29",
    "brandname": "Vimpat",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 471,
    "emanumber": "1007",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Duloxetine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-10-08",
    "brandname": "Duloxetine Boehringer Ingelheim",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 472,
    "emanumber": "944",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "rivaroxaban",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 244,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2008-09-30",
    "brandname": "Xarelto",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 473,
    "emanumber": "898",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human Fibrinogen / Human Thrombin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 137,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Poland",
    "decisiondate": "2008-10-06",
    "brandname": "Evicel",
    "mah": "Omrix Biopharmaceuticals N.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 474,
    "emanumber": "1019",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R01",
    "activesubstance": "Fluticasone furoate",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 57,
    "authorisationactivetime": 57,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "Ireland",
    "decisiondate": "2008-10-06",
    "brandname": "Alisade",
    "mah": "Glaxo Group Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 475,
    "emanumber": "961",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-10-07",
    "brandname": "Olanzapine Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 476,
    "emanumber": "1021",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "tadalafil",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 57,
    "authorisationactivetime": 57,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Portugal",
    "decisiondate": "2008-10-01",
    "brandname": "Adcirca",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 477,
    "emanumber": "796",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Histamine dihydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 511,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 309,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Sweden",
    "decisiondate": "2008-10-07",
    "brandname": "Ceplene",
    "mah": "Noventia Pharma Srl",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 478,
    "emanumber": "1015",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 57,
    "authorisationactivetime": 57,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2008-09-26",
    "brandname": "Prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 479,
    "emanumber": "890",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 433,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 235,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "France",
    "decisiondate": "2008-11-19",
    "brandname": "Zypadhera",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 480,
    "emanumber": "962",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-12-01",
    "brandname": "Ifirmasta",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 481,
    "emanumber": "943",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "sapropterin dihydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 307,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 107,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Belgium",
    "decisiondate": "2008-12-02",
    "brandname": "Kuvan",
    "mah": "BioMarin International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 482,
    "emanumber": "960",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "brinzolamide / timolol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2008-11-25",
    "brandname": "Azarga",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 483,
    "emanumber": "1049",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin / metformin hydrochloride",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2008-12-01",
    "brandname": "Zomarist",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 484,
    "emanumber": "1050",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin / metformin hydrochloride",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2008-12-01",
    "brandname": "Icandra",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 485,
    "emanumber": "1048",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2008-11-19",
    "brandname": "Jalra",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 486,
    "emanumber": "1051",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "vildagliptin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2008-11-19",
    "brandname": "Xiliarx",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 488,
    "emanumber": "978",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Azacitidine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 69,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2008-12-17",
    "brandname": "Vidaza",
    "mah": "Bristol Myers Squibb Pharma EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 489,
    "emanumber": "819",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "eptotermin alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 491,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 289,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Ireland",
    "decisiondate": "2009-02-19",
    "brandname": "Opgenra",
    "mah": "Olympus Biotech International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 490,
    "emanumber": "940",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2008-12-18",
    "brandname": "Pramipexole Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 491,
    "emanumber": "964",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren hemifumarate / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 195,
    "authorisationstoppedtime": 135,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2009-01-16",
    "brandname": "Rasilez HCT",
    "mah": "Noden Pharma DAC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 492,
    "emanumber": "955",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "tocilizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Hungary",
    "decisiondate": "2009-01-16",
    "brandname": "RoActemra",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 494,
    "emanumber": "958",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "ustekinumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 327,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 123,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2009-01-16",
    "brandname": "Stelara",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 495,
    "emanumber": "917",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-02-06",
    "brandname": "Zarzio",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 496,
    "emanumber": "918",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-02-06",
    "brandname": "Filgrastim Hexal",
    "mah": "Hexal AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 497,
    "emanumber": "942",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "romiplostim",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-02-04",
    "brandname": "Nplate",
    "mah": "Amgen Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 498,
    "emanumber": "916",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "agomelatine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 217,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Sweden",
    "decisiondate": "2009-02-19",
    "brandname": "Thymanax",
    "mah": "Servier (Ireland) Industries Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 499,
    "emanumber": "915",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "agomelatine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 420,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 217,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Sweden",
    "decisiondate": "2009-02-19",
    "brandname": "Valdoxan",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 500,
    "emanumber": "977",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "lasofoxifene",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-02-24",
    "brandname": "Fablyn",
    "mah": "Dr Friedrich Eberth Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 501,
    "emanumber": "963",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Japanese Encephalitis vaccine (inactivated, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2009-03-31",
    "brandname": "Ixiaro",
    "mah": "Valneva Austria GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 502,
    "emanumber": "802",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "mifamurtide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 757,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 552,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2009-03-06",
    "brandname": "Mepact",
    "mah": "Takeda France SAS",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 503,
    "emanumber": "984",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "prasugrel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 91,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2009-02-25",
    "brandname": "Efient",
    "mah": "Daiichi Sankyo Europe GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 504,
    "emanumber": "986",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "degarelix (as acetate)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 195,
    "authorisationstoppedtime": 72,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Norway",
    "decisiondate": "2009-02-17",
    "brandname": "Firmagon",
    "mah": "Ferring Pharmaceuticals A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 505,
    "emanumber": "957",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Influenza Vaccine (split virion, inactivated)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2009-02-24",
    "brandname": "Intanza",
    "mah": "Sanofi Pasteur Europe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 506,
    "emanumber": "982",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H1N1) (whole virion, Vero cell derived, inactivated) A/California/07/2009 (H1N1)v",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2009-03-04",
    "brandname": "Celvapan",
    "mah": "Nanotherapeutics Bohumil, s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 507,
    "emanumber": "966",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Influenza Vaccine (split virion, inactivated)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2009-02-24",
    "brandname": "IDflu",
    "mah": "Sanofi Pasteur SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 508,
    "emanumber": "973",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pneumococcal polysaccharide conjugate vaccine (adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 149,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2009-03-30",
    "brandname": "Synflorix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 509,
    "emanumber": "1018",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-03-31",
    "brandname": "Ribavirin Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 510,
    "emanumber": "1042",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "follitropin beta",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 179,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2009-03-19",
    "brandname": "Fertavid",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 511,
    "emanumber": "913",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "bazedoxifene",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 511,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 309,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2009-04-17",
    "brandname": "Conbriza",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 512,
    "emanumber": "972",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Catumaxomab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 386,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2009-04-20",
    "brandname": "Removab",
    "mah": "Neovii Biotech GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 513,
    "emanumber": "1044",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-04-17",
    "brandname": "Rivastigmine Teva",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 514,
    "emanumber": "988",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "eslicarbazepine acetate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Czech Republic",
    "decisiondate": "2009-04-21",
    "brandname": "Zebinix",
    "mah": "Bial - Portela & C¬™, SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 515,
    "emanumber": "1097",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "pantoprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-06-12",
    "brandname": "CONTROLOC Control",
    "mah": "Takeda GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 516,
    "emanumber": "1098",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "pantoprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-06-12",
    "brandname": "SOMAC Control",
    "mah": "Takeda GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 517,
    "emanumber": "1013",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "pantoprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 70,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-06-12",
    "brandname": "PANTOZOL Control",
    "mah": "Takeda GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 518,
    "emanumber": "1099",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "pantoprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-06-12",
    "brandname": "PANTECTA Control",
    "mah": "Takeda GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 519,
    "emanumber": "1100",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "pantoprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 88,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-06-12",
    "brandname": "PANTOLOC Control",
    "mah": "Takeda GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 520,
    "emanumber": "987",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "eslicarbazepine acetate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Czech Republic",
    "decisiondate": "2009-04-21",
    "brandname": "Exalief",
    "mah": "Bial - Portela & C¬™, SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 521,
    "emanumber": "993",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "sevelamer (carbonate)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-06-10",
    "brandname": "Renvela",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 522,
    "emanumber": "1027",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "ulipristal acetate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2009-05-15",
    "brandname": "ellaOne",
    "mah": "Laboratoire HRA Pharma",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 523,
    "emanumber": "954",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Tacrolimus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Lithuania",
    "decisiondate": "2009-05-15",
    "brandname": "Modigraf",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 524,
    "emanumber": "909",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "Capsaicin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 539,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 337,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Hungary",
    "decisiondate": "2009-05-15",
    "brandname": "Qutenza",
    "mah": "Gr√ºnenthal GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 525,
    "emanumber": "1029",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 69,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-05-11",
    "brandname": "Nimvastid",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 526,
    "emanumber": "1016",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "gefitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 329,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2009-06-24",
    "brandname": "Iressa",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 527,
    "emanumber": "1064",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-01",
    "brandname": "Ribavirin Teva Pharma BV",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 528,
    "emanumber": "1014",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Caffeine citrate",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 126,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Portugal",
    "decisiondate": "2009-07-02",
    "brandname": "Peyona",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 529,
    "emanumber": "1026",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "liraglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 98,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2009-06-30",
    "brandname": "Victoza",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 530,
    "emanumber": "1067",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-06-29",
    "brandname": "Repaglinide Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 531,
    "emanumber": "959",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "Fentanyl",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2009-07-20",
    "brandname": "Instanyl",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 532,
    "emanumber": "1166",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 30,
    "authorisationactivetime": 30,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Clopidogrel Acino",
    "mah": "Acino AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 533,
    "emanumber": "920",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A11",
    "activesubstance": "tocofersolan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 483,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 273,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Hungary",
    "decisiondate": "2009-07-24",
    "brandname": "Vedrop",
    "mah": "Recordati Rare Diseases",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 534,
    "emanumber": "1139",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 96,
    "authorisationactivetime": 87,
    "authorisationstoppedtime": 9,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Clopidogrel Hexal",
    "mah": "Acino Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 535,
    "emanumber": "1059",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Grepid",
    "mah": "Pharmathen S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 536,
    "emanumber": "1031",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "topotecan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-24",
    "brandname": "Topotecan Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 537,
    "emanumber": "1030",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Plerixafor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 131,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2009-07-31",
    "brandname": "Mozobil",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 538,
    "emanumber": "1038",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "everolimus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 104,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2009-08-03",
    "brandname": "Afinitor",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 539,
    "emanumber": "980",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C03",
    "activesubstance": "tolvaptan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 457,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 250,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2009-08-03",
    "brandname": "Samsca",
    "mah": "Otsuka Pharmaceutical Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 540,
    "emanumber": "1053",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Clopidogrel Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 541,
    "emanumber": "1165",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 30,
    "authorisationactivetime": 30,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Clopidogrel ratiopharm GmbH",
    "mah": "Archie Samuel s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 542,
    "emanumber": "1054",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-07-28",
    "brandname": "Clopidogrel 1A Pharma",
    "mah": "Acino Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 543,
    "emanumber": "996",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "aztreonam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "2009-09-21",
    "brandname": "Cayston",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 544,
    "emanumber": "1037",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "certolizumab pegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": null,
    "brandname": "Cimzia",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 545,
    "emanumber": "1039",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "saxagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2009-10-01",
    "brandname": "Onglyza",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 546,
    "emanumber": "992",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "golimumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2009-10-01",
    "brandname": "Simponi",
    "mah": "Janssen Biologics B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 547,
    "emanumber": "1174",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 21,
    "authorisationactivetime": 21,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel Sandoz",
    "mah": "Acino Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 548,
    "emanumber": "1175",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 63,
    "authorisationactivetime": 55,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel Acino Pharma GmbH",
    "mah": "Acino Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 549,
    "emanumber": "1172",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 21,
    "authorisationactivetime": 21,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-28",
    "brandname": "Clopidogrel Acino Pharma",
    "mah": "Acino Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 550,
    "emanumber": "983",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "vinflunine ditartrate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 288,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2009-09-21",
    "brandname": "Javlor",
    "mah": "Pierre Fabre M√©dicament",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 551,
    "emanumber": "1076",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 49,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Vizarsin",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 552,
    "emanumber": "1071",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "topotecan",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 177,
    "authorisationstoppedtime": 69,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Topotecan Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 553,
    "emanumber": "1058",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-28",
    "brandname": "Zyllt",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 554,
    "emanumber": "1173",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 21,
    "authorisationactivetime": 21,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-23",
    "brandname": "Clopidogrel ratiopharm",
    "mah": "Archie Samuel s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 555,
    "emanumber": "1136",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-23",
    "brandname": "Clopidogrel TAD",
    "mah": "TAD Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 556,
    "emanumber": "1056",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-23",
    "brandname": "Clopidogrel Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 557,
    "emanumber": "1135",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-23",
    "brandname": "Clopidogrel Qualimed",
    "mah": "Qualimed",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 558,
    "emanumber": "1138",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel BGR",
    "mah": "Laboratoires BIOGARAN",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 559,
    "emanumber": "1134",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 560,
    "emanumber": "1132",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel DURA",
    "mah": "Mylan dura GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 561,
    "emanumber": "1133",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel Teva Pharma",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 562,
    "emanumber": "1137",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 80,
    "authorisationstoppedtime": 12,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-09-21",
    "brandname": "Clopidogrel Krka d.d.",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 563,
    "emanumber": "878",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "Characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 556,
    "authorisationactivetime": 195,
    "authorisationstoppedtime": 361,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2009-10-05",
    "brandname": "ChondroCelect",
    "mah": "TiGenix NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 564,
    "emanumber": "1109",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Canakinumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2009-10-23",
    "brandname": "Ilaris",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 565,
    "emanumber": "1036",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin theta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2009-10-23",
    "brandname": "Biopoin",
    "mah": "Teva GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 566,
    "emanumber": "1113",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Lamivudine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-10-23",
    "brandname": "Lamivudine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 568,
    "emanumber": "1189",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 21,
    "authorisationactivetime": 21,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-10-16",
    "brandname": "Clopidogrel Taw Pharma",
    "mah": "Taw Pharma (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 569,
    "emanumber": "1068",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 96,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2009-10-16",
    "brandname": "Exforge HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 570,
    "emanumber": "1161",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2009-10-15",
    "brandname": "Imprida HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 571,
    "emanumber": "1200",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H5N1 whole virion, Vero cell derived, inactivated)",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 13,
    "authorisationactivetime": 13,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2009-10-16",
    "brandname": "Pandemic influenza vaccine H5N1 BAXTER",
    "mah": "Ology Bioservices Ireland LTD",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 572,
    "emanumber": "1180",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "alendronic acid / colecalciferol",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Austria",
    "decisiondate": "2009-10-16",
    "brandname": "Vantavo",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 573,
    "emanumber": "1033",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "epoetin theta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2009-10-29",
    "brandname": "Eporatio",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 574,
    "emanumber": "1160",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2009-11-04",
    "brandname": "Dafiro HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 575,
    "emanumber": "1159",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine besylate / valsartan / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Estonia",
    "decisiondate": "2009-11-04",
    "brandname": "Copalia HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 576,
    "emanumber": "1093",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-10-30",
    "brandname": "Irbesartan Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 577,
    "emanumber": "1208",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "A/Viet Nam/1194/2004 (H5N1) virus surface inactivated antigen",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 9,
    "authorisationactivetime": 9,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-10-19",
    "brandname": "Foclivia",
    "mah": "Seqirus S.r.l.,",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 578,
    "emanumber": "1206",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Purified antigen fractions of inactivated split virions A/VietNam/1194/2004 NIBRG-14 (H5N1)",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 8,
    "authorisationactivetime": 8,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2009-10-19",
    "brandname": "Adjupanrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 579,
    "emanumber": "1066",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 96,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-11-04",
    "brandname": "Repaglinide Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 580,
    "emanumber": "1065",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 305,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 96,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-10-14",
    "brandname": "Enyglid",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 581,
    "emanumber": "1012",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A06",
    "activesubstance": "prucalopride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 215,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2009-10-15",
    "brandname": "Resolor",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 582,
    "emanumber": "1047",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Rilonacept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 197,
    "authorisationstoppedtime": 168,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2009-10-23",
    "brandname": "Rilonacept Regeneron",
    "mah": "Regeneron UK Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 583,
    "emanumber": "1112",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 148,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-11-26",
    "brandname": "Irbesartan / Hydrochlorothiazide Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 584,
    "emanumber": "1073",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 129,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-11-30",
    "brandname": "Sildenafil Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 585,
    "emanumber": "1181",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 123,
    "authorisationactivetime": 30,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2009-12-11",
    "brandname": "Rivastigmine 1 A Pharma",
    "mah": "1 A Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 586,
    "emanumber": "1210",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2009-11-30",
    "brandname": "Oslif Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 587,
    "emanumber": "1085",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 102,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-03",
    "brandname": "Olanzapine Glenmark",
    "mah": "Glenmark Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 588,
    "emanumber": "1086",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 102,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-03",
    "brandname": "Olanzapine Glenmark Europe",
    "mah": "Glenmark Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 589,
    "emanumber": "1182",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 123,
    "authorisationactivetime": 30,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2009-12-11",
    "brandname": "Rivastigmine HEXAL",
    "mah": "Hexal AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 590,
    "emanumber": "1104",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 70,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2009-12-09",
    "brandname": "Prevenar 13",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 591,
    "emanumber": "1043",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "dronedarone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 245,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Hungary",
    "decisiondate": "2009-11-26",
    "brandname": "Multaq",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 592,
    "emanumber": "1088",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 102,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-10",
    "brandname": "Olazax Disperzi",
    "mah": "Glenmark Pharmaceuticals s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 593,
    "emanumber": "1114",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2009-11-30",
    "brandname": "Onbrez Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 594,
    "emanumber": "1211",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2009-11-30",
    "brandname": "Hirobriz Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 595,
    "emanumber": "1090",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 367,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-10",
    "brandname": "Sildenafil Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 596,
    "emanumber": "1111",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Lamivudine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 176,
    "authorisationstoppedtime": 35,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-10",
    "brandname": "Lamivudine Teva Pharma B.V.",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 597,
    "emanumber": "1087",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 102,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-11",
    "brandname": "Olazax",
    "mah": "Glenmark Pharmaceuticals s.r.o.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 598,
    "emanumber": "1119",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "nevirapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-11-30",
    "brandname": "Nevirapine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 599,
    "emanumber": "1183",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 123,
    "authorisationactivetime": 30,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2009-12-11",
    "brandname": "Rivastigmine Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 600,
    "emanumber": "1089",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "Human Hepatitis B Immunoglobulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 105,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2009-11-30",
    "brandname": "Zutectra",
    "mah": "Biotest Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 601,
    "emanumber": "1032",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "amifampridine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 196,
    "authorisationstoppedtime": 288,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2009-12-23",
    "brandname": "Firdapse",
    "mah": "SERB S.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 602,
    "emanumber": "1045",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "besilesomab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 253,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2010-01-11",
    "brandname": "Scintimun",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 603,
    "emanumber": "1080",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2009-12-23",
    "brandname": "Sildenafil ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 604,
    "emanumber": "1129",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2010-01-08",
    "brandname": "Leflunomide Zentiva",
    "mah": "Zentiva k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 605,
    "emanumber": "1124",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-01-25",
    "brandname": "Temomedac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 606,
    "emanumber": "1126",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-01-28",
    "brandname": "Temozolomide Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 607,
    "emanumber": "1209",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "silodosin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 118,
    "authorisationactivetime": 85,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2010-01-29",
    "brandname": "Silodyx",
    "mah": "Recordati Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 608,
    "emanumber": "1092",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "silodosin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2010-01-29",
    "brandname": "Urorec",
    "mah": "Recordati Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 609,
    "emanumber": "1106",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "corifollitropin alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "2010-01-25",
    "brandname": "Elonva",
    "mah": "N.V. Organon",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 610,
    "emanumber": "1146",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-01-26",
    "brandname": "Telmisartan Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 611,
    "emanumber": "1107",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 123,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-01-26",
    "brandname": "Docetaxel Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 612,
    "emanumber": "1110",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Eltrombopag",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 159,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2010-03-11",
    "brandname": "Revolade",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 613,
    "emanumber": "1055",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "Human Hepatitis B Immunoglobulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2010-03-15",
    "brandname": "ImmunoGam",
    "mah": "Cangene Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 614,
    "emanumber": "1095",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Meningococcal Group A, C, W135 and Y Conjugate Vaccine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2010-03-15",
    "brandname": "Menveo",
    "mah": "GSK Vaccines S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 615,
    "emanumber": "1125",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-03-15",
    "brandname": "Temozolomide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 616,
    "emanumber": "1127",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-03-15",
    "brandname": "Temozolomide HEXAL",
    "mah": "Hexal AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 617,
    "emanumber": "1128",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-03-15",
    "brandname": "Temozolomide Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 618,
    "emanumber": "1120",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "denosumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 111,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2010-05-26",
    "brandname": "Prolia",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 619,
    "emanumber": "1143",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "clopidogrel / acetylsalicylic acid",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 95,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "2010-03-15",
    "brandname": "DuoPlavin",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 620,
    "emanumber": "1235",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin / metformin hydrochloride",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2010-03-15",
    "brandname": "Ristfor",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 621,
    "emanumber": "1234",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sitagliptin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2010-03-15",
    "brandname": "Ristaben",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 622,
    "emanumber": "1046",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Thiotepa",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 306,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "2010-03-15",
    "brandname": "Tepadina",
    "mah": "ADIENNE S.r.l.S.U.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 623,
    "emanumber": "1144",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "clopidogrel / acetylsalicylic acid",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 95,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Belgium",
    "decisiondate": "2010-03-15",
    "brandname": "Clopidogrel/Acetylsalicylic acid Zentiva",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 624,
    "emanumber": "1201",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 1,
    "authorisationactivetime": 1,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2010-03-23",
    "brandname": "Arepanrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 625,
    "emanumber": "1131",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Ofatumumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 188,
    "authorisationstoppedtime": 142,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Norway",
    "decisiondate": "2010-04-19",
    "brandname": "Arzerra",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 626,
    "emanumber": "1184",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-04-06",
    "brandname": "Ribavirin BioPartners",
    "mah": "BioPartners GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 627,
    "emanumber": "1075",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Raloxifene hydrochloride",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 283,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-04-29",
    "brandname": "Raloxifene Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 628,
    "emanumber": "1141",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Pazopanib hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2010-06-14",
    "brandname": "Votrient",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 629,
    "emanumber": "1202",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (X-179A)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 34,
    "authorisationactivetime": 34,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2010-06-08",
    "brandname": "Humenza",
    "mah": "Sanofi Pasteur SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 630,
    "emanumber": "1074",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 240,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-05-10",
    "brandname": "Docefrez",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 631,
    "emanumber": "1142",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Czech Republic",
    "decisiondate": "2010-06-08",
    "brandname": "Nivestim",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 632,
    "emanumber": "1196",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-06-04",
    "brandname": "Tolura",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 633,
    "emanumber": "1192",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "topotecan",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-06-10",
    "brandname": "Topotecan Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 634,
    "emanumber": "1185",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ribavirin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 198,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-06-10",
    "brandname": "Ribavirin Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 635,
    "emanumber": "1178",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Olanzapine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 96,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-06-10",
    "brandname": "Olanzapine Apotex",
    "mah": "Apotex Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 636,
    "emanumber": "1179",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "roflumilast",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2010-07-05",
    "brandname": "Daxas",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 637,
    "emanumber": "1227",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-07-28",
    "brandname": "Leflunomide medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 638,
    "emanumber": "1140",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "dexamethasone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2010-07-27",
    "brandname": "Ozurdex",
    "mah": "Allergan Pharmaceuticals Ireland",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 639,
    "emanumber": "1168",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-09-30",
    "brandname": "Telmisartan Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 640,
    "emanumber": "1177",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "asenapine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2010-09-01",
    "brandname": "Sycrest",
    "mah": "Organon N.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 641,
    "emanumber": "1223",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "Conestat alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2010-10-28",
    "brandname": "Ruconest",
    "mah": "Pharming Group N.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 642,
    "emanumber": "1195",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-09-17",
    "brandname": "Ibandronic Acid Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 643,
    "emanumber": "1176",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "regadenoson",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 184,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2010-09-06",
    "brandname": "Rapiscan",
    "mah": "GE Healthcare AS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 644,
    "emanumber": "1164",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "Fentanyl",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2010-08-31",
    "brandname": "PecFent",
    "mah": "Kyowa Kirin Holdings B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 645,
    "emanumber": "1215",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "vernakalant hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 100,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2010-09-01",
    "brandname": "Brinavess",
    "mah": "Correvio",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 646,
    "emanumber": "1249",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Velaglucerase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2010-08-26",
    "brandname": "VPRIV",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 647,
    "emanumber": "1218",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Mycophenolate mofetil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 122,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-10-07",
    "brandname": "Myclausen",
    "mah": "Passauer Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 648,
    "emanumber": "1224",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan / amlodipine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Estonia",
    "decisiondate": "2010-10-07",
    "brandname": "Twynsta",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 649,
    "emanumber": "1226",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-06-16",
    "brandname": "Clopidogrel Teva Pharma B.V.",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 650,
    "emanumber": "2254",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-10-28",
    "brandname": "Clopidogrel Teva Generics B.V.",
    "mah": "Teva Generics B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 651,
    "emanumber": "2255",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-10-28",
    "brandname": "Clopidogrel HCS",
    "mah": "HCS bvba",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 652,
    "emanumber": "2155",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Tobramycin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Poland",
    "decisiondate": "2011-07-20",
    "brandname": "TOBI Podhaler",
    "mah": "Mylan IRE Healthcare Ltd",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 654,
    "emanumber": "2035",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "No Co-rap",
    "decisiondate": "2010-11-29",
    "brandname": "Leflunomide ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 655,
    "emanumber": "1241",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "ticagrelor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 103,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2010-12-03",
    "brandname": "Brilique",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 656,
    "emanumber": "2303",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "ticagrelor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 87,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2010-12-03",
    "brandname": "Possia",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 657,
    "emanumber": "2269",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2010-11-29",
    "brandname": "Prepandemic Influenza",
    "mah": "Novartis Vaccines and Diagnostics S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 658,
    "emanumber": "2094",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2010-11-29",
    "brandname": "Aflunov",
    "mah": "Seqirus S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 659,
    "emanumber": "2025",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 273,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 68,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-01-21",
    "brandname": "Iasibon",
    "mah": "Pharmathen S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 660,
    "emanumber": "2282",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "topotecan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-01-06",
    "brandname": "Potactasol",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 661,
    "emanumber": "1101",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "influenza vaccine (live attenuated, nasal)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 664,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 454,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Belgium",
    "decisiondate": "2011-01-27",
    "brandname": "FLUENZ",
    "mah": "MedImmune, LLC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 662,
    "emanumber": "2032",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-01-21",
    "brandname": "Docetaxel Teva Pharma",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 663,
    "emanumber": "1236",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "lamivudine / zidovudine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-02-28",
    "brandname": "Lamivudine / Zidovudine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 664,
    "emanumber": "1212",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 91,
    "authorisationstoppedtime": 365,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2011-03-04",
    "brandname": "Pumarix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 665,
    "emanumber": "2075",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "entacapone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 24,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-02-18",
    "brandname": "Entacapone Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 666,
    "emanumber": "2399",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "roflumilast",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2011-02-28",
    "brandname": "Libertek",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 667,
    "emanumber": "2154",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Pirfenidone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2011-02-28",
    "brandname": "Esbriet",
    "mah": "Roche Registration GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 668,
    "emanumber": "2398",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "roflumilast",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2011-02-28",
    "brandname": "Daliresp",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 669,
    "emanumber": "1242",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Tegafur / gimeracil / oteracil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2011-03-14",
    "brandname": "Teysuno",
    "mah": "Nordic Group B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 671,
    "emanumber": "2048",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "collagenase clostridium histolyticum",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 329,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 119,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2011-02-28",
    "brandname": "Xiapex",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 672,
    "emanumber": "2105",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "paliperidone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 178,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2011-03-04",
    "brandname": "Xeplion",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 673,
    "emanumber": "2302",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan / hydrochlorothiazide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 24,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-03-04",
    "brandname": "Ifirmacombi",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 674,
    "emanumber": "1222",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 239,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-03-14",
    "brandname": "Repso",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 675,
    "emanumber": "2356",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "leflunomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 85,
    "authorisationactivetime": 55,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-03-10",
    "brandname": "Leflunomide Teva",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 676,
    "emanumber": "2018",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cabazitaxel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-03-17",
    "brandname": "JEVTANA",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 677,
    "emanumber": "2202",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Fingolimod",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 364,
    "authorisationactivetime": 181,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2011-03-17",
    "brandname": "Gilenya",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 678,
    "emanumber": "2084",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "eribulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2011-03-17",
    "brandname": "HALAVEN",
    "mah": "Eisai GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 679,
    "emanumber": "1243",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "fenofibrate / pravastatin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "2011-04-14",
    "brandname": "Pravafenix",
    "mah": "LABORATOIRES SMB SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 680,
    "emanumber": "2420",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren / hydrochlorothiazide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2011-04-13",
    "brandname": "Riprazo HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 681,
    "emanumber": "1245",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "retigabine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2011-03-28",
    "brandname": "Trobalt",
    "mah": "Glaxo Group Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 682,
    "emanumber": "2108",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "methylthioninium chloride",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 392,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 182,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Ireland",
    "decisiondate": "2011-05-06",
    "brandname": "Methylthioninium chloride Proveblue",
    "mah": "Provepharm S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 683,
    "emanumber": "2421",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren / hydrochlorothiazide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2011-06-23",
    "brandname": "Sprimeo HCT",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 685,
    "emanumber": "2367",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-07-26",
    "brandname": "Ibandronic acid Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 686,
    "emanumber": "2073",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren / amlodipine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 213,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2011-04-14",
    "brandname": "Rasilamlo",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 687,
    "emanumber": "2127",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "human normal immunoglobulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2011-04-14",
    "brandname": "Hizentra",
    "mah": "CSL Behring GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 688,
    "emanumber": "1207",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "C1 inhibitor, human",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-06-15",
    "brandname": "Cinryze",
    "mah": "Shire Services BVBA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 689,
    "emanumber": "2068",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "nomegestrol / estradiol",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 239,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Hungary",
    "decisiondate": "2011-11-16",
    "brandname": "IOA",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 690,
    "emanumber": "1213",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "nomegestrol / estradiol",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 575,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 365,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Hungary",
    "decisiondate": "2011-07-27",
    "brandname": "Zoely",
    "mah": "Theramex Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 691,
    "emanumber": "2148",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "apixaban",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-05-18",
    "brandname": "Eliquis",
    "mah": "Bristol-Myers Squibb/Pfizer EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 692,
    "emanumber": "1198",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "bromfenac",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 603,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 393,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2011-05-18",
    "brandname": "Yellox",
    "mah": "Bausch Health Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 693,
    "emanumber": "2036",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-06-16",
    "brandname": "Rivastigmine Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 694,
    "emanumber": "2098",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "belatacept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 414,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Lithuania",
    "decisiondate": "2011-06-17",
    "brandname": "NULOJIX",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 695,
    "emanumber": "2380",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "Rotigotine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Netherlands",
    "decisiondate": "2011-06-16",
    "brandname": "Leganto",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 696,
    "emanumber": "2020",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "exenatide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 386,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 203,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2011-06-17",
    "brandname": "Bydureon",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 697,
    "emanumber": "2198",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "temozolomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-07-13",
    "brandname": "Temozolomide SUN",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 698,
    "emanumber": "2213",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ipilimumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2011-07-13",
    "brandname": "YERVOY",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 699,
    "emanumber": "2097",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "fampridine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 364,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2011-07-20",
    "brandname": "Fampyra",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 700,
    "emanumber": "2015",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "belimumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2011-07-13",
    "brandname": "Benlysta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 701,
    "emanumber": "2316",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-08-26",
    "brandname": "Levetiracetam Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 702,
    "emanumber": "2244",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-08-26",
    "brandname": "Levetiracetam ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 703,
    "emanumber": "2173",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "denosumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2011-07-13",
    "brandname": "Xgeva",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 704,
    "emanumber": "2332",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "boceprevir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 155,
    "authorisationactivetime": 145,
    "authorisationstoppedtime": 10,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Netherlands",
    "decisiondate": "2011-07-18",
    "brandname": "Victrelis",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 705,
    "emanumber": "1240",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "telavancin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 337,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2011-09-02",
    "brandname": "Vibativ",
    "mah": "Theravance Biopharma Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 706,
    "emanumber": "2441",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "Levodopa,carbidopa,entacapone",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Portugal",
    "decisiondate": "2011-08-24",
    "brandname": "Levodopa/Carbidopa/Entacapone Orion",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 707,
    "emanumber": "2110",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "linagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2011-08-24",
    "brandname": "Trajenta",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 708,
    "emanumber": "2440",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "entacapone",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Luxembourg",
    "decisiondate": "2011-08-18",
    "brandname": "Entacapone Orion",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 709,
    "emanumber": "2267",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "midazolam",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-09-05",
    "brandname": "Buccolam",
    "mah": "Laboratorios Lesvi, S.L.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 710,
    "emanumber": "2311",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "everolimus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-09-02",
    "brandname": "Votubia",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 711,
    "emanumber": "2024",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 68,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "Belgium",
    "decisiondate": "2011-10-03",
    "brandname": "Matever",
    "mah": "Pharmathen S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 712,
    "emanumber": "2290",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 46,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-10-03",
    "brandname": "Levetiracetam Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 713,
    "emanumber": "2355",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-10-03",
    "brandname": "Levetiracetam Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 714,
    "emanumber": "2321",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "abiraterone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-09-05",
    "brandname": "Zytiga",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 715,
    "emanumber": "2185",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H02",
    "activesubstance": "hydrocortisone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2011-11-03",
    "brandname": "Plenadren",
    "mah": "Shire Services BVBA",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 716,
    "emanumber": "1199",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "P01",
    "activesubstance": "piperaquine tetraphosphate/artenimol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 701,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 492,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2011-10-27",
    "brandname": "Eurartesim",
    "mah": "Alfasigma S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 717,
    "emanumber": "2294",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "tafamidis",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Portugal",
    "decisiondate": "2011-11-16",
    "brandname": "Vyndaqel",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 718,
    "emanumber": "2268",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "dexmedetomidine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 73,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2011-09-16",
    "brandname": "Dexdor",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 719,
    "emanumber": "2511",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-10-03",
    "brandname": "Telmisartan Teva Pharma",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 720,
    "emanumber": "2313",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "telaprevir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2011-09-19",
    "brandname": "Incivo",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 721,
    "emanumber": "2309",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 46,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-21",
    "brandname": "Paglitaz",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 722,
    "emanumber": "2277",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 46,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-21",
    "brandname": "Pioglitazone Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 723,
    "emanumber": "2453",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 46,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-21",
    "brandname": "Pioglitazone Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 727,
    "emanumber": "2022",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Mercaptopurine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 165,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2012-03-09",
    "brandname": "Xaluprine",
    "mah": "Nova Laboratories Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 728,
    "emanumber": "2291",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "pramipexole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 200,
    "authorisationstoppedtime": 46,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-09-30",
    "brandname": "Pramipexole Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 729,
    "emanumber": "2118",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan / amlodipine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 55,
    "authorisationactivetime": 55,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Estonia",
    "decisiondate": "2011-11-24",
    "brandname": "Onduarp",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 730,
    "emanumber": "2017",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "aliskiren / amlodipine / hydrochlorothiazide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Hungary",
    "decisiondate": "2011-11-22",
    "brandname": "Rasitrio",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 731,
    "emanumber": "2059",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "saxagliptin / metformin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2011-11-24",
    "brandname": "Komboglyze",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 732,
    "emanumber": "2419",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-11-24",
    "brandname": "Desloratadine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 733,
    "emanumber": "2087",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A07",
    "activesubstance": "fidaxomicin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2011-12-05",
    "brandname": "Dificlir",
    "mah": "Tillotts Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 734,
    "emanumber": "2293",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "azilsartan medoxomil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2011-12-07",
    "brandname": "Edarbi",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 735,
    "emanumber": "2517",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "azilsartan medoxomil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2011-12-07",
    "brandname": "Ipreziv",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 736,
    "emanumber": "2264",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "rilpivirine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2011-11-28",
    "brandname": "EDURANT",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 737,
    "emanumber": "2312",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / rilpivirine (as hydrochloride) / tenofovir disoproxil (as fumarate)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2011-11-28",
    "brandname": "Eviplera",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 738,
    "emanumber": "2305",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-12-05",
    "brandname": "Levetiracetam Actavis Group",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 739,
    "emanumber": "2310",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-11-28",
    "brandname": "Dasselta",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 740,
    "emanumber": "2204",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "5-Aminolaevulinic acid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2011-12-14",
    "brandname": "Ameluz",
    "mah": "Biofrontera Bioscience GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 741,
    "emanumber": "2051",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-12-14",
    "brandname": "Levetiracetam SUN",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 742,
    "emanumber": "2352",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 108,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-01-09",
    "brandname": "Efavirenz Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 743,
    "emanumber": "2318",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Repaglinide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 129,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-12-22",
    "brandname": "Repaglinide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 744,
    "emanumber": "2261",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "topotecan",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2011-12-22",
    "brandname": "Topotecan Eagle",
    "mah": "Eagle Laboratories Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 745,
    "emanumber": "2435",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-01-13",
    "brandname": "Desloratadine Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 746,
    "emanumber": "2404",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R06",
    "activesubstance": "desloratadine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-01-13",
    "brandname": "Desloratadine ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 747,
    "emanumber": "1225",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Colistimethate sodium",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2012-02-13",
    "brandname": "Colobreathe",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 748,
    "emanumber": "2317",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-01-31",
    "brandname": "Docetaxel Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 749,
    "emanumber": "2315",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "vandetanib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Netherlands",
    "decisiondate": "2012-02-17",
    "brandname": "Caprelsa",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 750,
    "emanumber": "2041",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "ulipristal acetate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 233,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2012-02-23",
    "brandname": "Esmya",
    "mah": "Gedeon Richter Plc.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 751,
    "emanumber": "2409",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "vemurafenib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 203,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 23,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2012-02-17",
    "brandname": "Zelboraf",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 752,
    "emanumber": "2089",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Prepandemic influenza vaccine (A/H5N1) (whole virion, Vero cell derived, inactivated)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2012-02-17",
    "brandname": "Vepacel",
    "mah": "Ology Bioservices Ireland LTD",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 753,
    "emanumber": "2052",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "pasireotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 242,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2012-04-24",
    "brandname": "Signifor",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 754,
    "emanumber": "2021",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-09",
    "brandname": "Sepioglin",
    "mah": "Vaia S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 755,
    "emanumber": "2324",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-15",
    "brandname": "Pioglitazone Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 756,
    "emanumber": "2558",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 92,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-15",
    "brandname": "Glidipion",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 757,
    "emanumber": "2297",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-26",
    "brandname": "Pioglitazone Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 758,
    "emanumber": "2410",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "pioglitazone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 151,
    "authorisationactivetime": 92,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-03-26",
    "brandname": "Pioglitazone Teva Pharma",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 759,
    "emanumber": "2488",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-04-20",
    "brandname": "Zoledronic acid Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 760,
    "emanumber": "1252",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R05",
    "activesubstance": "Mannitol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 841,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2012-04-13",
    "brandname": "Bronchitol",
    "mah": "Pharmaxis Europe Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 761,
    "emanumber": "2362",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-04-20",
    "brandname": "Capecitabine Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 762,
    "emanumber": "2386",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-04-20",
    "brandname": "Capecitabine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 763,
    "emanumber": "2605",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-04-20",
    "brandname": "Ecansya",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 764,
    "emanumber": "2055",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pixantrone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 255,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2012-05-10",
    "brandname": "Pixuvri",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 765,
    "emanumber": "2510",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Irbesartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-04-13",
    "brandname": "Sabervel",
    "mah": "Pharmathen S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 766,
    "emanumber": "2296",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "granisetron",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 247,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "Belgium",
    "decisiondate": "2012-04-20",
    "brandname": "SANCUSO",
    "mah": "Kyowa Kirin Holdings B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 767,
    "emanumber": "2226",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Meningococcal group A, C, W-135 and Y conjugate vaccine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2012-04-20",
    "brandname": "Nimenrix",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 768,
    "emanumber": "2622",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Riluzole",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-05-07",
    "brandname": "Riluzole Zentiva",
    "mah": "Zentiva k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 769,
    "emanumber": "2539",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-05-22",
    "brandname": "Docetaxel Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 770,
    "emanumber": "2325",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-05-22",
    "brandname": "Docetaxel Kabi",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 771,
    "emanumber": "2439",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-08-16",
    "brandname": "Zoledronic acid Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 772,
    "emanumber": "2437",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-08-16",
    "brandname": "Zoledronic acid Teva Pharma",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 773,
    "emanumber": "2464",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ruxolitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 94,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2012-08-23",
    "brandname": "Jakavi",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 774,
    "emanumber": "2215",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "Ferumoxytol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 666,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 458,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Lithuania",
    "decisiondate": "2012-06-15",
    "brandname": "Rienso",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 775,
    "emanumber": "2284",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "catridecacog",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2012-09-03",
    "brandname": "NovoThirteen",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 776,
    "emanumber": "2434",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "Perampanel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 129,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2012-07-23",
    "brandname": "Fycompa",
    "mah": "Eisai GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 777,
    "emanumber": "2406",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Axitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Denmark",
    "decisiondate": "2012-09-03",
    "brandname": "Inlyta",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 778,
    "emanumber": "2211",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "aclidinium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 73,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2012-07-20",
    "brandname": "Eklira Genuair",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 779,
    "emanumber": "2359",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-08-03",
    "brandname": "Zoledronic acid medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 780,
    "emanumber": "2279",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "linagliptin/metformin hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 101,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2012-07-20",
    "brandname": "Jentadueto",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 781,
    "emanumber": "2706",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "aclidinium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 91,
    "authorisationactivetime": 84,
    "authorisationstoppedtime": 7,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2012-07-20",
    "brandname": "Bretaris Genuair",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 782,
    "emanumber": "2494",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R07",
    "activesubstance": "ivacaftor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Hungary",
    "decisiondate": "2012-07-23",
    "brandname": "Kalydeco",
    "mah": "Vertex Pharmaceuticals (Ireland) Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 783,
    "emanumber": "2387",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D06",
    "activesubstance": "Imiquimod",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 136,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-08-23",
    "brandname": "Zyclara",
    "mah": "Meda AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 784,
    "emanumber": "2136",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "NA",
    "activesubstance": "Copper <sup>64</sup>Cu chloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 610,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 409,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2012-08-23",
    "brandname": "Cuprymina",
    "mah": "A.C.O.M. -ADVANCED CENTER ONCOLOGY MACERATA -S.R.L.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 785,
    "emanumber": "2252",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "ceftaroline fosamil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 519,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 318,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Estonia",
    "decisiondate": "2012-08-23",
    "brandname": "Zinforo",
    "mah": "Pfizer Ireland Pharmaceuticals",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 786,
    "emanumber": "2482",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 192,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-08-23",
    "brandname": "Zoledronic acid Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 787,
    "emanumber": "2345",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "teduglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 255,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "2012-08-30",
    "brandname": "Revestive",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 788,
    "emanumber": "2430",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "glycopyrronium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 73,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2012-09-28",
    "brandname": "Seebri Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 789,
    "emanumber": "2691",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "glycopyrronium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2012-09-28",
    "brandname": "Enurev Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 790,
    "emanumber": "2690",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "glycopyrronium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2012-09-28",
    "brandname": "Tovanor Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 791,
    "emanumber": "2145",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "Alipogene tiparvovec",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 638,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2012-10-25",
    "brandname": "Glybera",
    "mah": "uniQure biopharma B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 792,
    "emanumber": "2221",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Decitabine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2012-09-20",
    "brandname": "Dacogen",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 793,
    "emanumber": "2489",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "crizotinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 136,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2012-10-23",
    "brandname": "XALKORI",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 794,
    "emanumber": "2455",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Brentuximab vedotin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2012-10-25",
    "brandname": "ADCETRIS",
    "mah": "Takeda Pharma A/S",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 795,
    "emanumber": "2322",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "dapagliflozin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 248,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2012-11-12",
    "brandname": "Forxiga",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 796,
    "emanumber": "2275",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D06",
    "activesubstance": "ingenol mebutate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2012-11-15",
    "brandname": "Picato",
    "mah": "LEO Laboratories Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 797,
    "emanumber": "2392",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "aflibercept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2012-11-22",
    "brandname": "Eylea",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 798,
    "emanumber": "2638",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Ibandronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-11-19",
    "brandname": "Ibandronic acid Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 799,
    "emanumber": "2711",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-11-22",
    "brandname": "Memantine Merz",
    "mah": "Merz Pharmaceuticals GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 800,
    "emanumber": "2365",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-11-19",
    "brandname": "Zoledronic acid Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 801,
    "emanumber": "2490",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A06",
    "activesubstance": "linaclotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "unknown",
    "decisiondate": "2012-11-26",
    "brandname": "Constella",
    "mah": "Allergan Pharmaceuticals International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 802,
    "emanumber": "2568",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 129,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2012-11-19",
    "brandname": "Capecitabine medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 803,
    "emanumber": "2246",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D03",
    "activesubstance": "Concentrate of proteolytic enzymes enriched in bromelain",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 673,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 463,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2012-12-18",
    "brandname": "NexoBrid",
    "mah": "MediWound Germany GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 804,
    "emanumber": "2377",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "colestilan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Lithuania",
    "decisiondate": "2013-01-21",
    "brandname": "BindRen",
    "mah": "Mitsubishi Tanabe Pharma Europe Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 805,
    "emanumber": "2422",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "Florbetapir (<sup>18</sup>F)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 65,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2013-01-14",
    "brandname": "Amyvid",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 806,
    "emanumber": "2499",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin degludec/insulin aspart",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2013-01-21",
    "brandname": "Ryzodeg",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 807,
    "emanumber": "2498",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin degludec",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2013-01-21",
    "brandname": "Tresiba",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 808,
    "emanumber": "2585",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 101,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-01-08",
    "brandname": "Imatinib Teva",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 809,
    "emanumber": "2388",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "mirabegron",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 192,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2012-12-20",
    "brandname": "Betmiga",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 810,
    "emanumber": "2208",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "pegloticase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 311,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2013-01-08",
    "brandname": "Krystexxa",
    "mah": "Crealta Pharmaceuticals Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 811,
    "emanumber": "2445",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "lixisenatide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 378,
    "authorisationactivetime": 214,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2013-02-01",
    "brandname": "Lyxumia",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 812,
    "emanumber": "2333",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Meningococcal group B Vaccine (rDNA, component, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 666,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 465,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2013-01-14",
    "brandname": "Bexsero",
    "mah": "GlaxoSmithKline Vaccines S.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 813,
    "emanumber": "2547",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pertuzumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2013-03-04",
    "brandname": "Perjeta",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 814,
    "emanumber": "2532",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "aflibercept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2013-02-01",
    "brandname": "ZALTRAP",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 815,
    "emanumber": "2583",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "nalmefene",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2013-02-25",
    "brandname": "Selincro",
    "mah": "H. Lundbeck A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 817,
    "emanumber": "2676",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "Telmisartan / hydrochlorothiazide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 237,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-03-13",
    "brandname": "Actelsar HCT",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 818,
    "emanumber": "2373",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Bosutinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 517,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 307,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2013-03-27",
    "brandname": "Bosulif",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 819,
    "emanumber": "2381",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "ocriplasmin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2013-03-13",
    "brandname": "JETREA",
    "mah": "Inceptua AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 820,
    "emanumber": "2658",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-04-29",
    "brandname": "Marixino",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 821,
    "emanumber": "2549",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "telmisartan/hydrochlorothiazide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 237,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-03-13",
    "brandname": "Tolucombi",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 822,
    "emanumber": "2500",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Sodium phenylbutyrate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 335,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-07-31",
    "brandname": "PHEBURANE",
    "mah": "Eurocept International BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 823,
    "emanumber": "2400",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "loxapine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 332,
    "authorisationactivetime": 170,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2013-02-20",
    "brandname": "Adasuve",
    "mah": "Ferrer Internacional S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 824,
    "emanumber": "2680",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 244,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-04-22",
    "brandname": "Nemdatine",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 825,
    "emanumber": "2594",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-04-17",
    "brandname": "Imatinib Actavis",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 826,
    "emanumber": "2630",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 65,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-04-22",
    "brandname": "Memantine LEK",
    "mah": "Pharmathen S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 827,
    "emanumber": "2660",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 219,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 37,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-04-22",
    "brandname": "Memantine Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 828,
    "emanumber": "2702",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 156,
    "authorisationactivetime": 117,
    "authorisationstoppedtime": 39,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2013-04-17",
    "brandname": "Hexacima",
    "mah": "Sanofi Pasteur",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 829,
    "emanumber": "2796",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and <i>Haemophilus influenzae</i> type b conjugate vaccine (adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 155,
    "authorisationactivetime": 116,
    "authorisationstoppedtime": 39,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2013-04-17",
    "brandname": "Hexyon",
    "mah": "Sanofi Pasteur",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 830,
    "emanumber": "2574",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil (as fumarate)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 253,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2013-05-24",
    "brandname": "Stribild",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 831,
    "emanumber": "2050",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "capecitabine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 307,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-06-21",
    "brandname": "Capecitabine SUN",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 832,
    "emanumber": "2644",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "bosentan",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2013-06-24",
    "brandname": "Stayveer",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 833,
    "emanumber": "2560",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Dextromethorphan / quinidine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 524,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 316,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2013-06-24",
    "brandname": "Nuedexta",
    "mah": "Jenson Pharmaceutical Services Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 834,
    "emanumber": "2667",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 545,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 335,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-01-16",
    "brandname": "Zoledronic acid Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 835,
    "emanumber": "2669",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "voriconazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-05-16",
    "brandname": "Voriconazole Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 836,
    "emanumber": "2671",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-06-13",
    "brandname": "Memantine ratiopharm",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 837,
    "emanumber": "2601",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Dimethyl fumarate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 363,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-01-30",
    "brandname": "Tecfidera",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 838,
    "emanumber": "2514",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Teriflunomide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 391,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2013-08-26",
    "brandname": "AUBAGIO",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 839,
    "emanumber": "2695",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ponatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2013-07-01",
    "brandname": "Iclusig",
    "mah": "Incyte Biosciences Distribution B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 840,
    "emanumber": "2491",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "human normal immunoglobulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 517,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 316,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2013-05-16",
    "brandname": "HyQvia",
    "mah": "Baxalta Innovations GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 841,
    "emanumber": "2581",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "avanafil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 398,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Italy",
    "decisiondate": "2013-06-21",
    "brandname": "Spedra",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 842,
    "emanumber": "2178",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "alogliptin / pioglitazone",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 370,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2013-09-19",
    "brandname": "Incresync",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 843,
    "emanumber": "2654",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "alogliptin / metformin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 370,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 160,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2013-09-19",
    "brandname": "Vipdomet",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 844,
    "emanumber": "2182",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "alogliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 398,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2013-09-19",
    "brandname": "Vipidia",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 845,
    "emanumber": "2681",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 307,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-07-01",
    "brandname": "Imatinib Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 846,
    "emanumber": "2639",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "enzalutamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 251,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 41,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2013-06-21",
    "brandname": "Xtandi",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 847,
    "emanumber": "2522",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "Matrix applied characterised autologous cultured chondrocytes",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 580,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 375,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2013-06-27",
    "brandname": "MACI",
    "mah": "Vericel Denmark ApS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 848,
    "emanumber": "2602",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "vismodegib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 489,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 281,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2013-07-12",
    "brandname": "Erivedge",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 849,
    "emanumber": "2196",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H01",
    "activesubstance": "Somatropin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 461,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 252,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2013-08-05",
    "brandname": "Somatropin Biopartners",
    "mah": "BioPartners GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 850,
    "emanumber": "2682",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Pomalidomide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 342,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2013-08-05",
    "brandname": "Imnovid",
    "mah": "Bristol Myers Squibb Pharma EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 851,
    "emanumber": "2578",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "Lomitapide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 433,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 223,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2013-07-31",
    "brandname": "Lojuxta",
    "mah": "Amryt Pharmaceuticals DAC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 852,
    "emanumber": "2329",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G02",
    "activesubstance": "Atosiban",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 254,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 72,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-07-31",
    "brandname": "Atosiban SUN",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 853,
    "emanumber": "2576",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "infliximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 461,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 260,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2013-09-10",
    "brandname": "Remsima",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 854,
    "emanumber": "2778",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "infliximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 349,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 260,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2013-09-10",
    "brandname": "Inflectra",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 855,
    "emanumber": "2596",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "modified vaccinia ankara virus",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 433,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 224,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2013-07-31",
    "brandname": "Imvanex",
    "mah": "Bavarian Nordic A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 856,
    "emanumber": "2556",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "lipegfilgrastim",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 524,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 314,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2013-07-25",
    "brandname": "Lonquex",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 857,
    "emanumber": "2493",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "human coagulation factor VIII / human von Willebrand factor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 524,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 314,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2013-08-12",
    "brandname": "Voncento",
    "mah": "CSL Behring GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 858,
    "emanumber": "2573",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "regorafenib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 398,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2013-08-26",
    "brandname": "Stivarga",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 859,
    "emanumber": "2785",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "levodopa / carbidopa / entacapone",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 145,
    "authorisationactivetime": 92,
    "authorisationstoppedtime": 53,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Portugal",
    "decisiondate": "2013-11-11",
    "brandname": "Corbilta",
    "mah": "Orion Corporation",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 860,
    "emanumber": "2618",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A02",
    "activesubstance": "esomeprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 342,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 132,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "United Kingdom",
    "decisiondate": "2013-08-26",
    "brandname": "Nexium Control",
    "mah": "GlaxoSmithKline Dungarvan Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 861,
    "emanumber": "2465",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "mercaptamine (cysteamine bitartrate)",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 461,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 260,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Ireland",
    "decisiondate": "2013-09-06",
    "brandname": "Procysbi",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 862,
    "emanumber": "2679",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol/glycopyrronium bromide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 272,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2013-09-19",
    "brandname": "Ultibro Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 863,
    "emanumber": "3755",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol/glycopyrronium bromide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 51,
    "authorisationstoppedtime": 69,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2013-09-19",
    "brandname": "Xoterna Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 865,
    "emanumber": "2604",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "DABRAFENIB",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 314,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 104,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2013-08-26",
    "brandname": "Tafinlar",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 866,
    "emanumber": "2559",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "fenofibrate / simvastatin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 517,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 316,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Estonia",
    "decisiondate": "2013-08-26",
    "brandname": "Cholib",
    "mah": "Mylan IRE Healthcare Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 867,
    "emanumber": "2513",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Autologous peripheral blood mononuclear cells activated with PAP-GM-CSF (Sipuleucel-T)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 284,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2013-09-06",
    "brandname": "Provenge",
    "mah": "Dendreon UK Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 868,
    "emanumber": "2515",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human fibrinogen/Human thrombin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 461,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 260,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Poland",
    "decisiondate": "2013-09-25",
    "brandname": "EVARREST",
    "mah": "Omrix Biopharmaceuticals N.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 869,
    "emanumber": "3718",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Alemtuzumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 160,
    "authorisationactivetime": 84,
    "authorisationstoppedtime": 76,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2013-09-12",
    "brandname": "Lemtrada",
    "mah": "Sanofi Belgium",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 870,
    "emanumber": "1250",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A05",
    "activesubstance": "Cholic acid",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2012-05-25",
    "brandname": "Orphacol",
    "mah": "Laboratoires CTRS",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 871,
    "emanumber": "2608",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Follitropin alfa",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 489,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Hungary",
    "decisiondate": "2013-09-27",
    "brandname": "Ovaleap",
    "mah": "Theramex Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 872,
    "emanumber": "2572",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "cobicistat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2013-09-19",
    "brandname": "Tybost",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 873,
    "emanumber": "2653",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "Radium Ra 223 dichloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 233,
    "authorisationactivetime": 183,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2013-11-13",
    "brandname": "Xofigo",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 875,
    "emanumber": "2552",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J04",
    "activesubstance": "delamanid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 701,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Belgium",
    "decisiondate": "2014-04-28",
    "brandname": "Deltyba",
    "mah": "Otsuka Novel Products GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 876,
    "emanumber": "2692",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 93,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-09-25",
    "brandname": "Imatinib Medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 877,
    "emanumber": "2150",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2013-10-18",
    "brandname": "Grastofil",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 878,
    "emanumber": "2393",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "defibrotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 792,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2013-10-18",
    "brandname": "Defitelio",
    "mah": "Gentium S.r.I.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 879,
    "emanumber": "2280",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "afatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 307,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2013-09-25",
    "brandname": "Giotrif",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 880,
    "emanumber": "2766",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Memantine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 363,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2013-12-04",
    "brandname": "Memantine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 881,
    "emanumber": "2693",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "lidocaine / prilocaine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2013-11-15",
    "brandname": "Fortacin",
    "mah": "Recordati Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 882,
    "emanumber": "2755",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 265,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Greece",
    "decisiondate": "2013-11-15",
    "brandname": "ABILIFY MAINTENA",
    "mah": "Otsuka Pharmaceutical Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 883,
    "emanumber": "2577",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "elvitegravir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2013-11-13",
    "brandname": "Vitekta",
    "mah": "Gilead Sciences International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 884,
    "emanumber": "2649",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "canagliflozin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2013-11-15",
    "brandname": "Invokana",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 885,
    "emanumber": "2389",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Trastuzumab emtansine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 363,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2013-11-15",
    "brandname": "Kadcyla",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 886,
    "emanumber": "2673",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "fluticasone furoate/vilanterol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2013-11-13",
    "brandname": "Relvar Ellipta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 887,
    "emanumber": "2617",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "influenza vaccine (live attenuated, nasal)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 328,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Norway",
    "decisiondate": "2013-12-04",
    "brandname": "Fluenz Tetra",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 888,
    "emanumber": "2719",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "turoctocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 300,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2013-11-13",
    "brandname": "NovoEight",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 889,
    "emanumber": "2783",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "levetiracetam",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 300,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-01-08",
    "brandname": "Levetiracetam Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 890,
    "emanumber": "2640",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cabozantinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 391,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2014-03-21",
    "brandname": "Cometriq",
    "mah": "Ipsen Pharma",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 891,
    "emanumber": "2717",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "vortioxetine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 398,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2013-12-18",
    "brandname": "Brintellix",
    "mah": "H. Lundbeck A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 892,
    "emanumber": "2753",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "dolutegravir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 293,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2014-01-16",
    "brandname": "Tivicay",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 893,
    "emanumber": "2697",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "macitentan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 335,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2013-12-20",
    "brandname": "Opsumit",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 894,
    "emanumber": "2798",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "sofosbuvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Estonia",
    "decisiondate": "2014-01-16",
    "brandname": "Sovaldi",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 895,
    "emanumber": "2081",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A05",
    "activesubstance": "Cholic acid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 552,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 370,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-04-04",
    "brandname": "Kolbam",
    "mah": "Retrophin Europe Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 896,
    "emanumber": "2709",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J04",
    "activesubstance": "Para-aminosalicylic acid",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 616,
    "authorisationactivetime": 218,
    "authorisationstoppedtime": 398,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2014-04-07",
    "brandname": "Granupas",
    "mah": "Eurocept International B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 898,
    "emanumber": "2751",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "umeclidinium bromide / vilanterol trifenatate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 387,
    "authorisationactivetime": 205,
    "authorisationstoppedtime": 182,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-05-08",
    "brandname": "Anoro Ellipta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 899,
    "emanumber": "3754",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "umeclidinium bromide / vilanterol trifenatate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 149,
    "authorisationstoppedtime": 182,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-05-08",
    "brandname": "Laventair Ellipta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 900,
    "emanumber": "2672",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "dapagliflozin/metformin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 328,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": "2014-01-16",
    "brandname": "Xigduo",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 901,
    "emanumber": "2614",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J04",
    "activesubstance": "bedaquiline",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2014-03-05",
    "brandname": "Sirturo",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 902,
    "emanumber": "2720",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "ataluren",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2014-07-31",
    "brandname": "Translarna",
    "mah": "PTC Therapeutics International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 904,
    "emanumber": "2642",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "brimonidine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 321,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 111,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2014-02-21",
    "brandname": "Mirvaso",
    "mah": "Galderma International",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 905,
    "emanumber": "2738",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Travoprost",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 320,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 111,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "unknown",
    "decisiondate": "2014-02-20",
    "brandname": "Izba",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 906,
    "emanumber": "2553",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "florbetaben (<sup>18</sup>F)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 321,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 111,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2014-02-20",
    "brandname": "Neuraceq",
    "mah": "Life Radiopharma Berlin GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 907,
    "emanumber": "2737",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "riociguat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2014-03-27",
    "brandname": "Adempas",
    "mah": "Bayer AG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 908,
    "emanumber": "2735",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "albiglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2014-03-21",
    "brandname": "Eperzan",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 909,
    "emanumber": "2615",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "Follitropin alfa",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 426,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2014-03-27",
    "brandname": "Bemfola",
    "mah": "Gedeon Richter Plc.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 911,
    "emanumber": "3824",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Rivastigmine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-04-03",
    "brandname": "Rivastigmine 3M Health Care Ltd.",
    "mah": "3M Health Care Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 912,
    "emanumber": "2805",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "zoledronic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-03-27",
    "brandname": "Zoledronic acid Teva Generics",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 913,
    "emanumber": "2713",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "lurasidone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 454,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-03-21",
    "brandname": "Latuda",
    "mah": "Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 914,
    "emanumber": "2779",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "elosulfase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2014-04-28",
    "brandname": "Vimizim",
    "mah": "BioMarin International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 915,
    "emanumber": "3717",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Oseltamivir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-05-22",
    "brandname": "Ebilfumin",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 916,
    "emanumber": "3880",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Portugal",
    "decisiondate": "2014-04-10",
    "brandname": "Pregabalin Pfizer",
    "mah": "Upjohn EESV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 917,
    "emanumber": "3875",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol/glycopyrronium bromide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Ireland",
    "decisiondate": "2014-04-23",
    "brandname": "Ulunar Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 918,
    "emanumber": "2656",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "canagliflozin / metformin hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2014-04-23",
    "brandname": "Vokanamet",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 919,
    "emanumber": "2621",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C07",
    "activesubstance": "propranolol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-04-23",
    "brandname": "Hemangiol",
    "mah": "Pierre Fabre Dermatologie",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 920,
    "emanumber": "2348",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-04-28",
    "brandname": "DuoResp Spiromax",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 921,
    "emanumber": "3890",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 63,
    "authorisationactivetime": 32,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-04-28",
    "brandname": "BiResp Spiromax",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 922,
    "emanumber": "2809",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "umeclidinium bromide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-04-28",
    "brandname": "Incruse Ellipta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 923,
    "emanumber": "2782",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "vedolizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 149,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2014-05-22",
    "brandname": "Entyvio",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 924,
    "emanumber": "2777",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "simeprevir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Italy",
    "decisiondate": "2014-05-14",
    "brandname": "OLYSIO",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 928,
    "emanumber": "3708",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "siltuximab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 177,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-05-22",
    "brandname": "Sylvant",
    "mah": "EUSA Pharma (Netherlands) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 929,
    "emanumber": "2745",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "fluticasone furoate / vilanterol",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2014-05-02",
    "brandname": "Revinty Ellipta",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 930,
    "emanumber": "2677",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Empagliflozin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2014-05-22",
    "brandname": "Jardiance",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 931,
    "emanumber": "2643",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trametinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 415,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 205,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2014-06-30",
    "brandname": "Mekinist",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 932,
    "emanumber": "2633",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Tobramycin",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 582,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 372,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-03-18",
    "brandname": "Vantobra",
    "mah": "PARI Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 933,
    "emanumber": "3698",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Brinzolamide / Brimonidine tartrate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2014-07-18",
    "brandname": "Simbrinza",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 934,
    "emanumber": "2827",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "peginterferon beta-1a",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2014-07-18",
    "brandname": "Plegridy",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 935,
    "emanumber": "2655",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Tacrolimus",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-07-18",
    "brandname": "Envarsus",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 936,
    "emanumber": "2813",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "simoctocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2014-07-22",
    "brandname": "Nuwiq",
    "mah": "Octapharma AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 937,
    "emanumber": "2799",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "obinutuzumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "France",
    "decisiondate": "2014-07-23",
    "brandname": "Gazyvaro",
    "mah": "Roche Registration GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 938,
    "emanumber": "3843",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "idelalisib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2014-09-18",
    "brandname": "Zydelig",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 939,
    "emanumber": "3768",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "daclatasvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-08-22",
    "brandname": "Daklinza",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 940,
    "emanumber": "2754",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "dolutegravir / abacavir / lamivudine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 219,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 37,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2014-09-01",
    "brandname": "Triumeq",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 941,
    "emanumber": "2557",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "flutemetamol (18F)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 548,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 335,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2014-08-22",
    "brandname": "Vizamyl",
    "mah": "GE Healthcare AS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 942,
    "emanumber": "2272",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "clopidogrel / acetylsalicylic acid",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 98,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Estonia",
    "decisiondate": "2014-09-01",
    "brandname": "Clopidogrel / Acetylsalicylic acid Teva",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 943,
    "emanumber": "2705",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "mixture of polynuclear iron(iii)-oxyhydroxide, sucrose and starches",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 513,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 302,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Lithuania",
    "decisiondate": "2014-08-26",
    "brandname": "Velphoro",
    "mah": "Vifor Fresenius Medical Care Renal Pharma France",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 944,
    "emanumber": "2835",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 199,
    "authorisationstoppedtime": 167,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Hungary",
    "decisiondate": "2014-09-09",
    "brandname": "Abasaglar",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 945,
    "emanumber": "3791",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Ibrutinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2014-10-21",
    "brandname": "IMBRUVICA",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 946,
    "emanumber": "3956",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "filgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Spain",
    "decisiondate": "2014-09-18",
    "brandname": "Accofil",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 947,
    "emanumber": "2647",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin degludec / liraglutide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-09-18",
    "brandname": "Xultophy",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 948,
    "emanumber": "3951",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 63,
    "authorisationactivetime": 32,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-11-19",
    "brandname": "Budesonide/Formoterol Teva",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 949,
    "emanumber": "3952",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 154,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-11-19",
    "brandname": "Vylaer Spiromax",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 950,
    "emanumber": "3953",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 154,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-11-19",
    "brandname": "Budesonide/Formoterol Teva Pharma B.V.",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 951,
    "emanumber": "2806",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "busulfan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-09-22",
    "brandname": "Busulfan Fresenius Kabi",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 952,
    "emanumber": "3971",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Sevelamer carbonate",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 117,
    "authorisationactivetime": 94,
    "authorisationstoppedtime": 23,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-01-15",
    "brandname": "Sevelamer carbonate Winthrop",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 953,
    "emanumber": "3968",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "sevelamer hydrochloride",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 145,
    "authorisationactivetime": 122,
    "authorisationstoppedtime": 23,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Belgium",
    "decisiondate": "2015-02-26",
    "brandname": "Tasermity",
    "mah": "Genzyme Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 954,
    "emanumber": "2569",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "nintedanib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Norway",
    "decisiondate": "2014-11-21",
    "brandname": "Vargatef",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 955,
    "emanumber": "2085",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "tilmanocept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 604,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 391,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2014-11-19",
    "brandname": "Lymphoseek",
    "mah": "Navidea Biopharmaceuticals Europe Ltd.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 956,
    "emanumber": "2825",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "dulaglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2014-11-21",
    "brandname": "Trulicity",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 957,
    "emanumber": "2829",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ramucirumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Iceland",
    "decisiondate": "2014-12-19",
    "brandname": "Cyramza",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 958,
    "emanumber": "3850",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ledipasvir/sofosbuvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2014-11-17",
    "brandname": "Harvoni",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 959,
    "emanumber": "3726",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Olaparib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Belgium",
    "decisiondate": "2014-12-16",
    "brandname": "Lynparza",
    "mah": "AstraZeneca AB",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 960,
    "emanumber": "2314",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "oestrogens conjugated / bazedoxifene",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 825,
    "authorisationactivetime": 201,
    "authorisationstoppedtime": 624,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2014-12-16",
    "brandname": "DUAVIVE",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 961,
    "emanumber": "3787",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "tadalafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2014-11-21",
    "brandname": "Tadalafil Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 962,
    "emanumber": "2810",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A06",
    "activesubstance": "naloxegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Poland",
    "decisiondate": "2014-12-08",
    "brandname": "Moventig",
    "mah": "Kyowa Kirin Holdings B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 963,
    "emanumber": "3969",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "aclidinium bromide / formoterol fumarate dihydrate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 213,
    "authorisationactivetime": 116,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2014-11-19",
    "brandname": "Brimica Genuair",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 964,
    "emanumber": "3745",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "aclidinium bromide / formoterol fumarate dihydrate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 97,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2014-11-19",
    "brandname": "Duaklir Genuair",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 965,
    "emanumber": "3906",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "ketoconazole",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 60,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2014-11-19",
    "brandname": "Ketoconazole HRA",
    "mah": "HRA Pharma Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 967,
    "emanumber": "2819",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Darunavir/Cobicistat",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2014-11-19",
    "brandname": "Rezolsta",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 969,
    "emanumber": "2548",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D02",
    "activesubstance": "afamelanotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 953,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 743,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2014-12-22",
    "brandname": "SCENESSE",
    "mah": "Clinuvel Europe Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 970,
    "emanumber": "3771",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "nonacog gamma",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "France",
    "decisiondate": "2014-12-19",
    "brandname": "Rixubis",
    "mah": "Baxalta Innovations GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 971,
    "emanumber": "4066",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "paliperidone",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2014-12-05",
    "brandname": "Trevicta",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 972,
    "emanumber": "4000",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Duloxetine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 152,
    "authorisationactivetime": 122,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Sweden",
    "decisiondate": "2014-12-08",
    "brandname": "Duloxetine Lilly",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 973,
    "emanumber": "2789",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "levofloxacin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Czech Republic",
    "decisiondate": "2015-03-26",
    "brandname": "Quinsair",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 974,
    "emanumber": "3724",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "eliglustat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2015-01-19",
    "brandname": "Cerdelga",
    "mah": "Genzyme Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 975,
    "emanumber": "4006",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Clopidogrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 145,
    "authorisationactivetime": 114,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-02-19",
    "brandname": "Clopidogrel ratiopharm",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 976,
    "emanumber": "2814",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "vorapaxar",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 117,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Estonia",
    "decisiondate": "2015-01-19",
    "brandname": "Zontivity",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 977,
    "emanumber": "3957",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "rasagiline",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 61,
    "authorisationactivetime": 61,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Ireland",
    "decisiondate": "2015-01-12",
    "brandname": "Rasagiline ratiopharm",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 978,
    "emanumber": "2780",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "ospemifene",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 604,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 391,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2015-01-15",
    "brandname": "Senshio",
    "mah": "Shionogi B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 979,
    "emanumber": "3821",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "nintedanib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 177,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-01-15",
    "brandname": "Ofev",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 980,
    "emanumber": "3729",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "secukinumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Sweden",
    "decisiondate": "2015-01-15",
    "brandname": "Cosentyx",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 981,
    "emanumber": "3746",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "apremilast",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 117,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-01-15",
    "brandname": "Otezla",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 982,
    "emanumber": "3839",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ombitasvir / paritaprevir / ritonavir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 177,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-01-15",
    "brandname": "Viekirax",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 983,
    "emanumber": "3837",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "dasabuvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 177,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-01-15",
    "brandname": "Exviera",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 984,
    "emanumber": "2396",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "safinamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-02-24",
    "brandname": "Xadago",
    "mah": "Zambon S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 985,
    "emanumber": "2807",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human Fibrinogen / Human Thrombin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Poland",
    "decisiondate": "2015-03-19",
    "brandname": "Raplixa",
    "mah": "Mallinckrodt Pharmaceuticals Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 986,
    "emanumber": "2840",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Dalbavancin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 145,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2015-02-19",
    "brandname": "Xydalba",
    "mah": "Allergan Pharmaceuticals International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 987,
    "emanumber": "2450",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Ex vivo expanded autologous human corneal epithelial cells containing stem cells",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 632,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 424,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2015-02-17",
    "brandname": "Holoclar",
    "mah": "Holostem Terapie Avanzate S.r.l.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 988,
    "emanumber": "3687",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A08",
    "activesubstance": "naltrexone / bupropion",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-03-26",
    "brandname": "Mysimba",
    "mah": "Orexigen Therapeutics Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 989,
    "emanumber": "3785",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "oritavancin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2015-03-19",
    "brandname": "Orbactiv",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 990,
    "emanumber": "2066",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Ciclosporin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Hungary",
    "decisiondate": "2015-03-19",
    "brandname": "IKERVIS",
    "mah": "Santen Oy",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 991,
    "emanumber": "2846",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "tedizolid phosphate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Sweden",
    "decisiondate": "2015-03-23",
    "brandname": "Sivextro",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 992,
    "emanumber": "3780",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "liraglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2015-03-23",
    "brandname": "Saxenda",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 993,
    "emanumber": "2629",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "edoxaban",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2015-06-19",
    "brandname": "Lixiana",
    "mah": "Daiichi Sankyo Europe GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 994,
    "emanumber": "3773",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "cangrelor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 180,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2015-03-23",
    "brandname": "Kengrexal",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 995,
    "emanumber": "3823",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "lamivudine / raltegravir",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2015-03-26",
    "brandname": "DUTREBIS",
    "mah": "Merck Sharp & Dohme Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 996,
    "emanumber": "3910",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 159,
    "authorisationactivetime": 92,
    "authorisationstoppedtime": 67,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-04-13",
    "brandname": "Ristempa",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 997,
    "emanumber": "4078",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-25",
    "brandname": "Pregabalin Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 998,
    "emanumber": "3962",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-25",
    "brandname": "Pregabalin Mylan Pharma",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 999,
    "emanumber": "3819",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ceritinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Norway",
    "decisiondate": "2015-05-06",
    "brandname": "Zykadia",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1000,
    "emanumber": "2788",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C03",
    "activesubstance": "tolvaptan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 215,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2015-05-27",
    "brandname": "Jinarc",
    "mah": "Otsuka Pharmaceutical Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1001,
    "emanumber": "3728",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "‚Äònetupitant/palonosetron‚Äô or ‚Äòfosnetupitant/palonosetron‚Äô",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 216,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "France",
    "decisiondate": "2015-05-27",
    "brandname": "Akynzeo",
    "mah": "Helsinn Birex Pharmaceuticals Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1002,
    "emanumber": "3727",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "lenvatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-05-28",
    "brandname": "Lenvima",
    "mah": "Eisai GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1003,
    "emanumber": "3770",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "empagliflozin / metformin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 65,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2015-05-27",
    "brandname": "Synjardy",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1004,
    "emanumber": "3737",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "voriconazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-05-27",
    "brandname": "Voriconazole Hikma",
    "mah": "Hikma Farmac√™utica (Portugal), S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1005,
    "emanumber": "3803",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-30",
    "brandname": "Aripiprazole Mylan Pharma",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1006,
    "emanumber": "2739",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "human alpha1-proteinase inhibitor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 334,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2015-08-20",
    "brandname": "Respreeza",
    "mah": "CSL Behring GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1007,
    "emanumber": "3852",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "human papillomavirus 9-valent vaccine (recombinant, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2015-06-10",
    "brandname": "Gardasil 9",
    "mah": "MSD VACCINS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1008,
    "emanumber": "3870",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "tasimelteon",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2015-07-03",
    "brandname": "Hetlioz",
    "mah": "Vanda Pharmaceuticals Netherlands B.V.,",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1009,
    "emanumber": "3899",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-25",
    "brandname": "Aripiprazole Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1010,
    "emanumber": "3981",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Duloxetine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 8,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-19",
    "brandname": "Duloxetine Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1011,
    "emanumber": "4010",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-19",
    "brandname": "Pregabalin Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1012,
    "emanumber": "4070",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 247,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-06-19",
    "brandname": "Pregabalin Sandoz GmbH",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1013,
    "emanumber": "2749",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "lutetium, isotope of mass 177",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 209,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2015-06-19",
    "brandname": "Lumark",
    "mah": "IDB Holland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1014,
    "emanumber": "3985",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "nivolumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 175,
    "authorisationstoppedtime": 37,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-06-19",
    "brandname": "OPDIVO",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1015,
    "emanumber": "3794",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "asfotase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2015-08-28",
    "brandname": "Strensiq",
    "mah": "Alexion Europe SAS",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1016,
    "emanumber": "3766",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "evolocumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 240,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2015-07-17",
    "brandname": "Repatha",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1017,
    "emanumber": "3925",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Docetaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-08-28",
    "brandname": "Taxespira",
    "mah": "Hospira UK Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1018,
    "emanumber": "3702",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "phenylephrine / ketorolac",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 604,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 394,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Hungary",
    "decisiondate": "2015-07-28",
    "brandname": "Omidria",
    "mah": "Omeros Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1019,
    "emanumber": "3984",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bortezomib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-07-20",
    "brandname": "Bortezomib Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1020,
    "emanumber": "3834",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "idebenone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "Austria",
    "decisiondate": "2015-09-08",
    "brandname": "Raxone",
    "mah": "Santhera Pharmaceuticals (Deutschland) GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1021,
    "emanumber": "3900",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-07-17",
    "brandname": "Pregabalin Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1022,
    "emanumber": "2800",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "dinutuximab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 299,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2015-08-14",
    "brandname": "Unituxin",
    "mah": "United Therapeutics Europe Ltd",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1023,
    "emanumber": "3725",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "panobinostat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 177,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2015-08-28",
    "brandname": "Farydak",
    "mah": "Secura Bio Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1024,
    "emanumber": "3820",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pembrolizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Germany",
    "decisiondate": "2015-07-17",
    "brandname": "KEYTRUDA",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1025,
    "emanumber": "3904",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "atazanavir / cobicistat",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-07-13",
    "brandname": "EVOTAZ",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1026,
    "emanumber": "3840",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "nivolumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 240,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 58,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2015-07-20",
    "brandname": "Nivolumab BMS",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1027,
    "emanumber": "4024",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-08-28",
    "brandname": "Pregabalin Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1028,
    "emanumber": "3935",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Duloxetine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-08-20",
    "brandname": "Duloxetine Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1029,
    "emanumber": "4008",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-08-20",
    "brandname": "Aripiprazole Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1030,
    "emanumber": "2839",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "sonidegib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 181,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2015-08-14",
    "brandname": "Odomzo",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1031,
    "emanumber": "3882",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "alirocumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2015-09-23",
    "brandname": "Praluent",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1032,
    "emanumber": "3772",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "ceftolozane / tazobactam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2015-09-18",
    "brandname": "Zerbaxa",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1033,
    "emanumber": "4004",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "sebelipase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 152,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Portugal",
    "decisiondate": "2015-08-28",
    "brandname": "Kanuma",
    "mah": "Alexion Europe SAS",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1034,
    "emanumber": "4114",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 212,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 30,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-09-14",
    "brandname": "Pemetrexed Lilly",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1035,
    "emanumber": "2792",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "susoctocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2015-11-11",
    "brandname": "OBIZUR",
    "mah": "Baxalta Innovations GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1036,
    "emanumber": "2734",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "isavuconazole",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 125,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2015-10-15",
    "brandname": "Cresemba",
    "mah": "Basilea Pharmaceutica Deutschland GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1037,
    "emanumber": "4011",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 268,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-09-18",
    "brandname": "Pemetrexed Sandoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1038,
    "emanumber": "3905",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-11-27",
    "brandname": "Pemetrexed medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1039,
    "emanumber": "3776",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "ferric citrate coordination complex",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 272,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "Italy",
    "decisiondate": "2015-09-23",
    "brandname": "Fexeric",
    "mah": "Akebia Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1040,
    "emanumber": "3759",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "guanfacine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 279,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Poland",
    "decisiondate": "2015-09-17",
    "brandname": "Intuniv",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1041,
    "emanumber": "4187",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2015-09-08",
    "brandname": "Ivabradine Anpharm",
    "mah": "ANPHARM Przedsiebiorstwo Farmaceutyczne S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1042,
    "emanumber": "2784",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "Sufentanil",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Hungary",
    "decisiondate": "2015-09-18",
    "brandname": "Zalviso",
    "mah": "Gr√ºnenthal GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1043,
    "emanumber": "3860",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "mepolizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2015-12-02",
    "brandname": "Nucala",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1044,
    "emanumber": "2611",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "levodopa / carbidopa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Hungary",
    "decisiondate": "2015-11-19",
    "brandname": "Numient",
    "mah": "Amneal Pharma Europe Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1045,
    "emanumber": "4021",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "aripiprazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 188,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-11-16",
    "brandname": "Aripiprazole Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1046,
    "emanumber": "3964",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "efmoroctocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2015-11-19",
    "brandname": "Elocta",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1047,
    "emanumber": "3731",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "blinatumomab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2015-11-23",
    "brandname": "BLINCYTO",
    "mah": "Amgen Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1048,
    "emanumber": "3960",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cobimetinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2015-11-20",
    "brandname": "Cotellic",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1049,
    "emanumber": "3769",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "mercaptamine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 751,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 539,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-01-19",
    "brandname": "Cystadrops",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1050,
    "emanumber": "2715",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "Fentanyl",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 153,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2015-11-19",
    "brandname": "IONSYS",
    "mah": "Incline Therapeutics Europe Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1051,
    "emanumber": "4162",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "dapagliflozin / metformin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": "2015-11-16",
    "brandname": "Ebymect",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1052,
    "emanumber": "4161",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "dapagliflozin",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2015-11-09",
    "brandname": "Edistride",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1053,
    "emanumber": "4071",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H02",
    "activesubstance": "dexamethasone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 387,
    "authorisationactivetime": 106,
    "authorisationstoppedtime": 281,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2016-03-16",
    "brandname": "Neofordex",
    "mah": "Laboratoires CTRS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1054,
    "emanumber": "4014",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Cinacalcet",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-11-19",
    "brandname": "Cinacalcet Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1055,
    "emanumber": "3788",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-12-02",
    "brandname": "Ciambra",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1056,
    "emanumber": "3986",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "idarucizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2015-11-20",
    "brandname": "Praxbind",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1057,
    "emanumber": "3970",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2015-11-20",
    "brandname": "Pemetrexed Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1058,
    "emanumber": "4062",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "sacubitril / valsartan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2015-11-19",
    "brandname": "Entresto",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1059,
    "emanumber": "3954",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R07",
    "activesubstance": "Lumacaftor/Ivacaftor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 303,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2015-11-19",
    "brandname": "Orkambi",
    "mah": "Vertex Pharmaceuticals (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1060,
    "emanumber": "3790",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "carfilzomib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2015-11-19",
    "brandname": "Kyprolis",
    "mah": "Amgen Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1061,
    "emanumber": "4042",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 275,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 62,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2015-11-19",
    "brandname": "Genvoya",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1062,
    "emanumber": "3822",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Glycerol phenylbutyrate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 457,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 244,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2015-11-27",
    "brandname": "Ravicti",
    "mah": "Immedica Pharma AB",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1063,
    "emanumber": "4109",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-01-18",
    "brandname": "Armisarte",
    "mah": "Actavis Group PTC ehf.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1064,
    "emanumber": "2771",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "talimogene laherparepvec",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 236,
    "authorisationstoppedtime": 158,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2015-12-16",
    "brandname": "Imlygic",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1065,
    "emanumber": "4104",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "Eptifibatide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-01-11",
    "brandname": "Eptifibatide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1066,
    "emanumber": "2790",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "opicapone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 492,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 280,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2016-06-24",
    "brandname": "Ongentys",
    "mah": "Bial - Portela & C¬™, SA",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1067,
    "emanumber": "4025",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "lopinavir / Ritonavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-01-14",
    "brandname": "Lopinavir/Ritonavir Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1068,
    "emanumber": "2616",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "Pitolisant hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 541,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 337,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-03-31",
    "brandname": "Wakix",
    "mah": "Bioprojet Pharma",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1069,
    "emanumber": "3938",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D03",
    "activesubstance": "birch bark extract",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 387,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 174,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Latvia",
    "decisiondate": "2016-01-14",
    "brandname": "Episalvan",
    "mah": "Amryt GMBH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1070,
    "emanumber": "3789",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pegaspargase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 272,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Italy",
    "decisiondate": "2016-01-14",
    "brandname": "Oncaspar",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1071,
    "emanumber": "4072",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-01-18",
    "brandname": "Pemetrexed Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1072,
    "emanumber": "2661",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "asparaginase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 694,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 490,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2016-01-14",
    "brandname": "Spectrila",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1073,
    "emanumber": "3898",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "brivaracetam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2016-01-14",
    "brandname": "Briviact",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1074,
    "emanumber": "4007",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Etanercept",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Finland",
    "decisiondate": "2016-01-14",
    "brandname": "Benepali",
    "mah": "Samsung Bioepis NL B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1075,
    "emanumber": "2733",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "ferric maltol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 149,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2016-02-18",
    "brandname": "Feraccru",
    "mah": "Norgine B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1076,
    "emanumber": "3825",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "octocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-02-18",
    "brandname": "Kovaltry",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1077,
    "emanumber": "4147",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "octocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 363,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 146,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-02-18",
    "brandname": "Iblias",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1078,
    "emanumber": "3861",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Parathyroid hormone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 821,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 609,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-04-24",
    "brandname": "Natpar",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1079,
    "emanumber": "3982",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Norway",
    "decisiondate": "2016-02-15",
    "brandname": "Vaxelis",
    "mah": "MCM Vaccine B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1080,
    "emanumber": "3932",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "lesinurad",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 118,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-02-18",
    "brandname": "Zurampic",
    "mah": "Gr√ºnenthal GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1081,
    "emanumber": "4134",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "caspofungin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 268,
    "authorisationactivetime": 213,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-02-11",
    "brandname": "Caspofungin Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1082,
    "emanumber": "4059",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "migalastat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 79,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Czech Republic",
    "decisiondate": "2016-05-26",
    "brandname": "Galafold",
    "mah": "Amicus Therapeutics Europe Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1083,
    "emanumber": "3774",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "selexipag",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 219,
    "authorisationstoppedtime": 182,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2016-05-12",
    "brandname": "Uptravi",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1084,
    "emanumber": "3886",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "necitumumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 359,
    "authorisationactivetime": 204,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2016-02-15",
    "brandname": "Portrazza",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1085,
    "emanumber": "3943",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "ixekizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-04-25",
    "brandname": "Taltz",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1086,
    "emanumber": "4124",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "osimertinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Norway",
    "decisiondate": "2016-02-02",
    "brandname": "TAGRISSO",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1087,
    "emanumber": "3855",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "human coagulation factor X",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Germany",
    "decisiondate": "2016-03-16",
    "brandname": "Coagadex",
    "mah": "BPL Bioproducts Laboratory GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1088,
    "emanumber": "3967",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "elotuzumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2016-05-11",
    "brandname": "Empliciti",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1089,
    "emanumber": "3963",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Pandemic influenza vaccine (H5N1) (live attenuated, nasal)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 374,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 163,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2016-05-20",
    "brandname": "Pandemic influenza vaccine H5N1 AstraZeneca",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1090,
    "emanumber": "4064",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "rasagiline",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 98,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-04-04",
    "brandname": "Rasagiline Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1091,
    "emanumber": "4048",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "atazanavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 520,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 308,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-08-22",
    "brandname": "Atazanavir Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1092,
    "emanumber": "4037",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "amlodipine/valsartan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 126,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-03-22",
    "brandname": "Amlodipine/Valsartan Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1093,
    "emanumber": "4127",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "zonisamide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 218,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 38,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-03-31",
    "brandname": "Zonisamide Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1094,
    "emanumber": "3844",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ixazomib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 174,
    "authorisationstoppedtime": 107,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2016-11-21",
    "brandname": "Ninlaro",
    "mah": "Takeda Pharma A/S",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1095,
    "emanumber": "3955",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "albutrepenonacog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 126,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2016-05-11",
    "brandname": "IDELVION",
    "mah": "CSL Behring GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1096,
    "emanumber": "3897",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trifluridine / tipiracil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 126,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2016-04-25",
    "brandname": "Lonsurf",
    "mah": "Les Laboratoires Servier",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1097,
    "emanumber": "3854",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 100,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "Spain",
    "decisiondate": "2016-05-26",
    "brandname": "Strimvelis",
    "mah": "Orchard Therapeutics (Netherlands) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1098,
    "emanumber": "4142",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "eftrenonacog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Spain",
    "decisiondate": "2016-05-12",
    "brandname": "ALPROLIX",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1099,
    "emanumber": "4094",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir alafenamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2016-04-21",
    "brandname": "Descovy",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1100,
    "emanumber": "4069",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "Palonosetron",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 274,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 94,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-04-08",
    "brandname": "Palonosetron Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1101,
    "emanumber": "4077",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "daratumumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 184,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 34,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2016-05-20",
    "brandname": "Darzalex",
    "mah": "Janssen-Cilag International NV",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1102,
    "emanumber": "4076",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bortezomib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Croatia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-07-22",
    "brandname": "Bortezomib SUN",
    "mah": "Sun Pharmaceutical Industries Europe BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1103,
    "emanumber": "4343",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C09",
    "activesubstance": "sacubitril / valsartan",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2016-05-26",
    "brandname": "Neparvis",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1104,
    "emanumber": "4129",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "Palonosetron",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 310,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 100,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-05-26",
    "brandname": "Palonosetron Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1105,
    "emanumber": "3999",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "Lutetium (<sup>177</sup> Lu) chloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-07-06",
    "brandname": "EndolucinBeta",
    "mah": "ITM Medical Isotopes GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1106,
    "emanumber": "4020",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "infliximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 374,
    "authorisationactivetime": 212,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2016-05-26",
    "brandname": "Flixabi",
    "mah": "Samsung Bioepis NL B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1107,
    "emanumber": "3862",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "daclizumab beta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 401,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 192,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "unknown",
    "decisiondate": "2016-07-01",
    "brandname": "Zinbryta",
    "mah": "Biogen Idec Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1108,
    "emanumber": "4057",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "saxagliptin / dapagliflozin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2016-07-15",
    "brandname": "Qtern",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1109,
    "emanumber": "4027",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "ceftazidime/avibactam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2016-06-24",
    "brandname": "Zavicefta",
    "mah": "Pfizer Ireland Pharmaceuticals",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1110,
    "emanumber": "4061",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A05",
    "activesubstance": "chenodeoxycholic acid",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Greece",
    "decisiondate": "2017-04-10",
    "brandname": "Chenodeoxycholic acid Leadiant",
    "mah": "Leadiant GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1112,
    "emanumber": "4156",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / rilpivirine / tenofovir alafenamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2016-06-21",
    "brandname": "Odefsey",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1113,
    "emanumber": "2070",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A09",
    "activesubstance": "pancreas powder",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2016-06-29",
    "brandname": "Enzepi",
    "mah": "Allergan Pharmaceuticals International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1114,
    "emanumber": "4207",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bortezomib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-07-22",
    "brandname": "Bortezomib Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1115,
    "emanumber": "3895",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-07-22",
    "brandname": "Pemetrexed Fresenius Kabi",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1116,
    "emanumber": "4210",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "sofosbuvir/velpatasvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 175,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Estonia",
    "decisiondate": "2016-07-06",
    "brandname": "Epclusa",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1119,
    "emanumber": "4126",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "elbasvir / grazoprevir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2016-07-22",
    "brandname": "Zepatier",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1121,
    "emanumber": "2801",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (<U+0394>LNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 821,
    "authorisationactivetime": 206,
    "authorisationstoppedtime": 615,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "Spain",
    "decisiondate": "2016-08-18",
    "brandname": "Zalmoxis",
    "mah": "MolMed S.p.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1122,
    "emanumber": "2752",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "salmeterol/fluticasone propionate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Malta",
    "decisiondate": "2016-08-18",
    "brandname": "Aerivio Spiromax",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1123,
    "emanumber": "4267",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "salmeterol/fluticasone propionate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 364,
    "authorisationactivetime": 209,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Malta",
    "decisiondate": "2016-08-18",
    "brandname": "Airexar Spiromax",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1124,
    "emanumber": "3983",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "methotrexate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-08-18",
    "brandname": "Nordimet",
    "mah": "Nordic Group B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1125,
    "emanumber": "3912",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "reslizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "2016-08-16",
    "brandname": "Cinqaero",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1126,
    "emanumber": "4098",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A07",
    "activesubstance": "eluxadoline",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-09-19",
    "brandname": "Truberzi",
    "mah": "Allergan Pharmaceuticals International Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1127,
    "emanumber": "4120",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-09-15",
    "brandname": "Tenofovir disoproxil Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1128,
    "emanumber": "4224",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "lenvatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-08-25",
    "brandname": "Kisplyx",
    "mah": "Eisai GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1129,
    "emanumber": "4049",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-12-08",
    "brandname": "Tenofovir disoproxil Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1130,
    "emanumber": "4125",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "irinotecan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2016-10-14",
    "brandname": "Onivyde pegylated liposomal",
    "mah": "Les Laboratoires Servier",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1131,
    "emanumber": "3795",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "enoxaparin sodium",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2016-09-15",
    "brandname": "Thorinane",
    "mah": "Techdow Pharma Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1132,
    "emanumber": "4264",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "enoxaparin sodium",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 119,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2016-09-15",
    "brandname": "Inhixa",
    "mah": "Techdow Pharma Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1133,
    "emanumber": "4050",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 239,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-12-16",
    "brandname": "Emtricitabine/Tenofovir disoproxil Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1134,
    "emanumber": "4186",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 231,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 51,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-09-15",
    "brandname": "Mysildecard",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1135,
    "emanumber": "3883",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A03",
    "activesubstance": "glycopyrronium bromide",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 429,
    "authorisationactivetime": 239,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Czech Republic",
    "decisiondate": "2016-09-15",
    "brandname": "Sialanar",
    "mah": "Proveca Pharma Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1136,
    "emanumber": "4163",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cabozantinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2016-09-09",
    "brandname": "CABOMETYX",
    "mah": "Ipsen Pharma",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1137,
    "emanumber": "4289",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "sildenafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 287,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 107,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-11-14",
    "brandname": "Granpidam",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1138,
    "emanumber": "4106",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "venetoclax",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 315,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 107,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2016-12-05",
    "brandname": "Venclyxto",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1139,
    "emanumber": "4093",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A05",
    "activesubstance": "obeticholic acid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 477,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Italy",
    "decisiondate": "2016-12-12",
    "brandname": "Ocaliva",
    "mah": "Intercept Pharma International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1140,
    "emanumber": "4068",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "darunavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 239,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-01-04",
    "brandname": "Darunavir Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1141,
    "emanumber": "4140",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "edotreotide",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Poland",
    "decisiondate": "2016-12-08",
    "brandname": "SomaKit TOC",
    "mah": "Advanced Accelerator Applications",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1142,
    "emanumber": "3995",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "etelcalcetide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Austria",
    "decisiondate": "2016-11-11",
    "brandname": "Parsabiv",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1143,
    "emanumber": "4216",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "olaratumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 54,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Italy",
    "decisiondate": "2016-11-09",
    "brandname": "Lartruvo",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1144,
    "emanumber": "4117",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 287,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 77,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-11-11",
    "brandname": "Ivabradine Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1145,
    "emanumber": "4217",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 287,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 107,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-11-11",
    "brandname": "Ivabradine JensonR",
    "mah": "JensonR+ Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1146,
    "emanumber": "3833",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "empagliflozin/linagliptin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2016-11-11",
    "brandname": "Glyxambi",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1147,
    "emanumber": "3853",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "palbociclib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2016-11-09",
    "brandname": "IBRANCE",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1148,
    "emanumber": "4137",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-11-09",
    "brandname": "Emtricitabine/Tenofovir disoproxil Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1150,
    "emanumber": "3994",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "follitropin delta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "United Kingdom",
    "decisiondate": "2016-12-12",
    "brandname": "Rekovelle",
    "mah": "Ferring Pharmaceuticals A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1151,
    "emanumber": "4215",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2016-12-08",
    "brandname": "Emtricitabine/Tenofovir disoproxil Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1152,
    "emanumber": "4339",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "edoxaban",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 165,
    "authorisationactivetime": 90,
    "authorisationstoppedtime": 75,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Germany",
    "decisiondate": "2017-04-20",
    "brandname": "Roteas",
    "mah": "Berlin-Chemie AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1153,
    "emanumber": "4297",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "tadalafil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-01-09",
    "brandname": "Talmanco",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1154,
    "emanumber": "4169",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "tenofovir alafenamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2017-01-09",
    "brandname": "Vemlidy",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1155,
    "emanumber": "3959",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "brodalumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 532,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 329,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2017-07-17",
    "brandname": "Kyntheum",
    "mah": "Leo Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1156,
    "emanumber": "4136",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "bezlotoxumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 343,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2017-01-18",
    "brandname": "ZINPLAVA",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1157,
    "emanumber": "4243",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine / lixisenatide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 232,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 29,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2017-01-11",
    "brandname": "Suliqua",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1158,
    "emanumber": "4075",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "lonoctocog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2017-01-04",
    "brandname": "AFSTYLA",
    "mah": "CSL Behring GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1159,
    "emanumber": "3916",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Teriparatide",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-01-04",
    "brandname": "Terrosa",
    "mah": "Gedeon Richter Plc.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1160,
    "emanumber": "4046",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin aspart",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2017-01-09",
    "brandname": "Fiasp",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1161,
    "emanumber": "4368",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Teriparatide",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 331,
    "authorisationactivetime": 225,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-01-11",
    "brandname": "Movymia",
    "mah": "STADA Arzneimittel AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1162,
    "emanumber": "4101",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Hungary",
    "decisiondate": "2017-01-04",
    "brandname": "Lusduna",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1163,
    "emanumber": "4373",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2017-03-22",
    "brandname": "SOLYMBIC",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1164,
    "emanumber": "4212",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2017-03-22",
    "brandname": "AMGEVITA",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1165,
    "emanumber": "4167",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Etanercept",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 120,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Belgium",
    "decisiondate": "2017-02-13",
    "brandname": "LIFMIOR",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1166,
    "emanumber": "4277",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "pregabalin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 207,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 87,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-02-27",
    "brandname": "Pregabalin Zentiva k.s",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1167,
    "emanumber": "4112",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 414,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 204,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-02-17",
    "brandname": "Truxima",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1168,
    "emanumber": "4459",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "simoctocog alfa",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2017-02-13",
    "brandname": "Vihuma",
    "mah": "Octapharma AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1169,
    "emanumber": "4164",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "alectinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 442,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 232,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2017-02-16",
    "brandname": "Alecensa",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1170,
    "emanumber": "4085",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "baricitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2017-02-13",
    "brandname": "Olumiant",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1171,
    "emanumber": "2826",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "chlormethine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 568,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 358,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2017-03-03",
    "brandname": "Ledaga",
    "mah": "Helsinn Birex Pharmaceuticals Ltd.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1172,
    "emanumber": "3756",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "methotrexate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 674,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 463,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-03-29",
    "brandname": "Jylamvo",
    "mah": "Therakind (Europe) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1173,
    "emanumber": "4029",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "sodium zirconium cyclosilicate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Lithuania",
    "corapporteur": "Poland",
    "decisiondate": "2018-03-22",
    "brandname": "Lokelma",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1174,
    "emanumber": "4654",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "umeclidinium",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Belgium",
    "decisiondate": "2017-03-20",
    "brandname": "Rolufta Ellipta",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1175,
    "emanumber": "4310",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Daptomycin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-03-22",
    "brandname": "Daptomycin Hospira",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1176,
    "emanumber": "4016",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Miglustat",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 674,
    "authorisationactivetime": 211,
    "authorisationstoppedtime": 463,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-03-22",
    "brandname": "Yargesa",
    "mah": "Piramal Critical Care B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1177,
    "emanumber": "4666",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "tadalafil",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Portugal",
    "decisiondate": "2017-03-22",
    "brandname": "Tadalafil Lilly",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1178,
    "emanumber": "4214",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Tofacitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Italy",
    "decisiondate": "2017-03-22",
    "brandname": "Xeljanz",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1179,
    "emanumber": "4180",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "patiromer",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2017-07-19",
    "brandname": "Veltassa",
    "mah": "Vifor Fresenius Medical Care Renal Pharma France",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1180,
    "emanumber": "4196",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A04",
    "activesubstance": "rolapitant",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Ireland",
    "decisiondate": "2017-04-20",
    "brandname": "Varuby",
    "mah": "TESARO Bio Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1181,
    "emanumber": "2736",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "spheroids of human autologous matrix-associated chondrocytes",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 1604,
    "authorisationactivetime": 202,
    "authorisationstoppedtime": 1402,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "unknown",
    "decisiondate": "2017-07-10",
    "brandname": "Spherox",
    "mah": "CO.DON AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1182,
    "emanumber": "4686",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-04-28",
    "brandname": "Emtricitabine /Tenofovir disoproxil Krka d.d.",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1183,
    "emanumber": "4488",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 255,
    "authorisationactivetime": 128,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-04-24",
    "brandname": "Pemetrexed Pfizer",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1184,
    "emanumber": "4729",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 127,
    "authorisationactivetime": 100,
    "authorisationstoppedtime": 27,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2017-06-15",
    "brandname": "Riximyo",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1185,
    "emanumber": "3903",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2017-06-15",
    "brandname": "Rixathon",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1186,
    "emanumber": "4197",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "fluciclovine (<sup>18</sup>F)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 449,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 239,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2017-05-22",
    "brandname": "Axumin",
    "mah": "Blue Earth Diagnostics Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1187,
    "emanumber": "4051",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "meningococcal group B vaccine (recombinant, adsorbed)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Sweden",
    "decisiondate": "2017-05-24",
    "brandname": "Trumenba",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1188,
    "emanumber": "4312",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "nusinersen",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 177,
    "authorisationactivetime": 145,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-05-30",
    "brandname": "Spinraza",
    "mah": "Biogen Netherlands B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1189,
    "emanumber": "4246",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "pentosan polysulfate sodium",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Lithuania",
    "decisiondate": "2017-06-02",
    "brandname": "Elmiron",
    "mah": "bene-Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1190,
    "emanumber": "4241",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Ivabradine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 476,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 266,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-05-22",
    "brandname": "Ivabradine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1191,
    "emanumber": "3918",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "dinutuximab beta",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 666,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 463,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Netherlands",
    "decisiondate": "2017-05-08",
    "brandname": "Qarziba",
    "mah": "EUSA Pharma (Netherlands) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1192,
    "emanumber": "4065",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "cerliponase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 219,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 69,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2017-05-30",
    "brandname": "Brineura",
    "mah": "BioMarin International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1193,
    "emanumber": "4178",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "nonacog beta pegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 213,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "France",
    "decisiondate": "2017-06-02",
    "brandname": "Refixia",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1194,
    "emanumber": "4374",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "febuxostat",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-06-15",
    "brandname": "Febuxostat Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1195,
    "emanumber": "4192",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Etanercept",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 505,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 295,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Finland",
    "decisiondate": "2017-06-23",
    "brandname": "Erelzi",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1196,
    "emanumber": "4254",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "sarilumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 72,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2017-06-23",
    "brandname": "Kevzara",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1197,
    "emanumber": "4209",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "cenegermin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Ireland",
    "decisiondate": "2017-07-06",
    "brandname": "OXERVATE",
    "mah": "Domp√© farmaceutici S.p.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1199,
    "emanumber": "4005",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "trientine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 478,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 268,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Austria",
    "decisiondate": "2017-09-05",
    "brandname": "Cuprior",
    "mah": "Orphalan",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1200,
    "emanumber": "4119",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "inotuzumab ozogamicin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2017-06-29",
    "brandname": "Besponsa",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1201,
    "emanumber": "2157",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Dimethyl fumarate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 478,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 268,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2017-06-23",
    "brandname": "Skilarence",
    "mah": "Almirall, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1202,
    "emanumber": "4019",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Carglumic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "Belgium",
    "decisiondate": "2017-06-23",
    "brandname": "Ucedane",
    "mah": "Eurocept International B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1203,
    "emanumber": "4303",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 232,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 29,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Germany",
    "decisiondate": "2017-07-19",
    "brandname": "Insulin lispro Sanofi",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1205,
    "emanumber": "4723",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-07-13",
    "brandname": "Blitzima",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1206,
    "emanumber": "4724",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-07-13",
    "brandname": "Rituzena",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1207,
    "emanumber": "4725",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-07-13",
    "brandname": "Ritemvia",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1208,
    "emanumber": "4257",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 24,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2017-07-17",
    "brandname": "Trimbow",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1209,
    "emanumber": "2770",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "cariprazine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 421,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Finland",
    "decisiondate": "2017-07-13",
    "brandname": "Reagila",
    "mah": "Gedeon Richter Plc.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1210,
    "emanumber": "4250",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz / emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-07-17",
    "brandname": "Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva",
    "mah": "Zentiva, k.s.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1211,
    "emanumber": "4458",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "entecavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-09-26",
    "brandname": "Entecavir Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1212,
    "emanumber": "4230",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Cladribine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Sweden",
    "decisiondate": "2017-08-22",
    "brandname": "MAVENCLAD",
    "mah": "Merck Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1213,
    "emanumber": "4430",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "glecaprevir / pibrentasvir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 154,
    "authorisationactivetime": 122,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Sweden",
    "decisiondate": "2017-07-26",
    "brandname": "Maviret",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1214,
    "emanumber": "4338",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "avelumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 64,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2017-09-18",
    "brandname": "Bavencio",
    "mah": "Merck Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1215,
    "emanumber": "4131",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "tivozanib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 248,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-08-24",
    "brandname": "Fotivda",
    "mah": "EUSA Pharma (Netherlands) B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1216,
    "emanumber": "4279",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Austria",
    "decisiondate": "2017-08-24",
    "brandname": "Imraldi",
    "mah": "Samsung Bioepis NL B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1217,
    "emanumber": "4281",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Nitisinone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "Belgium",
    "decisiondate": "2017-08-24",
    "brandname": "Nitisinone MDK",
    "mah": "MendeliKABS Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1218,
    "emanumber": "4095",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Midostaurin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Norway",
    "decisiondate": "2017-09-18",
    "brandname": "Rydapt",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1219,
    "emanumber": "4411",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "Ciclosporin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 182,
    "authorisationactivetime": 145,
    "authorisationstoppedtime": 37,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "France",
    "decisiondate": "2018-07-06",
    "brandname": "Verkazia",
    "mah": "Santen Oy",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1220,
    "emanumber": "4143",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "atezolizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 220,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "2017-09-21",
    "brandname": "Tecentriq",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1221,
    "emanumber": "4213",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "ribociclib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2017-08-22",
    "brandname": "Kisqali",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1222,
    "emanumber": "4240",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz / emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-09-05",
    "brandname": "Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1223,
    "emanumber": "4350",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "sofosbuvir / velpatasvir / voxilaprevir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 154,
    "authorisationactivetime": 122,
    "authorisationstoppedtime": 32,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-07-26",
    "brandname": "Vosevi",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1224,
    "emanumber": "3937",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "telotristat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Czech Republic",
    "decisiondate": "2017-09-18",
    "brandname": "Xermelo",
    "mah": "Ipsen Pharma",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1225,
    "emanumber": "4391",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "darunavir / cobicistat / emtricitabine / tenofovir alafenamide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2017-09-21",
    "brandname": "Symtuza",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1226,
    "emanumber": "4123",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V10",
    "activesubstance": "lutetium (<sup>177</sup>Lu) oxodotreotide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2017-09-26",
    "brandname": "Lutathera",
    "mah": "Advanced Accelerator Applications",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1227,
    "emanumber": "4377",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "entecavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-09-18",
    "brandname": "Entecavir Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1228,
    "emanumber": "4182",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "padeliporfin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 596,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 386,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-11-10",
    "brandname": "TOOKAD",
    "mah": "Steba Biotech S.A",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1229,
    "emanumber": "4390",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "dupilumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 59,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2017-09-26",
    "brandname": "Dupixent",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1230,
    "emanumber": "4443",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "lacosamide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-09-18",
    "brandname": "Lacosamide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1231,
    "emanumber": "4043",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "ocrelizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 540,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 337,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2018-01-08",
    "brandname": "Ocrevus",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1232,
    "emanumber": "4366",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Miglustat",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 183,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-04-28",
    "brandname": "Miglustat Gen.Orph",
    "mah": "Gen.Orph",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1233,
    "emanumber": "4407",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "buprenorphine / naloxone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Czech Republic",
    "decisiondate": "2017-11-10",
    "brandname": "Zubsolv",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1234,
    "emanumber": "4271",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Guselkumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "Ireland",
    "decisiondate": "2017-11-10",
    "brandname": "Tremfya",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1235,
    "emanumber": "4249",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "niraparib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "France",
    "decisiondate": "2017-11-16",
    "brandname": "Zejula",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1236,
    "emanumber": "4363",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "fluticasone furoate/umeclidinium/vilanterol",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Germany",
    "decisiondate": "2017-11-15",
    "brandname": "Trelegy Ellipta",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1237,
    "emanumber": "4781",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "fluticasone furoate/umeclidinium/vilanterol",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 175,
    "authorisationactivetime": 112,
    "authorisationstoppedtime": 63,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Germany",
    "decisiondate": "2017-11-15",
    "brandname": "Elebrato Ellipta",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1238,
    "emanumber": "4325",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "naloxone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Latvia",
    "decisiondate": "2017-11-10",
    "brandname": "Nyxoid",
    "mah": "Mundipharma Corporation (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1239,
    "emanumber": "4446",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "Human Fibrinogen / Human Thrombin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 86,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Poland",
    "decisiondate": "2017-11-10",
    "brandname": "VeraSeal",
    "mah": "Instituto Grifols, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1240,
    "emanumber": "4319",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Germany",
    "decisiondate": "2017-11-10",
    "brandname": "Cyltezo",
    "mah": "Boehringer Ingelheim International GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1241,
    "emanumber": "4323",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "United Kingdom",
    "decisiondate": "2017-11-15",
    "brandname": "Ontruzant",
    "mah": "Samsung Bioepis NL B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1242,
    "emanumber": "4549",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "Ritonavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-11-10",
    "brandname": "Ritonavir Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1243,
    "emanumber": "4748",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Imatinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 144,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 24,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Belgium",
    "decisiondate": "2017-11-15",
    "brandname": "Imatinib Teva B.V.",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1244,
    "emanumber": "4435",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Tacrolimus",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 294,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 84,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2017-12-08",
    "brandname": "Tacforius",
    "mah": "Teva B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1245,
    "emanumber": "4536",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "letermovir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 166,
    "authorisationstoppedtime": 38,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Denmark",
    "decisiondate": "2018-01-08",
    "brandname": "PREVYMIS",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1246,
    "emanumber": "4728",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bevacizumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 322,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-01-15",
    "brandname": "Mvasi",
    "mah": "Amgen Technology (Ireland) UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1247,
    "emanumber": "4195",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "rurioctocog alfa pegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 596,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 393,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Sweden",
    "decisiondate": "2018-01-08",
    "brandname": "ADYNOVI",
    "mah": "Baxalta Innovations GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1248,
    "emanumber": "4891",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "darunavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 119,
    "authorisationactivetime": 93,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-01-18",
    "brandname": "Darunavir Krka d.d.",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1249,
    "emanumber": "4273",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "darunavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-01-26",
    "brandname": "Darunavir Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1250,
    "emanumber": "4272",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "rucaparib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 281,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-05-24",
    "brandname": "Rubraca",
    "mah": "Clovis Oncology Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1251,
    "emanumber": "4174",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "semaglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 154,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2018-02-08",
    "brandname": "Ozempic",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1252,
    "emanumber": "4433",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "benralizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 322,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2018-01-08",
    "brandname": "Fasenra",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1253,
    "emanumber": "4649",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "Fulvestrant",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 322,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 112,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "Belgium",
    "decisiondate": "2018-01-08",
    "brandname": "Fulvestrant Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1254,
    "emanumber": "4655",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A07",
    "activesubstance": "budesonide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 148,
    "authorisationactivetime": 122,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Czech Republic",
    "decisiondate": "2018-01-08",
    "brandname": "Jorveza",
    "mah": "Dr Falk Pharma GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1255,
    "emanumber": "4138",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "prasterone",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 652,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 442,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Ireland",
    "decisiondate": "2018-01-08",
    "brandname": "Intrarosa",
    "mah": "Endoceutics S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1256,
    "emanumber": "4585",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "anagrelide",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-02-15",
    "brandname": "Anagrelide Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1257,
    "emanumber": "2575",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 414,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 211,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2018-02-09",
    "brandname": "Herzuma",
    "mah": "Celltrion Healthcare Hungary Kft.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1258,
    "emanumber": "3922",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "velmanase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 281,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2018-03-23",
    "brandname": "Lamzede",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1260,
    "emanumber": "4416",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H02",
    "activesubstance": "hydrocortisone",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Iceland",
    "decisiondate": "2018-02-09",
    "brandname": "Alkindi",
    "mah": "Diurnal Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1261,
    "emanumber": "4258",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Darvadstrocel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 631,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 421,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2018-03-23",
    "brandname": "Alofisel",
    "mah": "Takeda Pharma A/S",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1262,
    "emanumber": "4275",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "Burosumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 357,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 147,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-02-19",
    "brandname": "CRYSVITA",
    "mah": "Kyowa Kirin Holdings B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1263,
    "emanumber": "4274",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "efavirenz / emtricitabine / tenofovir disoproxil",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 31,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "Belgium",
    "decisiondate": "2018-02-08",
    "brandname": "Efavirenz/Emtricitabine/Tenofovir disoproxil Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1264,
    "emanumber": "4248",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "brigatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 575,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 365,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-11-22",
    "brandname": "Alunbrig",
    "mah": "Takeda Pharma A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1265,
    "emanumber": "4314",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "ertugliflozin / metformin hydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": "2018-03-23",
    "brandname": "Segluromet",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1266,
    "emanumber": "4313",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "ertugliflozin / sitagliptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": "2018-03-23",
    "brandname": "Steglujan",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1267,
    "emanumber": "4315",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "ertugliflozin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Hungary",
    "decisiondate": "2018-03-21",
    "brandname": "Steglatro",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1269,
    "emanumber": "4299",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "peramivir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 197,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2018-04-13",
    "brandname": "Alpivab",
    "mah": "BioCryst Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1270,
    "emanumber": "4280",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "insulin glargine",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Hungary",
    "decisiondate": "2018-03-23",
    "brandname": "Semglee",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1271,
    "emanumber": "4406",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "emicizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 197,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 54,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "France",
    "decisiondate": "2018-02-23",
    "brandname": "Hemlibra",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1272,
    "emanumber": "4336",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "herpes zoster vaccine (recombinant, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 399,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 196,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2018-03-21",
    "brandname": "Shingrix",
    "mah": "GlaxoSmithKline Biologicals S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1273,
    "emanumber": "4644",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "prasugrel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-05-16",
    "brandname": "Prasugrel Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1274,
    "emanumber": "4702",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2018-04-26",
    "brandname": "Trydonis",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1275,
    "emanumber": "4836",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "beclometasone / formoterol / glycopyrronium bromide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2018-04-23",
    "brandname": "Riarify",
    "mah": "Chiesi Farmaceutici S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1276,
    "emanumber": "4218",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "metreleptin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 498,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 288,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Hungary",
    "decisiondate": "2018-07-30",
    "brandname": "Myalepta",
    "mah": "Amryt Pharmaceuticals DAC",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1277,
    "emanumber": "4204",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "gemtuzumab ozogamicin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 427,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 217,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2018-04-19",
    "brandname": "Mylotarg",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1278,
    "emanumber": "4326",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "carmustine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 680,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 470,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-07-19",
    "brandname": "Carmustine Obvius",
    "mah": "Obvius Investment B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1279,
    "emanumber": "4379",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "glibenclamide",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 304,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Hungary",
    "decisiondate": "2018-05-24",
    "brandname": "AMGLIDIA",
    "mah": "AMMTeK",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1280,
    "emanumber": "4647",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "infliximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Norway",
    "decisiondate": "2018-05-18",
    "brandname": "Zessly",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1281,
    "emanumber": "4361",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2018-05-16",
    "brandname": "KANJINTI",
    "mah": "Amgen Europe B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1282,
    "emanumber": "4427",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "dolutegravir / rilpivirine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2018-05-16",
    "brandname": "Juluca",
    "mah": "ViiV Healthcare B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1283,
    "emanumber": "3958",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pemetrexed",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 71,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "Belgium",
    "decisiondate": "2018-05-22",
    "brandname": "Pemetrexed Krka",
    "mah": "KRKA, d.d.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1284,
    "emanumber": "4335",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "Sufentanil",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "Hungary",
    "decisiondate": "2018-06-25",
    "brandname": "Dzuveo",
    "mah": "FGK Representative Service GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1286,
    "emanumber": "4320",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 176,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2018-07-26",
    "brandname": "Hyrimoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1287,
    "emanumber": "4865",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 157,
    "authorisationactivetime": 82,
    "authorisationstoppedtime": 75,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2018-07-26",
    "brandname": "Hefiya",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1288,
    "emanumber": "4866",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 164,
    "authorisationactivetime": 89,
    "authorisationstoppedtime": 75,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2018-07-26",
    "brandname": "Halimatoz",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1289,
    "emanumber": "4449",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "bictegravir / emtricitabine / tenofovir alafenamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Portugal",
    "decisiondate": "2018-06-21",
    "brandname": "Biktarvy",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1290,
    "emanumber": "4582",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Nitisinone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 463,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 260,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-07-26",
    "brandname": "Nityr",
    "mah": "Cycle Pharmaceuticals (Europe) Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1291,
    "emanumber": "4256",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A06",
    "activesubstance": "naldemedine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 631,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 421,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Belgium",
    "decisiondate": "2019-02-18",
    "brandname": "Rizmoic",
    "mah": "Shionogi B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1292,
    "emanumber": "4154",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "paclitaxel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 939,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 729,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Poland",
    "decisiondate": "2018-11-20",
    "brandname": "Apealea",
    "mah": "Oasmia Pharmaceutical AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1293,
    "emanumber": "4447",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "erenumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2018-07-26",
    "brandname": "Aimovig",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1294,
    "emanumber": "3841",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "brexpiprazole",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-07-26",
    "brandname": "RXULTI",
    "mah": "Otsuka Pharmaceutical Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1295,
    "emanumber": "4463",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2018-07-26",
    "brandname": "Trazimera",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1296,
    "emanumber": "4782",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "inotersen",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 190,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 47,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Finland",
    "decisiondate": "2018-07-06",
    "brandname": "Tegsedi",
    "mah": "Akcea Therapeutics Ireland Ltd",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1297,
    "emanumber": "4090",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "tisagenlecleucel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 246,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 74,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-08-23",
    "brandname": "Kymriah",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1298,
    "emanumber": "4454",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "vonicog alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 176,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2018-08-31",
    "brandname": "VEYVONDI",
    "mah": "Baxalta Innovations GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1299,
    "emanumber": "4480",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "axicabtagene ciloleucel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Belgium",
    "decisiondate": "2018-08-23",
    "brandname": "Yescarta",
    "mah": "Kite Pharma EU B.V.",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1300,
    "emanumber": "4412",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "allopurinol / lesinurad",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Czech Republic",
    "decisiondate": "2018-08-23",
    "brandname": "Duzallo",
    "mah": "Gr√ºnenthal GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1301,
    "emanumber": "4438",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "vestronidase alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 407,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 197,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2018-08-23",
    "brandname": "Mepsevii",
    "mah": "Ultragenyx Germany GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1302,
    "emanumber": "4534",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "vigabatrin",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-09-20",
    "brandname": "Kigabeq",
    "mah": "ORPHELIA Pharma SAS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1303,
    "emanumber": "4413",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 610,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 407,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-09-21",
    "brandname": "Udenyca",
    "mah": "ERA Consulting GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1305,
    "emanumber": "4426",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "caplacizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 491,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 288,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2018-08-31",
    "brandname": "Cablivi",
    "mah": "Ablynx N.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1306,
    "emanumber": "4682",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R07",
    "activesubstance": "tezacaftor/ivacaftor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-10-31",
    "brandname": "Symkevi",
    "mah": "Vertex Pharmaceuticals (Ireland) Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1307,
    "emanumber": "4302",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "abemaciclib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2018-09-27",
    "brandname": "Verzenios",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1308,
    "emanumber": "4282",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "daunorubicin / cytarabine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 218,
    "authorisationactivetime": 166,
    "authorisationstoppedtime": 52,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Finland",
    "decisiondate": "2018-08-23",
    "brandname": "Vyxeos liposomal",
    "mah": "Jazz Pharmaceuticals Ireland Ltd",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1309,
    "emanumber": "5017",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G03",
    "activesubstance": "ulipristal acetate",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2018-08-27",
    "brandname": "Ulipristal Acetate Gedeon Richter",
    "mah": "Gedeon Richter Plc.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1310,
    "emanumber": "4710",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "Deferiprone",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-09-20",
    "brandname": "Deferiprone Lipomed",
    "mah": "Lipomed GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1311,
    "emanumber": "4030",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "neratinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 554,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 346,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": "2018-08-31",
    "brandname": "Nerlynx",
    "mah": "Pierre Fabre M√©dicament",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1312,
    "emanumber": "4237",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Eravacycline",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Norway",
    "decisiondate": "2018-09-20",
    "brandname": "Xerava",
    "mah": "PAION Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1313,
    "emanumber": "3961",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Czech Republic",
    "decisiondate": "2018-09-21",
    "brandname": "Pelgraz",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1314,
    "emanumber": "4580",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "encorafenib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2018-09-20",
    "brandname": "Braftovi",
    "mah": "Pierre Fabre M√©dicament",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1315,
    "emanumber": "4579",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "binimetinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Germany",
    "decisiondate": "2018-09-20",
    "brandname": "Mektovi",
    "mah": "Pierre Fabre M√©dicament",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1316,
    "emanumber": "4857",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Lenalidomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-09-20",
    "brandname": "Lenalidomide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1317,
    "emanumber": "4441",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "paclitaxel",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 561,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 358,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-05-06",
    "brandname": "Pazenir",
    "mah": "ratiopharm GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1318,
    "emanumber": "4425",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "Melatonin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Czech Republic",
    "decisiondate": "2018-09-20",
    "brandname": "Slenyto",
    "mah": "RAD Neurim Pharmaceuticals EEC SARL",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1319,
    "emanumber": "4429",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "United Kingdom",
    "decisiondate": "2018-09-17",
    "brandname": "Hulio",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1320,
    "emanumber": "4699",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "patisiran",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2018-08-27",
    "brandname": "Onpattro",
    "mah": "Alnylam Netherlands B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1321,
    "emanumber": "4826",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "gefitinib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Croatia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2018-09-27",
    "brandname": "Gefitinib Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1322,
    "emanumber": "4771",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "durvalumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Spain",
    "decisiondate": "2018-09-21",
    "brandname": "Imfinzi",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1323,
    "emanumber": "4514",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "tildrakizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 491,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 281,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Ireland",
    "decisiondate": "2018-09-17",
    "brandname": "Ilumetri",
    "mah": "Almirall, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1324,
    "emanumber": "4054",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "damoctocog alfa pegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Denmark",
    "decisiondate": "2018-11-22",
    "brandname": "Jivi",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1325,
    "emanumber": "4584",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "Mexiletine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 220,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Sweden",
    "decisiondate": "2018-12-18",
    "brandname": "Namuscla",
    "mah": "Lupin Europe GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1326,
    "emanumber": "4814",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "influenza vaccine (surface antigen, inactivated, prepared in cell cultures)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 122,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2018-12-12",
    "brandname": "Flucelvax Tetra",
    "mah": "Seqirus Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1327,
    "emanumber": "4802",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Romania",
    "decisiondate": "2018-11-22",
    "brandname": "Ziextenzo",
    "mah": "Sandoz GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1328,
    "emanumber": "4700",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2018-11-20",
    "brandname": "Pelmeg",
    "mah": "Mundipharma Corporation (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1329,
    "emanumber": "4915",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 122,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2018-11-20",
    "brandname": "Fulphila",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1330,
    "emanumber": "4648",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "galcanezumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Sweden",
    "decisiondate": "2018-11-14",
    "brandname": "Emgality",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1331,
    "emanumber": "4451",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "voretigene neparvovec",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "unknown",
    "corapporteur": "Spain",
    "decisiondate": "2018-11-22",
    "brandname": "Luxturna",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1332,
    "emanumber": "4747",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "doravirine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2018-11-22",
    "brandname": "Pifeltro",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1333,
    "emanumber": "4746",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "doravirine / lamivudine / tenofovir disoproxil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 302,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 92,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Netherlands",
    "decisiondate": "2018-11-22",
    "brandname": "Delstrigo",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1334,
    "emanumber": "4669",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "meropenem/vaborbactam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Sweden",
    "decisiondate": "2018-11-20",
    "brandname": "Vaborem",
    "mah": "Menarini International Operations Luxembourg S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1335,
    "emanumber": "4232",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Mogamulizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 120,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2018-11-22",
    "brandname": "Poteligeo",
    "mah": "Kyowa Kirin Holdings B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1336,
    "emanumber": "4651",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "buprenorphine",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2018-11-20",
    "brandname": "Buvidal",
    "mah": "Camurus AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1337,
    "emanumber": "4660",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V04",
    "activesubstance": "macimorelin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 358,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2019-01-11",
    "brandname": "Macimorelin Consilient Health",
    "mah": "Consilient Health Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1338,
    "emanumber": "4171",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "dengue tetravalent vaccine (live, attenuated)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 939,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 731,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Spain",
    "decisiondate": "2018-12-12",
    "brandname": "Dengvaxia",
    "mah": "Sanofi Pasteur",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1339,
    "emanumber": "4245",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "glycopyrronium bromide / formoterol",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 463,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 253,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Ireland",
    "decisiondate": "2018-12-18",
    "brandname": "Bevespi Aerosphere",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1340,
    "emanumber": "4806",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "lanadelumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2018-11-22",
    "brandname": "TAKHZYRO",
    "mah": "Shire Pharmaceuticals Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1341,
    "emanumber": "4916",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 330,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2018-12-12",
    "brandname": "Ogivri",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1342,
    "emanumber": "4452",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "apalutamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Latvia",
    "decisiondate": "2019-01-14",
    "brandname": "Erleada",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1343,
    "emanumber": "4964",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "G04",
    "activesubstance": "silodosin",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 200,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 80,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Croatia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-01-07",
    "brandname": "Silodosin Recordati",
    "mah": "Recordati Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1344,
    "emanumber": "4697",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bevacizumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "France",
    "decisiondate": "2019-02-14",
    "brandname": "Zirabev",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1345,
    "emanumber": "4108",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "andexanet alfa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 925,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 715,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Spain",
    "decisiondate": "2019-04-26",
    "brandname": "Ondexxya",
    "mah": "Alexion Europe S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1346,
    "emanumber": "4904",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "Miglustat",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovakia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-02-18",
    "brandname": "Miglustat Dipharma",
    "mah": "Dipharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1347,
    "emanumber": "4773",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M04",
    "activesubstance": "febuxostat",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 43,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-03-28",
    "brandname": "Febuxostat Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1348,
    "emanumber": "4720",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "lusutrombopag",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Poland",
    "decisiondate": "2019-02-18",
    "brandname": "Mulpleo",
    "mah": "Shionogi B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1349,
    "emanumber": "4102",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "zanamivir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "United Kingdom",
    "decisiondate": "2019-04-26",
    "brandname": "Dectova",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1350,
    "emanumber": "5086",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Tobramycin",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 90,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-02-18",
    "brandname": "Tobramycin PARI",
    "mah": "PARI Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1351,
    "emanumber": "4751",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "treosulfan",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Portugal",
    "decisiondate": null,
    "brandname": "Trecondi",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1352,
    "emanumber": "4128",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "ropeginterferon alfa-2b",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 659,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 456,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "France",
    "decisiondate": "2019-02-15",
    "brandname": "Besremi",
    "mah": "AOP Orphan Pharmaceuticals AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1353,
    "emanumber": "4859",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "atazanavir",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-03-25",
    "brandname": "Atazanavir Krka",
    "mah": "KRKA d d., Novo mesto",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1354,
    "emanumber": "4779",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "dacomitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Norway",
    "decisiondate": "2019-04-02",
    "brandname": "Vizimpro",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1355,
    "emanumber": "4646",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "lorlatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 393,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 185,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Italy",
    "decisiondate": "2019-05-06",
    "brandname": "Lorviqua",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1356,
    "emanumber": "4475",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 435,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 225,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Lithuania",
    "decisiondate": "2019-04-02",
    "brandname": "Idacio",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1357,
    "emanumber": "5158",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 137,
    "authorisationactivetime": 90,
    "authorisationstoppedtime": 47,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Lithuania",
    "decisiondate": "2019-04-02",
    "brandname": "Kromeya",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1358,
    "emanumber": "4833",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N02",
    "activesubstance": "fremanezumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2019-03-28",
    "brandname": "AJOVY",
    "mah": "Teva GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1359,
    "emanumber": "4961",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "ibalizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 182,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2019-09-26",
    "brandname": "Trogarzo",
    "mah": "Theratechnologies Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1360,
    "emanumber": "4538",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "volanesorsen",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 561,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 351,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Belgium",
    "decisiondate": "2019-05-03",
    "brandname": "Waylivra",
    "mah": "Akcea Therapeutics Ireland Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1361,
    "emanumber": "4759",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "risankizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 281,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Hungary",
    "decisiondate": "2019-04-26",
    "brandname": "Skyrizi",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1362,
    "emanumber": "4744",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "pegvaliase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2019-05-03",
    "brandname": "Palynziq",
    "mah": "BioMarin International Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1363,
    "emanumber": "4889",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "sotagliflozin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2019-04-26",
    "brandname": "Zynquista",
    "mah": "Guidehouse Germany GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1364,
    "emanumber": "4587",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M03",
    "activesubstance": "botulinum toxin type A",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 653,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 445,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "United Kingdom",
    "corapporteur": "Ireland",
    "decisiondate": "2019-09-27",
    "brandname": "NUCEIVA",
    "mah": "Evolus Pharma Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1365,
    "emanumber": "4111",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "trientine dihydrochloride",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 455,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 245,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Greece",
    "decisiondate": "2019-07-25",
    "brandname": "Cufence",
    "mah": "Univar Solutions B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1366,
    "emanumber": "4837",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "hydroxycarbamide",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 422,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 219,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "Belgium",
    "decisiondate": "2019-07-01",
    "brandname": "Xromi",
    "mah": "Nova Laboratories Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1367,
    "emanumber": "3691",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "betibeglogene autotemcel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 1,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2019-05-29",
    "brandname": "Zynteglo",
    "mah": "bluebird bio (Netherlands) B.V.",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1368,
    "emanumber": "4985",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C02",
    "activesubstance": "Ambrisentan",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-06-20",
    "brandname": "Ambrisentan Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1369,
    "emanumber": "4743",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "buprenorphine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 520,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 310,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "United Kingdom",
    "decisiondate": "2019-06-20",
    "brandname": "Sixmo",
    "mah": "L. Molteni & C. dei F.lli Alitti Soc.Es.S.p.A",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1370,
    "emanumber": "4909",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "dolutegravir/lamivudine",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 205,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 25,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Portugal",
    "decisiondate": "2019-07-01",
    "brandname": "Dovato",
    "mah": "ViiV Healthcare B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1371,
    "emanumber": "4954",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Ravulizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 282,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 72,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Hungary",
    "decisiondate": "2019-07-02",
    "brandname": "Ultomiris",
    "mah": "Alexion Europe SAS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1372,
    "emanumber": "4745",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V09",
    "activesubstance": "ioflupane (<sup>123</sup>I)",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Poland",
    "corapporteur": "Romania",
    "decisiondate": "2019-06-25",
    "brandname": "Striascan",
    "mah": "CIS bio international",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1373,
    "emanumber": "4722",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "avatrombopag",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "2019-06-20",
    "brandname": "Doptelet",
    "mah": "Swedish Orphan Biovitrum AB (publ)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1374,
    "emanumber": "4883",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "turoctocog alfa pegol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Poland",
    "decisiondate": "2019-06-20",
    "brandname": "Esperoct",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1375,
    "emanumber": "4556",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 520,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 310,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2019-06-20",
    "brandname": "Grasustek",
    "mah": "Juta Pharma GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1376,
    "emanumber": "4844",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cemiplimab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 394,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 191,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Finland",
    "decisiondate": "2019-06-28",
    "brandname": "LIBTAYO",
    "mah": "Regeneron Ireland Designated Activity Company (DAC)",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1377,
    "emanumber": "4674",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "talazoparib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 338,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 128,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Iceland",
    "decisiondate": "2019-06-20",
    "brandname": "Talzenna",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1378,
    "emanumber": "5254",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "fluticasone furoate / umeclidinium / vilanterol",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-06-12",
    "brandname": "Temybric Ellipta",
    "mah": "GlaxoSmithKline Trading Services Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1379,
    "emanumber": "5005",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "Posaconazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 371,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 161,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-07-25",
    "brandname": "Posaconazole Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1380,
    "emanumber": "5028",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J02",
    "activesubstance": "Posaconazole",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 343,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-07-25",
    "brandname": "Posaconazole AHCL",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1381,
    "emanumber": "4541",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "arginine/lysine",
    "legalbasis": "article 10a",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 343,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 133,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2019-07-25",
    "brandname": "LysaKare",
    "mah": "Advanced Accelerator Applications",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1382,
    "emanumber": "5300",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Azacitidine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Spain",
    "decisiondate": "2019-08-02",
    "brandname": "Azacitidine Celgene",
    "mah": "Celgene Europe B.V",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1383,
    "emanumber": "5243",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "lacosamide",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-08-26",
    "brandname": "Lacosamide UCB",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1384,
    "emanumber": "4930",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C01",
    "activesubstance": "angiotensin II acetate",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 164,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "France",
    "decisiondate": "2019-08-23",
    "brandname": "Giapreza",
    "mah": "PAION Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1385,
    "emanumber": "4919",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "larotrectinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 178,
    "authorisationstoppedtime": 138,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2019-09-19",
    "brandname": "VITRAKVI",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1386,
    "emanumber": "5014",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "deferasirox",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Hungary",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-09-26",
    "brandname": "Deferasirox Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1387,
    "emanumber": "5298",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "lidocaine / prilocaine",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 116,
    "authorisationactivetime": 90,
    "authorisationstoppedtime": 26,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2019-11-14",
    "brandname": "Senstend",
    "mah": "Plethora Pharma Solutions Ltd.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1388,
    "emanumber": "4870",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "polatuzumab vedotin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 294,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 121,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Germany",
    "decisiondate": "2020-01-16",
    "brandname": "Polivy",
    "mah": "Roche Registration GmbH",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1389,
    "emanumber": "4675",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "cannabidiol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 540,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 332,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Czech Republic",
    "decisiondate": "2019-09-19",
    "brandname": "Epidyolex",
    "mah": "GW Pharma (International) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1390,
    "emanumber": "4786",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N04",
    "activesubstance": "levodopa",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "2019-09-19",
    "brandname": "Inbrija",
    "mah": "Acorda Therapeutics Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1392,
    "emanumber": "4554",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Ebola Zaire Vaccine (rVSV<U+2206>G-ZEBOV-GP, live)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 204,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2019-11-11",
    "brandname": "Ervebo",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 1
  },
  {
    "eunumber": 1393,
    "emanumber": "4860",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "delafloxacin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 309,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Estonia",
    "decisiondate": "2019-12-16",
    "brandname": "Quofenix",
    "mah": "A. Menarini - Industrie Farmaceutiche Riunite - s.r.l.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1394,
    "emanumber": "5114",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "Tigecycline",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 561,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 351,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-04-17",
    "brandname": "Tigecycline Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1395,
    "emanumber": "4996",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "clopidogrel / acetylsalicylic acid",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 407,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 197,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "Belgium",
    "decisiondate": "2020-01-09",
    "brandname": "Clopidogrel/Acetylsalicylic acid Mylan",
    "mah": "Mylan S.A.S.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1396,
    "emanumber": "5039",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "clofarabine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Romania",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-11-14",
    "brandname": "Ivozall",
    "mah": "ORPHELIA Pharma SAS",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1397,
    "emanumber": "5074",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bortezomib",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-11-14",
    "brandname": "Bortezomib Fresenius Kabi",
    "mah": "Fresenius Kabi Deutschland GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1398,
    "emanumber": "5175",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Arsenic trioxide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 266,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 56,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2019-11-14",
    "brandname": "Arsenic Trioxide Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1399,
    "emanumber": "4752",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "gilteritinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 205,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 55,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Latvia",
    "decisiondate": "2019-10-24",
    "brandname": "Xospata",
    "mah": "Astellas Pharma Europe B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1400,
    "emanumber": "4583",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "netarsudil",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2019-11-19",
    "brandname": "Rhokiinsa",
    "mah": "Aerie Pharmaceuticals Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1401,
    "emanumber": "4910",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "metformin hydrochloride / saxagliptin / dapagliflozin",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Estonia",
    "decisiondate": "2019-11-11",
    "brandname": "Qtrilmet",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1403,
    "emanumber": "4882",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "budesonide / formoterol fumarate dihydrate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 165,
    "authorisationactivetime": 120,
    "authorisationstoppedtime": 45,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-04-03",
    "brandname": "Budesonide/Formoterol Teva Pharma B.V.",
    "mah": "Teva Pharma B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1404,
    "emanumber": "4760",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "upadacitinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 261,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 58,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Finland",
    "decisiondate": "2019-12-16",
    "brandname": "Rinvoq",
    "mah": "AbbVie Deutschland GmbH & Co. KG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1405,
    "emanumber": "5012",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B02",
    "activesubstance": "fostamatinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 407,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 199,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Austria",
    "decisiondate": "2020-01-09",
    "brandname": "TAVLESSE",
    "mah": "Instituto Grifols, S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1406,
    "emanumber": "3848",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H04",
    "activesubstance": "Glucagon",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 218,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Germany",
    "decisiondate": "2019-12-16",
    "brandname": "Baqsimi",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1407,
    "emanumber": "4821",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H02",
    "activesubstance": "osilodrostat",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 148,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Belgium",
    "decisiondate": "2020-01-09",
    "brandname": "Isturisa",
    "mah": "Recordati Rare Diseases",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1408,
    "emanumber": "4893",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "solriamfetol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 143,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Italy",
    "decisiondate": "2020-01-16",
    "brandname": "Sunosi",
    "mah": "Jazz Pharmaceuticals Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1409,
    "emanumber": "5312",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Belgium",
    "corapporteur": "Austria",
    "decisiondate": "2019-12-19",
    "brandname": "Cegfila",
    "mah": "Mundipharma Corporation (Ireland) Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1410,
    "emanumber": "4535",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "esketamine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Netherlands",
    "decisiondate": "2019-12-18",
    "brandname": "Spravato",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1411,
    "emanumber": "4465",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M05",
    "activesubstance": "romosozumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 547,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 344,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Austria",
    "decisiondate": "2019-12-09",
    "brandname": "Evenity",
    "mah": "UCB Pharma S.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1412,
    "emanumber": "5156",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V03",
    "activesubstance": "deferasirox",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Belgium",
    "decisiondate": "2020-01-09",
    "brandname": "Deferasirox Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1413,
    "emanumber": "5147",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Azacitidine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 317,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 114,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "Belgium",
    "decisiondate": "2020-02-13",
    "brandname": "Azacitidine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1414,
    "emanumber": "4712",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "siponimod",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 407,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 197,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Germany",
    "decisiondate": "2020-01-13",
    "brandname": "Mayzent",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1415,
    "emanumber": "4879",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Adalimumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Romania",
    "decisiondate": "2020-02-13",
    "brandname": "Amsparity",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1416,
    "emanumber": "5075",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Azacitidine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 163,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-03-24",
    "brandname": "Azacitidine Betapharm",
    "mah": "betapharm Arzneimittel GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1417,
    "emanumber": "4913",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "S01",
    "activesubstance": "brolucizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 78,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "2020-02-13",
    "brandname": "Beovu",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1418,
    "emanumber": "5152",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "dexmedetomidine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 350,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 140,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Malta",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-02-13",
    "brandname": "Dexmedetomidine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1419,
    "emanumber": "5207",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "treprostinil sodium",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Poland",
    "decisiondate": "2020-04-03",
    "brandname": "Trepulmix",
    "mah": "SciPharm S√†rl",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1420,
    "emanumber": "4808",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "imipenem / cilastatin / relebactam",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Estonia",
    "decisiondate": "2020-02-13",
    "brandname": "Recarbrio",
    "mah": "Merck Sharp & Dohme B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1421,
    "emanumber": "4863",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "D11",
    "activesubstance": "crisaborole",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 617,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 409,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Ireland",
    "decisiondate": "2020-03-27",
    "brandname": "Staquis",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1422,
    "emanumber": "5037",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin lispro",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Belgium",
    "decisiondate": "2020-03-24",
    "brandname": "Lyumjev",
    "mah": "Eli Lilly Nederland B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1423,
    "emanumber": "3876",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Cholera vaccine (recombinant, live, oral)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 156,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Sweden",
    "decisiondate": "2020-04-01",
    "brandname": "Vaxchora",
    "mah": "Emergent Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1424,
    "emanumber": "4959",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "bempedoic acid / ezetimibe",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2020-03-27",
    "brandname": "Nustendi",
    "mah": "Daiichi Sankyo Europe GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1425,
    "emanumber": "4958",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "bempedoic acid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 127,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Estonia",
    "decisiondate": "2020-04-01",
    "brandname": "Nilemdo",
    "mah": "Daiichi Sankyo Europe GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1426,
    "emanumber": "4984",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Azacitidine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-03-27",
    "brandname": "Azacitidine Mylan",
    "mah": "Mylan Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1427,
    "emanumber": "5235",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Arsenic trioxide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-04-01",
    "brandname": "Arsenic trioxide Mylan",
    "mah": "Mylan Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1428,
    "emanumber": "4775",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "givosiran",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 197,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 54,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Portugal",
    "decisiondate": "2020-03-02",
    "brandname": "Givlaari",
    "mah": "Alnylam Netherlands B.V.",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1429,
    "emanumber": "5236",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Cinacalcet",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 366,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 163,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-04-03",
    "brandname": "Cinacalcet Accordpharma",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1430,
    "emanumber": "4953",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "semaglutide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 253,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 50,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Denmark",
    "decisiondate": "2020-04-03",
    "brandname": "Rybelsus",
    "mah": "Novo Nordisk A/S",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1431,
    "emanumber": "4696",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Rituximab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 533,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 330,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Germany",
    "decisiondate": "2020-04-01",
    "brandname": "Ruxience",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1432,
    "emanumber": "4790",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L02",
    "activesubstance": "darolutamide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Spain",
    "decisiondate": "2020-03-27",
    "brandname": "NUBEQA",
    "mah": "Bayer AG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1433,
    "emanumber": "4993",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "influenza vaccine (surface antigen, inactivated, adjuvanted)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Netherlands",
    "decisiondate": "2020-05-20",
    "brandname": "Fluad Tetra",
    "mah": "Seqirus Netherlands B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1434,
    "emanumber": "4829",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "cefiderocol",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 337,
    "authorisationactivetime": 180,
    "authorisationstoppedtime": 157,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Ireland",
    "decisiondate": "2020-04-23",
    "brandname": "Fetcroja",
    "mah": "Shionogi B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1435,
    "emanumber": "4977",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "isatuximab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 309,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2020-05-30",
    "brandname": "Sarclisa",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1436,
    "emanumber": "4711",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Etanercept",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 673,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 463,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Poland",
    "decisiondate": "2020-05-20",
    "brandname": "Nepexto",
    "mah": "Mylan IRE Healthcare Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1437,
    "emanumber": "5167",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J04",
    "activesubstance": "pretomanid",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2020-07-31",
    "brandname": "Dovprela",
    "mah": "Mylan IRE Healthcare Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1438,
    "emanumber": "5061",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol / glycopyrronium / mometasone furoate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-07-03",
    "brandname": "Enerzair Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1439,
    "emanumber": "5067",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol / mometasone furoate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 217,
    "authorisationstoppedtime": 99,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-05-30",
    "brandname": "Atectura Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1440,
    "emanumber": "5518",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol / glycopyrronium / mometasone furoate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 150,
    "authorisationactivetime": 82,
    "authorisationstoppedtime": 68,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-07-03",
    "brandname": "Zimbus Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1441,
    "emanumber": "5516",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "indacaterol / mometasone furoate",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 36,
    "authorisationactivetime": 36,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-05-30",
    "brandname": "Bemrist Breezhaler",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1442,
    "emanumber": "4835",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "ozanimod",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 365,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 155,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Portugal",
    "corapporteur": "Germany",
    "decisiondate": "2020-05-20",
    "brandname": "Zeposia",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1443,
    "emanumber": "4750",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "M09",
    "activesubstance": "onasemnogene abeparvovec",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 512,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 302,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Luxembourg",
    "decisiondate": "2020-05-18",
    "brandname": "Zolgensma",
    "mah": "Novartis Gene Therapies EU Limited",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1444,
    "emanumber": "5337",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Ebola vaccine (Ad26.ZEBOV-GP [recombinant])",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2020-07-01",
    "brandname": "Zabdeno",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1445,
    "emanumber": "5343",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Ebola vaccine (MVA-BN-Filo [recombinant])",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 183,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 40,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "France",
    "decisiondate": "2020-07-01",
    "brandname": "Mvabea",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1446,
    "emanumber": "4854",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "bulevirtide",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 211,
    "authorisationactivetime": 150,
    "authorisationstoppedtime": 61,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Italy",
    "decisiondate": "2020-07-31",
    "brandname": "Hepcludex",
    "mah": "MYR GmbH",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1447,
    "emanumber": "5033",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A10",
    "activesubstance": "Insulin aspart",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 316,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 106,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Hungary",
    "decisiondate": "2020-06-25",
    "brandname": "Insulin aspart Sanofi",
    "mah": "Sanofi-Aventis groupe",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1448,
    "emanumber": "5178",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "cabazitaxel",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Iceland",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-08-28",
    "brandname": "Cabazitaxel Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1450,
    "emanumber": "5191",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Fingolimod",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Croatia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-06-25",
    "brandname": "Fingolimod Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1451,
    "emanumber": "4878",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "glasdegib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Denmark",
    "decisiondate": "2020-06-26",
    "brandname": "Daurismo",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1452,
    "emanumber": "4444",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B03",
    "activesubstance": "luspatercept",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Poland",
    "decisiondate": "2020-06-25",
    "brandname": "Reblozyl",
    "mah": "Bristol-Myers Squibb Pharma EEIG",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1453,
    "emanumber": "5486",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N05",
    "activesubstance": "paliperidone",
    "legalbasis": "article 10c",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 60,
    "authorisationactivetime": 60,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Germany",
    "decisiondate": "2020-06-18",
    "brandname": "Paliperidone Janssen-Cilag International",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1454,
    "emanumber": "5106",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bevacizumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Hungary",
    "decisiondate": "2020-08-19",
    "brandname": "Aybintio",
    "mah": "Samsung Bioepis NL B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1455,
    "emanumber": "4804",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "alpelisib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 277,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Denmark",
    "decisiondate": "2020-07-27",
    "brandname": "Piqray",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1456,
    "emanumber": "5209",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "trastuzumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Belgium",
    "decisiondate": "2020-07-27",
    "brandname": "Zercepac",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1457,
    "emanumber": "5048",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "lefamulin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Norway",
    "decisiondate": "2020-07-27",
    "brandname": "Xenleta",
    "mah": "Nabriva Therapeutics Ireland DAC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1458,
    "emanumber": "5358",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "apixaban",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-07-23",
    "brandname": "Apixaban Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1459,
    "emanumber": "5622",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "remdesivir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 0,
    "authorisationactivetime": 0,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2020-07-03",
    "brandname": "Veklury",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1460,
    "emanumber": "4936",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "entrectinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 485,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 275,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Italy",
    "corapporteur": "Sweden",
    "decisiondate": "2020-07-31",
    "brandname": "Rozlytrek",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 1
  },
  {
    "eunumber": 1461,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2020-10-28",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1462,
    "emanumber": "5087",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Teriparatide",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 192,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Italy",
    "decisiondate": "2020-08-27",
    "brandname": "Livogiva",
    "mah": "Theramex Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1463,
    "emanumber": "5388",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "H05",
    "activesubstance": "Teriparatide",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 399,
    "authorisationactivetime": 207,
    "authorisationstoppedtime": 192,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Italy",
    "decisiondate": "2020-08-27",
    "brandname": "Qutavina",
    "mah": "EuroGenerics Holdings BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1465,
    "emanumber": "5435",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N06",
    "activesubstance": "Caffeine citrate",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 36,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Estonia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-08-19",
    "brandname": "Gencebok",
    "mah": "Gennisium Pharma",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1468,
    "emanumber": "5269",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R07",
    "activesubstance": "ivacaftor / tezacaftor / elexacaftor",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 239,
    "authorisationactivetime": 173,
    "authorisationstoppedtime": 66,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Ireland",
    "decisiondate": "2020-08-21",
    "brandname": "Kaftrio",
    "mah": "Vertex Pharmaceuticals (Ireland) Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1469,
    "emanumber": "5264",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J01",
    "activesubstance": "amikacin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 169,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-10-27",
    "brandname": "ARIKAYCE liposomal",
    "mah": "Insmed Netherlands B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1470,
    "emanumber": "2776",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V04",
    "activesubstance": "methylthioninium chloride",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Latvia",
    "decisiondate": "2020-08-19",
    "brandname": "Lumeblue",
    "mah": "Alfasigma S.p.A.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1471,
    "emanumber": "4849",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "imlifidase",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2020-08-25",
    "brandname": "Idefirix",
    "mah": "Hansa Biopharma AB",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1472,
    "emanumber": "5181",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "bevacizumab",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 295,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Norway",
    "corapporteur": "Finland",
    "decisiondate": "2020-09-24",
    "brandname": "Equidacent",
    "mah": "Centus Biotherapeutics Europe Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1473,
    "emanumber": "5208",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "avapritinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 372,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 162,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Spain",
    "corapporteur": "Norway",
    "decisiondate": "2020-09-24",
    "brandname": "AYVAKYT",
    "mah": "Blueprint Medicines (Netherlands) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1474,
    "emanumber": "4935",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "belantamab mafodotin",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Finland",
    "corapporteur": "Spain",
    "decisiondate": "2020-08-25",
    "brandname": "BLENREP",
    "mah": "GlaxoSmithKline (Ireland) Limited",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1475,
    "emanumber": "5218",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "Arsenic trioxide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-09-17",
    "brandname": "Arsenic trioxide medac",
    "mah": "medac Gesellschaft f√ºr klinische Spezialpr√§parate mbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1476,
    "emanumber": "4874",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B06",
    "activesubstance": "crizanlizumab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Finland",
    "decisiondate": "2020-10-28",
    "brandname": "Adakveo",
    "mah": "Novartis Europharm Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1477,
    "emanumber": "5359",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "fampridine",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovenia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-09-24",
    "brandname": "Fampridine Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1478,
    "emanumber": "5205",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "bupivacaine/meloxicam",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 484,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 274,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Latvia",
    "decisiondate": "2020-09-24",
    "brandname": "Zynrelef",
    "mah": "Heron Therapeutics, B.V.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1479,
    "emanumber": "5299",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "acalabrutinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 267,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "Spain",
    "decisiondate": "2020-11-05",
    "brandname": "Calquence",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1480,
    "emanumber": "5113",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "filgotinib",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 344,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 134,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2020-09-24",
    "brandname": "Jyseleca",
    "mah": "Gilead Sciences Ireland UC",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1481,
    "emanumber": "4976",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "cabotegravir",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 220,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "France",
    "corapporteur": "Netherlands",
    "decisiondate": "2020-12-17",
    "brandname": "Vocabria",
    "mah": "ViiV Healthcare BV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1482,
    "emanumber": "5060",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J05",
    "activesubstance": "rilpivirine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 428,
    "authorisationactivetime": 208,
    "authorisationstoppedtime": 220,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Portugal",
    "decisiondate": "2020-12-17",
    "brandname": "REKAMBYS",
    "mah": "Janssen-Cilag International NV",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1483,
    "emanumber": "5084",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "Meningococcal group A, C, W and Y conjugate vaccine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Austria",
    "corapporteur": "Norway",
    "decisiondate": "2020-11-18",
    "brandname": "MenQuadfi",
    "mah": "Sanofi Pasteur",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1484,
    "emanumber": "5159",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "quadrivalent influenza vaccine (recombinant, prepared in cell culture)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 113,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Austria",
    "decisiondate": "2020-11-16",
    "brandname": "Supemtek",
    "mah": "Sanofi Pasteur",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1485,
    "emanumber": "5169",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J06",
    "activesubstance": "obiltoxaximab",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Sweden",
    "decisiondate": "2020-11-18",
    "brandname": "Obiltoxaximab SFL",
    "mah": "SFL Pharmaceuticals Deutschland GmbH",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1486,
    "emanumber": "5085",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L03",
    "activesubstance": "Pegfilgrastim",
    "legalbasis": "article 10.4",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 351,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 141,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Czech Republic",
    "corapporteur": "Belgium",
    "decisiondate": "2020-11-18",
    "brandname": "Nyvepria",
    "mah": "Pfizer Europe MA EEIG",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1487,
    "emanumber": "5173",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "melphalan",
    "legalbasis": "article 10.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 540,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 330,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Latvia",
    "decisiondate": "2020-11-16",
    "brandname": "PHELINUN",
    "mah": "ADIENNE S.r.l.S.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1488,
    "emanumber": "5279",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "B01",
    "activesubstance": "rivaroxaban",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 400,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 190,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Slovakia",
    "corapporteur": "No Co-rap",
    "decisiondate": "2020-11-16",
    "brandname": "Rivaroxaban Accord",
    "mah": "Accord Healthcare S.L.U.",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1489,
    "emanumber": "4586",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N01",
    "activesubstance": "bupivacaine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 246,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Latvia",
    "corapporteur": "Croatia",
    "decisiondate": "2020-11-16",
    "brandname": "EXPAREL liposomal",
    "mah": "Pacira Ireland Ltd",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1490,
    "emanumber": "5306",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L04",
    "activesubstance": "Lenalidomide",
    "legalbasis": "article 10.1",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 379,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 176,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Greece",
    "corapporteur": "Belgium",
    "decisiondate": "2020-12-18",
    "brandname": "Lenalidomide Mylan",
    "mah": "Mylan Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1491,
    "emanumber": "3933",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N03",
    "activesubstance": "fenfluramine",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 596,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 393,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Netherlands",
    "decisiondate": "2020-12-18",
    "brandname": "Fintepla",
    "mah": "Zogenix ROI Limited",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1492,
    "emanumber": "5102",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "autologous anti-CD19-transduced CD3+ cells",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 262,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 90,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Norway",
    "decisiondate": "2020-12-14",
    "brandname": "Tecartus",
    "mah": "Kite Pharma EU B.V.",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1493,
    "emanumber": "5321",
    "newactivesubstance": 1,
    "atmp": 1,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "N07",
    "activesubstance": "atidarsagene autotemcel",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 323,
    "authorisationactivetime": 172,
    "authorisationstoppedtime": 151,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Netherlands",
    "corapporteur": "Italy",
    "decisiondate": "2020-12-17",
    "brandname": "Libmeldy",
    "mah": "Orchard Therapeutics (Netherlands) B.V.",
    "orphan": 1,
    "prime": 0
  },
  {
    "eunumber": 1494,
    "emanumber": "5333",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "C10",
    "activesubstance": "inclisiran",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 260,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 57,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Poland",
    "decisiondate": "2020-12-09",
    "brandname": "Leqvio",
    "mah": "Novartis Europharm Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1495,
    "emanumber": "4917",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "V01",
    "activesubstance": "defatted powder of Arachis hypogaea L., semen (peanuts)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 456,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 253,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Denmark",
    "decisiondate": "2020-12-17",
    "brandname": "Palforzia",
    "mah": "Aimmune Therapeutics Ireland Limited",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1496,
    "emanumber": "5040",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "A16",
    "activesubstance": "lumasiran",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 1,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 176,
    "authorisationactivetime": 143,
    "authorisationstoppedtime": 33,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Germany",
    "corapporteur": "Portugal",
    "decisiondate": "2020-11-19",
    "brandname": "Oxlumo",
    "mah": "Alnylam Netherlands B.V.",
    "orphan": 1,
    "prime": 1
  },
  {
    "eunumber": 1497,
    "emanumber": "5386",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "L01",
    "activesubstance": "pertuzumab / trastuzumab",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 288,
    "authorisationactivetime": 203,
    "authorisationstoppedtime": 85,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Denmark",
    "corapporteur": "Finland",
    "decisiondate": "2020-12-21",
    "brandname": "Phesgo",
    "mah": "Roche Registration GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1498,
    "emanumber": "4983",
    "newactivesubstance": 0,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "R03",
    "activesubstance": "Formoterol / glycopyrronium bromide / budesonide",
    "legalbasis": "article 10b",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 658,
    "authorisationactivetime": 210,
    "authorisationstoppedtime": 448,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Ireland",
    "corapporteur": "Poland",
    "decisiondate": "2020-12-09",
    "brandname": "TRIXEO AEROSPHERE",
    "mah": "AstraZeneca AB",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1499,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1500,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-07",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1501,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-31",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1502,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-07",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1503,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1504,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-07",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1505,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1506,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-05",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1507,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-06",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1508,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1509,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1510,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1511,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1512,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1513,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1514,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-08",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1515,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-21",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1516,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-21",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1517,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-30",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1518,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-04",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1519,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1520,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1521,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-12",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1522,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-08",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1523,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1524,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1525,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1526,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1527,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-02-11",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1528,
    "emanumber": "5735",
    "newactivesubstance": 1,
    "atmp": 0,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": "J07",
    "activesubstance": "COVID-19 mRNA Vaccine (nucleoside modified)",
    "legalbasis": "article 8.3",
    "legalscope": "regulation 726/2004",
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": 0,
    "acceleratedmaintained": 0,
    "authorisationtotaltime": 21,
    "authorisationactivetime": 21,
    "authorisationstoppedtime": 0,
    "decisiontime": null,
    "decisionurl": null,
    "annexurl": null,
    "eparurl": null,
    "rapporteur": "Sweden",
    "corapporteur": "France",
    "decisiondate": "2020-12-21",
    "brandname": "Comirnaty",
    "mah": "BioNTech Manufacturing GmbH",
    "orphan": 0,
    "prime": 0
  },
  {
    "eunumber": 1529,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-01-29",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1530,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1531,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1532,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1533,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1534,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1535,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1536,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1537,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-03-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1538,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-21",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1539,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1542,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-05-19",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1544,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-04-30",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1546,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-22",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1547,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-05-19",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1548,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-05-19",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1549,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-05-27",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1550,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-05-19",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1551,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-17",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1552,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-17",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1553,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-24",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1554,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-17",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1556,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-17",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1557,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-21",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1558,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1559,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-24",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1560,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-06-17",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1561,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1563,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1564,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1565,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1566,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1567,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-07-16",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1568,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-09-22",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1570,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1571,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-20",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1572,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1573,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1574,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-18",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1575,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-20",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  },
  {
    "eunumber": 1577,
    "emanumber": null,
    "newactivesubstance": null,
    "atmp": null,
    "referral": null,
    "suspension": null,
    "emaurl": null,
    "ecurl": null,
    "atccode": null,
    "activesubstance": null,
    "legalbasis": null,
    "legalscope": null,
    "medicinetype": null,
    "status": null,
    "acceleratedgranted": null,
    "acceleratedmaintained": null,
    "authorisationtotaltime": null,
    "authorisationactivetime": null,
    "authorisationstoppedtime": null,
    "decisiontime": null,
    "decisionurl": "",
    "annexurl": "",
    "eparurl": "",
    "rapporteur": null,
    "corapporteur": null,
    "decisiondate": "2021-08-26",
    "brandname": "",
    "mah": "",
    "orphan": null,
    "prime": null
  }
]
